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 ABSTRACT 
 
Obesity is the most common nutritional disorder in the developed world and represents a 
major risk factor for associated diseases like type 2 diabetes mellitus, cardiovascular 
diseases and hypertension. The condition affects the whole body homeostasis but mainly 
the adipose tissue and is characterised by low grade inflammation, insulin resistance and 
hyperlipidemia. In adipocytes, it has been associated with endoplasmic reticulum stress 
(ER stress) induction and activation of the unfolded protein response (UPR).  
ER stress has been shown to play a central role in the molecular events leading to 
inflammation and insulin resistance in obese adipocytes, but the physiological triggers of 
ER stress are still unknown. The aim of my thesis was to investigate the role of obesity-
related factors such as high concentrations of saturated fatty acids, cholesterol, 
proinflammatory cytokines or tissue remodelling-induced hypoxia and glucose starvation 
in ER stress induction 
My results indicate for the first time that glucose starvation and hypoxia, two markers of 
adipose tissue remodelling in obesity, represent physiological triggers of ER stress in in 
vitro differentiated 3T3-F442A and 3T3-L1 adipocytes.  High concentrations of saturated 
fatty acid palmitic acid, cholesterol or proinflammatory cytokines (TNFα, IL-6 and IL-1β), 
although shown to be potent inducers in other cell lines, do not induce ER stress in my 
model of in vitro differentiated adipocytes. 
In conclusion, my results suggest that the adipose tissue remodelling process in obesity 
could play a central role in ER stress induction in adipocytes. 
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1.1. Obesity – a growing epidemic 
 
 
1.1.2. Definition and causes 
 
Obesity is the most common nutritional disease in the developed countries and though per 
se is not considered a life threatening disease, its association with morbidities such as type 
2 diabetes, cardiovascular diseases and cancer [1-3] have made it one of the world’s leading 
public health issues in the last decades. Defined as accumulation of excess body fat that leads 
to health impairment, obesity is a complex multifactorial disease that affects the whole body 
homeostasis and leads to profound pathological changes in general metabolism [4]. 
The onset and increased prevalence of the disease is caused by various factors including life 
style, medication, pre-existent diseases, genetic factors and alterations in the gut 
microbiome. The most prevalent though, is the sedentary life style characterised by reduced 
physical activity associated with high caloric intake [5]. Its major effects and role in the 
growing incidence of obesity are correlated with the increasing technological progress and 
quality of life in developed countries. The continuously growing urban communities and 
increase in population have facilitated the introduction and excessive usage of processed, 
high fat and sugar-containing foods that further affect the metabolic balance of the body. 
This results in an imbalance between the caloric intake and expenditure that is balanced by 
progressive storage of energy as lipid deposits in the adipose tissue. Due to the plasticity of 
the tissue, the imbalance does not rapidly affect the general metabolism but prolonged excess 
intake associated with minimal expenditure of the energy deposits will finally lead to 
overexertion of the adipose tissue and subsequent dysfunction. This is reflected also in the 
statistics showing correlation of increased obesity prevalence and high urbanisation rates 
and establishment of fast food restaurant chains [5]. This correlation have been described 
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also in in vivo studies on animal models, exposure of C57BL/6J mice [6] and rat models 
(Wirstar or DIO rat) to food high in fat and sucrose [6] or carbohydrates (eg “cafeteria food”) 
leads to similar increased adiposity, hyperinsulinemia and hyperglycaemia phenotypes as in 
humans [7]. These effects could be reversed by switching to normal chow-diet suggesting 
that the phenotype is strictly related to the diet used. 
Other factors that can lead to obesity are: emotional distress (stress, depression), age, 
pregnancy, reduced sleep and usage of medication that can induce adipose tissue 
development or hormonal imbalance (eg. corticosteroids, epilepsy drugs, antidepressants or 
schizophrenia medicines). Pre-existent diseases such as hypothyroidism that affects general 
metabolism [8], Cushing’s syndrome characterized by increased secretion of adipogenic 
hormone cortisol [9] and polycystic ovarian syndrome that induce high secretion of 
androgens [10] can also contribute to  the development of obesity. In the recent years a large 
number of studies have also suggested that a shift in the gut microbial population in obese 
individuals could play a causal role in development of obesity [11]. These observations have 
been confirmed by the results obtained in the investigation of microbial populations in obese 
ob/ob mice versus lean animals. A population shift towards microbial species with greater 
energy extraction capacity was observed in the obese animals possibly contributing to 
increased fatty acid absorption at cecum level [12]. Furthermore, transfer of gut microbiota 
or cecum contents from obese animals to lean or germ-free recipients showed an increased 
weight gain and adiposity in the recipients [13] while diet-induced obese animals with 
transplanted microbiota from lean animals showed a reversion of the obese phenotype [12]. 
This suggests that the gut microbiota may indeed represent a key factor in the development 
of the obese phenotype in mice.  
There are no clear evidences so far for the involvement of gut microbiota in obesity in 
humans but considering the important role of gut bacteria in fatty acids absorption, 
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regulation of intestinal permeability, gut-hormone production and inflammatory 
lipopolysaccharide (LPS) production, future studies may provide a better insight on the role 
of this possible inducing factor of obesity. 
Another important factor involved in the onset of the disease is the genetic predisposition, 
though the number of cases determined by it is reduced compared to the other factors. In 
humans, one of the most common genetic factors inducing obesity is the Prader-Willi 
syndrome, an autozomal dominant disorder resulting from deletions in paternal  
chromosomal segment 15q11-q13 or the deletion of the entire paternal chromosome 15 
leading to expression of only the maternal chromosomes [14]. The syndrome has multiple 
physiological, neurological and metabolic effects and causes morbid obesity in affected 
children [15]. Few other monogenic causes of obesity have been described, all mutated genes 
encoding for central proteins that are  part of the adipose tissue - hypothalamic leptin axis 
that controls food intake and satiety [16]. These monogenic diseases include mutations in 
the genes encoding for leptin [17], the leptin receptor [16] [18], prohormone convertase 1 
(PC1) [19], pro-opiomelanocortin (POMC) [20],  melanocortin-4 receptor (MC4-R) [21] and 
peroxizome proliferator-activated receptor γ 2 (PPARγ2) [16]. Except for MC4-R that 
presents dominant inheritance but no apparent insulin or hormonal imbalance, mutations in 
these genes cause rare and recessive forms of morbid obesity, associated with multiple 
endocrine abnormalities [19, 22, 23]. The identification of the genetic alterations involved 
in obesity onset allowed the development of new animal models of obesity that can be used 
for molecular and pharmacological research and lead to development of new strategies to 
minimize the pathological burden. These models, depending on the number of mutated genes 
have been categorised as: monogenetic or polygenic models of obesity and present 
phenotypic characteristics similar to the ones induced by genetic factors in humans. The 
monogenic models include: models of defective genes for molecules involved in leptin 
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signalling (POMC -/-, MC4-R -/- mice) [24], lethal yellow mutant (KK-Ay) mouse that 
presents an adipose tissue-specific agouti gene overexpression and an overgrowth of adipose 
tissue without alteration of food intake [25], defective leptin receptor rats (Zucker rat) [24] 
and the leptin deficient ob/ob [26] and db/db [7] mice that both present impaired leptin 
signalling, hyperphagia, reduced energy expenditure, increased adiposity on normal chow 
diet compared to control animals, hyperglycaemia (severe in db/db model) and increased 
insulin levels [24]. Although single mutations are very rare in humans, the monogenic 
models are providing a deep insight into the role of different molecules and molecular 
mechanisms involved in the pathological progress of the disease.  
Polygenic models include animal models obtained by selective breeding in order to present 
obesity phenotypes at different onset of the disease allowing investigation of the pathological 
process in different stages of animal development. This category is best represented by the 
obesity-prone (DIO) and diet-resistant (DR) rats that initially become obese only after feed 
on high-fat diet and that after selective breeding can become obese without the necessity of 
the high fat diet [27]. Other models are the New Zeeland obese (NZO) mouse that presents 
several genetic susceptibility loci including the leptin receptor and the age-related obesity 
mice (LOO) [24]. 
 
1.1.3. Prevalence 
 
During the last decades, a steep increase in the number of overweight and obese individuals 
was observed. An extensive study spanning 33 years (1980-2013) investigating the 
prevalence of overweight and obese (defined as body mass index, BMI > 25 kg/m2) 
individuals in the global population showed a worldwide increase of ~ 16 % in the adult 
population representing 8.1 % increase in men and 8.2 % increase in women and ~ 13 % 
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increase in children and young population with an 6.2 % increase in boys and 6.9 % increase 
in girls [28]. Whereas in the US the high prevalence of obesity (34.9 % or 78.6 million 
individuals in 2013 [29]) has been in the public attention for a long time and numerous efforts 
have been made to limit its expansion, in Europe the disease has become an increasing 
problem only in the last two decades [4]. The prevalence of obesity has followed similar 
trends with the increase in the US though the percentage of the population affected is 
significantly lower, with an average prevalence of obesity in total population in European 
countries of 21.3 % in 2014 [4] (Table 1). 
 
Table 1.1.  Prevalence of obesity in adults in developed European countries in 2010-2014.  
Prevalence is presented as percentage of total adult population, according to gender distribution. 
Country Prevalence (%) 
men (aged 18 +) 
Prevalence (%) 
women (aged 18 +) 
Prevalence (%) 
in both genders 
Year 2010 2014 %increase 2010 2014 %increase 2010 2014 
Germany 19.9 21.9 2 17.2 18.5 1.3 18.5 20.1 
France 21.8 23.8   2 22.3 24 1.7 22 23.9 
Spain 21.1 22.8 1.7 23.1 24.7 1.6 22.1 23.7 
UK 24.1 26.9 2.8 26.8 29.2 2.4 25.5 28.1 
According to the World Health Organisation (WHO) report for 2014  UK has the highest 
obesity prevalence in a European country, the number of obese individuals (both genders) 
amounting for 28.1 % of the total population [4]. The gender distribution indicated also the 
highest number of obese individuals for each gender than in any other European country 
investigated, with an increase in prevalence between 2012 and 2014 of 2.8 % in men and 2.4 
% in women (Table 1). The high prevalence presented in the WHO reports corresponds to 
the previous national reported data by the Health and Social Care Info Centre report for the 
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year 2013 [30] showing that 24.7 % of the population in the UK can be classified as obese 
and are in accordance (0.7 % vs 1.28 % in men and 0.6 % vs 0.7 % in women) with the 
relatively stable annual increase trend data described in the Health Survey for England (HSE) 
report for 2013 [31] (Table 2) 
 
Table 1.2. Gender distribution of obesity prelevance in adult population in the UK between 
1993 and 2013. Data presented according to Health Survey for England report for 2013. 
 
Prelevance (%) Year Average % 
increase/year 1993 2013 
Men (aged 18 +) 13.2 26 1.28 
Women (aged 18+) 16.4 23.8 0.74 
 
 
Globally, the most recent WHO reported data indicate that in 2014 more than 1.9 billion 
people aged over 18 years (39 % of world population) were overweight out of which more 
than 600 million were obese (13 % of world population). The extent of the disease in the 
world population, the continuous increase in prevalence and the medical and economic 
implications have made obesity one of the major health issues of the century. Although 
various local and global strategies have been developed in order to decrease or slow the 
extent of the problem, most of them are fighting the existing health complications of the 
disease but not its causes. Life style and diet changes have become urgent for disease control 
as the health and economic burden of obesity and associated complications are continuously 
increasing. 
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1.1.4. Health and economic implications 
 
Though obesity is not a life-threatening disease, through its associated morbidities, it can 
affect the quality of life and can be disabling or even affect life expectancy. In 2010 obesity 
was shown to be responsible for more than 3.4 million deaths [28] and a 4 % decrease of in 
life expectancy worldwide [17, 32]. 
Various studies have shown that obesity represents a major risk factor for various diseases, 
with the most important being type 2 diabetes [33-36], cardiovascular diseases [2, 35] and 
various types of cancer [1, 37]. According to WHO reports, 44 % of type 2 diabetes cases, 
23 % of ischemic heart condition and 7 – 41 % of different type of cancers could be attributed 
to overweight and obesity [4]. Renehan et al [37] showed that for every additional 5 kg/m² 
in BMI there is an increase of 52% in the risk for development of oesophageal cancer and 
24 % for development of colon cancer suggesting a central role for obesity in the 
pathological onset of these diseases. But the health burden of obesity is not only represented 
by the association with pathologies as cancer and diabetes. Numerous studies have revealed 
that obesity is also an important risk factor for depression, with an 55 % higher risk of 
development in obese subjects [38], Alzheimer’s disease [39] and obstructive sleep apnoea 
[40]. It was also associated with diseases like disabiliting osteoarthritis [41] and fertility 
reduction [42]. Therefore, obesity is associated with virtually every aspect of health, from 
the contribution to chronic conditions such as diabetes, cardiovascular diseases and cancer, 
to interfering with cognitive functions, breathing, mood stability and reproduction. Taking 
into consideration the continuing increase in the prevalence of the disease, its effects will 
affect more than half of the world population by 2050 [4] and will become the largest health 
burden globally. 
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In order to minimize the health burden associated with obesity, numerous approaches have 
been developed in recent years. Some of the strategies implemented worldwide for reducing 
the effects of obesity are increased obesity research, development of new drugs that block 
lipid absorption eg. Orlistat) and gastric surgeries (bariatric surgeries). But all these 
strategies along with health care expenses of the already existent morbidities have become a 
huge economic burden globally [4]. 
In the US, the area with the highest prevalence of obesity in the world, it was estimated that 
the annual cost of obesity for 2008 was $ 147 billion, with the cost for general health care 
being increased with $ 1.429 per obese individual compared to normal weight due to 
associated morbidities [29].  
In Europe, a McKinsey Global Institute report indicates that the health-care system uses for 
obesity up to 2-7 % of the total health-care budget in the developing countries to which up 
to 20 % of the cost of treatment for associated diseases is added [43]. In the UK, the European 
country with the highest prevalence of obesity, it was estimated that in 2007 the heath care 
cost for overweight and obese related morbidities amounted to £ 15.8 billion, with obesity 
alone representing £4.2 billion, approximately 6 % the NHS costs [44]. Considering the 
prediction in the increase in prevalence of obesity in the next years, the economic burden in 
UK alone will amount to £ 5.2 billion for health-care for obesity alone by 2025 and £ 7.1 
billion by 2050 [44]. 
Globally, the cost of obesity pandemic represents ~ $ 2.0 trillion (2.8 % of global GDP) [43] 
indicating the extension of the health and economic burden of the disease. 
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1.2. Cellular and molecular implications of adipose tissue in obesity 
 
 
Obesity is a disease defined as abnormal accumulation of fat that can affect the body 
homeostasis and can contribute to metabolic dysfunction. It is characterised by dysregulation 
in glucose and lipid metabolism as a result of excessive accumulation of fat due to sustained 
imbalance between the energy intake and energy expenditure. As the main organ involved 
in the fat storage, the adipose tissue dysfunction in obesity is one of the key pathological 
events leading to lipotoxicity, inflammation and insulin resistance. Due to its role, the study 
of the anatomy and physiology of the adipose tissue in normal and pathological states has 
become central in the study of obesity. 
 
 
1.2.1. Composition and function of adipose tissue 
 
In mammals, the adipose tissue is represented by a connective tissue organised in numerous 
depots distributed throughout the body and that together form the adipose organ [45]. The 
depots size and localisation are strictly related to the function served and can present distinct 
tissue composition [46]. According to the cell composition, anatomical and physiological 
functions, two different types of adipose tissue have been described: the brown adipose 
tissue and the white adipose tissue. The brown adipose tissue is specialised in 
thermoregulation and is widely extended in small mammals and human newborns [47] but 
relatively low represented in adults [48, 49]. The white adipose tissue is specialised in lipid 
storage and metabolism and forms the majority of the fat depots in adult life contributing to 
both physical protection (subcutaneous) and metabolic homeostasis of the near organs 
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(visceral) [46]. While both type of tissues present similar cell type composition, the cell type 
ratio, adipocyte cell phenotype and metabolic functions are very different. 
 
 
1.2.1.1. The brown adipose tissue (BAT) 
 
BAT is a tissue especially abundant in newborns and hibernating mammals [50] and is 
mainly involved in both basal and inducible energy expenditure in the form of non-shivering 
thermogenesis [47]. It is a highly vascularised tissue formed mainly of brown adipocytes, 
preadipocytes and vascular cells. The brown adipocyte presents two unique characteristics: 
an increased number of intracellular lipid droplets and numerous mitochondria which 
uniquely express uncoupling protein 1 (UCP1) essential for its thermogenesis function [45, 
51]. This mitochondrial inner membrane protein uncouples the rates of substrate oxidation 
and adenosine triphosphate (ATP) production by favouring a loss of protons in the 
intermembrane space and accumulation of protons in the matrix resulting in release of energy 
in the form of heat. The process is highly regulated by the sympathetic nervous system via 
secretion of norepinephrine and is dependent of the fatty acid deposits in the brown adipose 
cell that are used as substrate [47]. 
BAT distribution and abundance is highly related to its function in thermogenesis. In small 
mammals and hibernating animals, the BAT tissue is maintained throughout the adult life as 
a result of increased needs for thermoregulation in cold environments [52]. In humans, it is 
found primarily in foetuses and newborns [47] and decreases shortly after birth, remaining 
present only in small depots throughout adult life [49]. Its role in young organisms is 
essential due to reduced capacity of the newly formed body to protect itself against cold [53]. 
Increased differentiation of white adipose tissue (WAT) with age ensures the “insulating” 
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necessities of the body, and the role of BAT becomes almost non-existent in adults and 
related only to thermoregulation in case of long-term exposure to cold or hyperadrenergic 
stimulation in pheochromocytoma [54]. However, the reduced role of BAT in adult humans 
have become questionable when an increased number of studies [55-57] have identified that 
BAT deposits are maintained in adult in a higher number than previously believed suggesting 
that the role of BAT may not limited to thermoregulation. Studies on animal models have 
brought evidence on BAT involvement in the body energy expenditure and metabolic 
efficiency. In 1979, Rothwell et al [58] study using rats fed with different types of “cafeteria 
food”  showed that BAT could play an important role in improving the body general 
metabolic efficiency suggesting that diet-induced thermogenesis could represent a 
mechanism of defence against caloric overload, or survival in case of exposure to low 
nutritional diets. Lowell et al [59] brought more evidence that BAT is involved regulation 
of metabolic efficiency by showing that transgenic toxigene UCP-1-ablated mice that exhibit 
reduced BAT develop obesity in the absence of hyperphagia suggesting increased metabolic 
efficiency in BAT deficient mice. Their observations were further consolidated by 
observations that in the mouse model where the UCP1 expression was restored, the obese 
phenotype was lost. The role of BAT and UCP1 in obesity was further consolidated by the 
study of Feldman et al [60] that showed development of obesity in UCP1-ablated mice 
irrespective of the diet used compared to wild-type mice. Later observations investigating 
the role of BAT in metabolic efficiency and obesity in human adults showed, decreased BAT 
activity in obese individuals compared to lean  [61, 62] and an inverse correlation between 
BAT and BMI values [54] and increased energy expenditure in cold-induced BAT activity 
[57]. These observations have brought new perspectives in the fight against obesity and 
different approaches have been studied since. Increasing BAT mass or activity via low 
temperature, genetic or pharmacological compounds represent some of these approaches that 
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are continuously studied in present. Though progress has been made using low temperature 
exposure [63], chemical uncouplers that mimic the actions of UCP1 [64], epinephrine or 
adrenergic agonists [54, 65], none of these approaches yet has been successful. The 
discovery of beige adipocytes [52] that present mixed brown and white adipocyte phenotype 
represent also possible new strategies. The cells localised in the adult human WAT are 
considered induced non-classical induced brown cells (from a precursor that is not common 
for brown cells) or transdifferentiated white-to-brown cells [52, 66]. New research focused 
on fatty acid uptake and metabolism and glucose utilisation by BAT are considered possible 
strategies in tackling obesity but further understanding of the mechanisms involved is needed 
in order to develop optimal strategies. 
 
 
1.2.1.2. The white adipose tissue (WAT) 
 
WAT is the most common type of adipose tissue representing, in the healthy adult, 20-25 % 
of body weight. It is composed primarily of large unilocular adipocytes that represent more 
than 50% of the tissue cells and also preadipocytes, fibroblasts, stem cells, endothelial cells, 
vascular muscle cells, macrophages and other infiltrating immune cells. The tissue is 
supported by a dense network of capillaries and numerous sympathetic nerve fibres that 
accompany the arteries and arterioles [67]  (Figure 1.1) 
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Figure 1.1. White human adipose tissue composition, haematoxylin and eosin staining, 
40X (with permission from A. Pistorio, 
www.medicalhistology.us/wiki/Main/AdipocyteImages) 
 
The size of white adipocytes varies in relation to the lipid content of the cell, ranging from 
30-130 µm in diameter in normal conditions [46] and being considerably bigger than brown 
adipocytes (25-40 µm) [68]. Compared to the brown adipocyte, the white adipocyte presents 
a single lipid droplet that can fill almost all the cell volume while the number of mitochondria 
is reduced and the nucleus is pushed towards the periphery of the cell [69]. The plasma 
membrane presents numerous receptors for lipids (low density lipoprotein-related receptor 
1, LRP1, fatty acid translocase FAT/CD36, scavenger receptor class B1, SR-B1), hormones, 
cytokines and other signalling molecules involved in cellular homeostasis, lipid metabolism, 
glucose and insulin uptake [70]. 
There are various WAT depots distributed throughout the human body that according to 
their local function can present different protein expression profiles and responsiveness to 
endocrine stimuli. Three types of WAT depots have been described: the subcutaneous, the 
visceral and the dermal adipose tissue. The first two types have been extensively studied in 
the last decades and their origin, cellular composition and functions are largely known. The 
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dermal adipose tissue was initially considered subcutaneous WAT and has only recently 
been revealed to be a distinct type of adipose tissue generated from a common precursor 
with the mesodermal fibroblasts but different from one of subcutaneous adipocytes [71]. 
The dermal adipocytes were shown to form early in development, during embryonic day 
14 of development for mice [71] and second trimester of gestation for humans [72] and 
their function was linked to epidermal homeostasis during hair follicle regeneration and 
wound healing [71]. 
 The subcutaneous tissue forms an insulating and protection layer under the skin while the 
visceral tissue surrounds the inner organs contributing to local energy homeostasis. The 
differences between the two types of WAT vary from cellular composition and gene 
expression to metabolic responsiveness and hormonal regulation. The subcutaneous WAT, 
corresponding to its protection function, presents a higher preadipocytes to adipocytes 
differentiation rate [73], increased vascularisation and angiogenic capacity [74]. The 
adipocyte cells size is smaller than the visceral one [75] while the secretion of adipocyte 
specific factors adiponectin [76] and leptin [77] have also been shown to be increased 
compared to the visceral counterpart.  The visceral adipocyte cells, due to their role in 
maintaining the lipid homeostasis of neighbouring organs present a higher insulin 
sensitivity [78], lipolytic activity [75], fatty acids up-take [79] and lipid metabolism rate. 
Secretion of proinflammatory cytokines is also increased in the visceral adipocytes in 
response to cellular dysfunction and due to the tissue proximity to the major organs, 
represents one of the most important cause of the general inflammation and lipotoxicity in 
obesity [80].  
 
 
 
School of Biological and Biomedical Sciences Chapter 1 
 
35 
 
 
1.2.1.2.1 WAT functions 
There are three main functions of the tissue which influence whole body homeostasis: lipid 
storage and metabolism and the regulatory endocrine function [46]. 
 
A. Lipid storage and metabolism 
 
Fatty acids (FAs) are essential molecules for cell structure, function and signalling. They act 
as building blocks in the synthesis of membrane phospholipids [81],  energy source via β-
oxidation [82] and signalling messengers [83, 84]. Due to their important functions, it is 
essential that the blood concentration of FAs is maintained within the physiological range in 
order to assure the cellular homeostasis. Decreased FAs levels could be, as previously 
described, associated with impaired cellular homeostasis and signalling whereas excess 
concentrations can lead to lipid overload, cellular toxicity and general dysfunction [85, 86]. 
Although FAs can be synthesised in mammalian cells with the involvement of fatty acids 
synthase [87], a major source is represented by the dietary lipids (esterified long-chain FAs 
or triacylglycerols) [81] that are hydrolysed by the pancreatic lipase in the lumen of the small 
intestine and absorbed in the blood stream as free fatty acids [88]. Via blood circulation they 
are distributed to the cells in need and the excess is taken up by the adipocytes and stored 
for times of demand. As the central energy storage organ of the body, the main function of 
the adipose tissue is to maintain the circulatory FAs concentration optimal in both 
postprandial and fasting states [89]  In order to accomplish this function, the adipocytes have 
developed cell-specific mechanisms that allow them to uptake high amounts of FAs and 
glucose in time of energy excess and store them as triacylglycerol (TAG) in the lipid droplet. 
In fasting periods or increased energy requirements (exercise, thermoregulation) the 
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adipocytes release the stored FAs via hydrolysis of TAG (lipolysis) and restore the 
circulating concentrations needed [81]. These two metabolic processes of adipocytes are 
highly regulated and the balance between the two is responsible for the general homeostasis 
of lipids. Cellular dysfunction can cause imbalance between the two processes leading to 
release of a high amount of FAs in the blood stream and, via systemic circulation, contributes 
to general lipotoxicity [90]. 
 
Triacylglycerol biosynthesis 
The synthesis of triacylglycerol (TAG) was described more than 40 years ago by Weiss et 
al [91] and it is a complex metabolic process that involves multiple steps catalysed by 
specific enzymes. Regulation of the TAG biosynthesis involves numerous hormonal and 
nutritional factors including insulin, carbohydrates and fatty acids, along with transcription 
factors as sterol regulatory element-binding protein 1c (SREBP-1c), carbohydrate response 
element binding protein (ChREBP) and PPARγ [92]. 
The process takes place mostly at the endoplasmic reticulum though it has been suggested 
that mitochondrial enzymes could be also involved [93]. In short, after the FA cellular 
uptake, TAG biosynthesis involves five steps (Figure 1.2): 
 
1. Formation of FA-CoA by esterification of FA with coenzyme A (CoA) in the 
cytoplasm. The process involves hydrolysis of adenosine triphosphate (ATP) to 
adenosine monophosphate (AMP) and pyrophosphate (PPi ) and it is catalysed 
by the enzyme acetyl-CoA synthetase. 
FA + ATP → FA-AMP + PPi 
FA-AMP + Coenzyme A → FA-CoA + AMP 
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2. Acylation of glycerol-3-phosphate with fatty acyl-CoA and formation of 1-acyl-
glycerol-3-phosphate (lysophosphatidic acid). The reaction takes place at the ER 
or mitochondria and is catalysed by glycerol-3-phosphate acyltransferases 3 and 
4 (GPAT 3 and 4) [92]. 
3. Further acylation of lysophosphatidic acid resulting in formation of 1,2-
diacylglycerol-3-phosphate (phosphatidic acid). The reaction is catalysed by 1-
acylglycerol-3-phosphate acyltransferase (AGPAT) and takes place at the ER. 
At this step, the phosphatidic acid can be shunted into the synthesis of various 
phospholipids or into the synthesis of TAG, the two separate branches of 
glycerolipid synthesis. 
4. Dephosphorylation of phosphatidic acid to the intermediate 1,2-diacylglycerol 
by the phosphatidic acid phosphohydrolases (PAPs)  [94]. 
5. Acylation of 1,2-diacylglycerol to triacylglycerol (TAG) is catalysed by acyl-
CoA: diacylglycerol acyltransferases 1 and 2 (DGAT 1 and 2) [95]. 
 
Figure 1.2. Biosynthesis of triacylglycerol in adipocytes (modified after Yen et al [96])  
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According to the nature of the dietary FAs uptaken from the circulation and substrate 
affinities of the enzymes involved in TAG biosynthesis, the process is more often including 
an additional step of desaturation of the FAs in the acyl-CoA thiolesters. It was observed 
that GPAT enzymes 3 and 4 exhibits marked specificity for saturated acyl-CoA thiolesters, 
AGPAT for mono- and dienoic fatty acyl-CoA thioesters [97] and DGAT 1 and 2 for 
unsaturated substrates [98], suggesting that the mono- and polyunsaturated fatty acids are 
preferred substrates in TAG biosynthesis. As the major part of the dietary FAs in processed 
food are represented by saturated long chain fatty acids, e.g. palmitic and stearic acid, the 
FAs desaturation have become a very important step in the TAG synthesis. The reaction is 
catalysed by stearoyl-CoA desaturase 1 (SCD1), an endoplasmic reticulum-resident Δ9 
desaturase and involves insertion of a cis double bond in the Δ-9 position of the FA. The 
enzyme can use different chain length fatty acids from C12:0 to C19:0 but has higher affinity 
for substrates such as palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0) that are converted 
to palmitoleoyl-CoA (C16:1) and oleoyl-CoA (C18:1), respectively [99]. These products are 
the most abundant monounsaturated FAs (MUFAs) and serve as substrates for the synthesis 
of various kinds of lipids, including phospholipids, TAG, cholesteryl esters and wax esters  
[100]. 
The important role of the desaturation step in TAG biosynthesis is indicated by up-regulation 
of SCD1 mRNA during adipocyte differentiation [101] and up-regulation of mRNA levels 
and protein activity in animals subjected to high saturated fat diets [102]. As desaturation 
represents a rate-limiting step in TAG biosynthesis and it is strictly regulated by the dietary 
FAs, expression and the activity of SCD1 have been investigated in the context of FA 
overloading of obese adipocytes. The onset of obesity have been shown to correlate with 
increased SCD1 expression and activity [103, 104]. Via desaturation of dietary saturated 
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fatty acids SCD1 increases the intracellular levels of MUFAs. Taking into consideration that 
MUFAs can be used as substrate for TAG synthesis, this process allows storage of the 
increased circulating FAs in the lipid droplet and protects the adipocytes against 
accumulation of toxic intracellular fatty acids in obesity [105, 106]. Also, by increasing the 
intracellular MUFAs, the enzyme indirectly contributes to increased biosynthesis of 
phospholipids that maintain the membrane structure integrity and fluidity during adipocyte 
hypertrophy as a result of lipid overload in obesity [107]. All these evidences indicate a 
protective role for SCD1 against adipocyte FAs overload-induced cellular stress. Other 
studies though, indicated that SCD1 deficiency protects against obesity. Ntambi et al [108] 
have shown that scd1-/- mice present generally reduced body adiposity in both chow and high 
fat diet and increased insulin sensitivity compared to the wild-type counterpart. The 
increased insulin sensitivity observed may be related to reduced adiposity and reduced levels 
of leptin in the plasma. Also, in scd1-/- mice hepatic expression of genes encoding for 
enzymes involved in lipid oxidation is up-regulated whereas lipid synthesis genes SREBP-
1, FAS and GPAT are down-regulated, suggesting that lipid oxidation is activated by scd1 
deficiency and to the oxidative pathway will be favoured to TAG synthesis and storage [108, 
109]. Similar evidences have shown that scd1 deficiency reduces ceramide synthesis in 
skeletal muscle of ob/ob mice [110]. In cultured 3T3-L1 adipocytes, Kim et al [111] also 
show that chemical inhibition of SCD1 decreases expression of lipogenic genes without 
altering the genes for enzymes involved in lipid oxidation suggesting a potential beneficial 
effect against cellular lipid accumulation in response to high lipid intake. But, according to 
the SCD1 described role in desaturation [100, 112], deficiency of scd1 in adipocytes should 
lead to accumulation of intracellular cytotoxic fatty acids and decreased TAG synthesis 
[104] and thus reduced postprandial circulating FA clearance resulting in possible systemic 
lipotoxicity. Considering its various effects SCD1 remain under investigation as a possible 
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candidate in tackling obesity but further research is needed to better understand the tissular 
and systemic effects of SCD1 modulation. 
 
TAG lipolysis 
During periods of energy demand, TAG stored in the adipocytes lipid droplets can be rapidly 
mobilised by the hydrolytic action of lipases and released as free FAs into the circulation in 
order to adjust the energy requirements of the organism [113]. By the hydrolysis, in the 
lipolytic process, one molecule of glycerol and three molecules of FAs are produced from 
one molecule of TAG. The resulting FAs can be either released into the circulation to be 
taken up by other tissues or used for re-esterification in adipocytes to produce TAG [114].  
For many years, hormone-sensitive lipase (HSL) has been considered to be the regulatory 
enzyme of the lipolytic process and the only one involved in the three successive hydrolysis 
reactions (Figure 1.3). HSL activity is regulated by hormones such as catecholamine and 
insulin that are under nutritional regulation [115, 116]. Catecholamine hormones induce 
HSL via activation of protein kinase A (PKA) due to increase intracellular concentrations of 
cyclic AMP (cAMP).  PKA activation of HSL can be either directly via serine 
phosphorylation of the protein [117], or indirect via phosphorylation of the lipid droplet-
associated protein perilipin A [118]. In contrast, insulin inhibits HSL phosphorylation by 
inducing hydrolysis of cAMP [119, 120] 
Recent work though has revealed existence of a novel adipocyte triglyceride lipase. HSL-
deficient mice fed a high-fat diet have been found to exhibit normal body weight and 
decreased fat mass, but their white adipose tissue still retained ~ 40 % of TAG lipase activity 
compared with wild type mice [121]. Detailed analysis identified a novel TAG lipase as 
lipid-droplet associated adipose triglyceride lipase (ATGL or desnutrin) [115] in mice and 
calcium-independent phospholipase A2 (iPLA2) ζ in humans [122]. In vitro experiments 
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indicated that desnutrin expression is up-regulated during adipocyte differentiation [123] 
while in mice ablation of ATGL increased adipose tissue mass and caused lipid deposition 
in other tissues [124]. ATGL activity is regulated by glucocorticoids and insulin, being 
induced by glucocorticoids during fasting [123] and down-regulated by re-feeding and 
insulin [125].  
Therefore, in the current proposed model of the lipolytic cascade, lipolysis is catalysed by at 
least three enzymes: ATGL, HSL and monoacylglycerol lipase, which is abundant and not 
regulated. The hydrolysis steps in lipolysis and regulation are (Figure 1.3.): 
 
1. TAG hydrolysis to 1,2-diacylglycerol and FA catalysed by adipose triglyceride 
lipase (ATGL) and hormone sensitive lipase (HSL). 
2. Hydrolysis of 1,2-diacylglycerol to 2-monoacylglycerol and FA catalysed by 
HSL. 
3. Hydrolysis of 2-monoacylglycerol to glycerol and FA catalysed by HSL and 
monoacylglycerol lipase. 
 
In obesity, decreased lipolysis leading to TAG and cholesteryl esters accumulation induces 
cellular lipotoxicity and dysfunction and has been associated with decreased HSL expression 
and catecholamine-induced lipolysis in adipocytes [116]. 
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            Figure 1.3. Lipolysis in adipocytes 
 
B. Adipose tissue - an endocrine organ  
 
For many decades it was believed that the adipose tissue represents only a passive energy 
storage organ. It was only in the last 30 years that adipose tissue was identified as a major 
site for secretion of a large variety of bioactive factors such as leptin [126] , adiponectin 
[127], adipsin [128] and pro- and anti-inflammatory cytokines [129]. These adipocyte factors 
that can act both locally (autocrine/paracrine) and systemic (endocrine) coordinating 
regulate multiple processes including energy metabolism, neuro-endocrine and immune 
functions. 
The importance of the endocrine function of adipose tissue became evident with the 
pathologies associated with its dysfunction. Obesity characterised by hypertrophy and 
hyperplasia of adipose tissue is associated with profound both local and systemic effects 
including dyslipidemia, insulin resistance, inflammation, hyperglycaemia and hypertension 
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[129]. Adipose tissue deficiency has also been associated with dyslipidemia, insulin 
resistance and other features of metabolic syndrome in both humans and animals [130]. 
The complexity of the endocrine function is reflected by the various adipokines secreted and 
their multiple roles in general homeostasis (Table 1.3). 
Biological effect Protein 
Metabolic regulators Adiponectin 
Leptin 
Resistin 
Visfatin 
Pressure regulators Angiotensinogen 
Coagulation regulators Plasminogen activator 1 (PAI 1) 
Mediators of inflammation Tumor necrosis factor α (TNF α) 
Interleukin 6 (IL-6) 
Interleukin 1 β (IL-1β) 
Macrophage migration inhibitory 
factor 1 (MIF 1) 
Growth factors Transforming growth factor β (TGF 
β) 
Angiogenesis factors Vascular endothelial growth factor 
(VEGF) 
Proteins of the alternative 
complement pathway 
Adipsin 
 
Table 1.3. Adipokines produced and secreted by the white adipose tissue 
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Taking into consideration the increased variety of factors secreted by adipocytes, I have 
focused on the two major hormones, leptin and adiponectin whose function and imbalance 
is highly related to the pathological process in obesity. 
 
Leptin  
Leptin was identified by Zhang et al [26] in 1994 as the product of the obese gene (ob) in 
ob/ob mice. It is a 16 kDa polypeptide containing 167 amino acids [125] secreted by 
adipocytes in response to the nutritional status and that presents with differences in secretion 
between the two type of WAT (increased secretion in subcutaneous  compared to visceral 
depots) [131]. Leptin expression and protein secretion is regulated by a variety of factors 
including insulin [132], glucocorticoids, TNFα and estrogens [129]  that positively correlates 
with both mRNA induction and protein levels, while β3-adrenergic stimulation [133], and  
FA [134], decrease its expression. 
The main function of leptin is regulation of general energy homeostasis as a rate limiting 
factor between the energy intake and expenditure. Leptin action on the neurons localised in 
the hypothalamic arcuate nucleus regulates hunger and satiety in accordance to the energy 
stores [135]. Studies on  ob/ob mice have brought evidence of the role of leptin in food intake 
regulation. The  leptin-deficient animals were shown to exhibit hyperphagia, obesity and 
insulin resistance and administration of leptin reversed their conditions [126]. The 
administration of leptin to lipoatrophic mice (which lack subcutaneous adipose tissue and 
thus have low levels of leptin) was also shown to improve metabolic abnormalities, including 
insulin resistance and hyperlipidemia [136]. Thus, leptin levels are correlated with both 
nutritional intake and the adipose tissue mass, the hormone levels being maintained 
decreased in case of caloric restriction [137] and increase in case of increased food intake or 
School of Biological and Biomedical Sciences Chapter 1 
 
45 
 
high caloric diet [138].  In obesity though, the increased adipose tissue mass is associated 
with increased leptin levels indicating that the leptin-hypothalamic signalling axis is affected 
by the condition [126]. This suggests a possible leptin resistance state in obesity and though 
the mechanisms are still largely unknown, it is believed that it may result from defects in 
leptin signalling or transport across the blood-brain barrier [139]. 
In addition to this important energy regulator function, leptin modulates neuroendocrine 
functions involved in reproduction and regulates other processes such as angiogenesis, 
immune response, blood pressure control and osteogenesis [129]. In ob/ob mice leptin 
deficiency is associated with activation of the hypothalamic-pituitary-adrenal (HPA) axis 
and suppression of the hypothalamic-pituitary-thyroid and -gonadal axes that leads to 
hypogonadism and reduced to absent fertility [140]. Leptin is also involved in immune 
system regulation by increases cytokine production, macrophage adhesion and phagocytosis, 
and proliferation of T cells [135, 141]. Leptin also promotes angiogenesis, and accelerates 
wound healing [142]. 
 
Adiponectin 
The protein adiponectin was first described in 1995 [129] and represents the most abundant 
adipose tissue-secreted hormone into the blood stream [135]. It is an adipocyte-specific 
protein highly induced during differentiation process [143] and that similar to leptin is 
expressed more in subcutaneous WAT then the visceral depot [131]. Structurally, the 30 
KDa protein containing a collagen-like domain and a C-terminal globular domain is exposed 
to   posttranslational modification (hydroxylation and glycosylation) resulting in formation 
of multiple isoforms that assemble through collagen-like domain interactions into trimers 
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and further stable multimeric oligomers [144]. All these forms along with proteolytic 
cleavage products containing the globular domain can be found in the circulation [145] 
Roles for adiponectin have been identified mostly from evidence related to obesity and 
metabolic disorders. Plasma levels of adiponectin have been shown to decline at the onset 
of obesity and are maintained low throughout the development of insulin resistance [146] 
while improvement of insulin sensitivity restore the secretion [147] suggesting involvement 
of the protein in insulin sensitivity and possible effects of adipose tissue expansion on its 
expression. Studies using adiponectin-deficient mice show that absence of the hormone is 
correlated with premature diet-induced glucose intolerance, insulin resistance and increased 
serum non-esterified FAs supporting the previous hypothesised role of adiponectin [148]. 
Along with the role in insulin sensitivity and glucose homeostasis adiponectin is also an 
important anti-atherosclerotic factor by stimulating angiogenesis and endothelial 
vasodilatation while inhibiting proinflammatory cytokine secretion and monocytes adhesion 
on the endothelial layer [135].    
 
 
1.2.2. Adipose tissue pathology in obesity  
 
The pathological onset of obesity, when non-genetic, is caused by a chronic imbalance 
between the energy intake in form of nutrients and energy expenditure. As the major energy 
storage organ, the adipose tissue is the primarily affected tissue by the pathological effects 
of this imbalance. Increasing energy intake leads to adipocytes increase in size (hypertrophy) 
and number (hyperplasia) and is associated with structural and metabolic alterations [149]. 
Due to the rapid progression of cellular alterations, the cells begin to display markers of 
cellular dysfunction, especially mitochondrial and endoplasmic reticulum stress [150]. 
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Altered glucose transport and metabolism, insulin resistance and inflammation become 
evident in the lipid-burdened dysfunctional adipocyte and contribute, via the endocrine 
function of the cell, to tissue inflammation, remodelling and lipotoxicity.  
Though the molecular mechanisms leading to adipose tissue dysfunction in obesity and their 
role in the pathological progress are still not fully understood, the adipose tissue remodelling, 
inflammation, cellular stress adipocyte insulin resistance and glucose metabolism 
impairment have been described to be the main factors affecting the progress and extent of 
the disease [149, 151-153]. 
 
Adipose tissue remodelling  
Adipose tissue remodelling is a continuous and often discrete process that reflects the tissue 
capacity to rapidly and dynamically respond to variations in nutrient intake. It is influenced 
by the high plasticity of the adipocytes and turnover of the different adipose tissue cells, and 
plays a very important role in the normal development of the body and metabolic 
homeostasis [149, 154]. Adipose tissue remodelling, though an adaptative ongoing process 
throughout the life, it is pathologically accelerated in obesity and associated with adipocyte 
dysfunction, increased macrophage infiltration and reduced angiogenic remodelling [149]. 
In obesity, adipocyte hypertrophy, hyperplasia and subsequent dysfunction represent the 
starting point of the pathological process affecting the homeostasis of this tissue. Overloaded 
adipocytes exhibit mitochondrial and endoplasmic reticulum (ER) stress [150] that activate 
proinflammatory pathways and lead to secretion of inflammatory cytokines (TNFα, IL-6, 
IL-1β) [70, 155] and chemotactic proteins (MIF). Accumulation of reactive oxygen species 
(ROS) as a result of increased metabolic processes contributes to the inflammatory status of 
the cell and secretion of proinflammatory adipokines. This proinflammatory adipokine 
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secretion initiates macrophage recruitment and infiltration in the adipose tissue and the 
inflammatory status of the tissue [156, 157]. 
 
Macrophage infiltration 
In obesity, an increase in macrophage population of the adipose tissue has been described, 
leading from 10 % in lean mice and humans to 50 % in obese, leptin-deficient mice and 40 
% in obese humans [152]. This increase in macrophage recruitment was shown to be 
multifactorial and positively correlated with the adipose tissue mass and insulin resistance 
[152]. It is a process highly induced and regulated by adipose tissue remodelling via multiple 
effects that are closely connected with adipocyte dysfunction: adipokine-induced 
chemotaxis, apoptosis, low vascular supply and dysregulation of fatty acid fluxes [158]. 
Though most of the adipose tissue cells secrete proinflammatory cytokines, macrophage 
infiltration is the major factor involved in the inflammatory status of the obese adipose tissue, 
being considered the second major event in obesity progression and the major determinant 
of the adipose tissue low grade inflammation specific to the obesity pathology [154, 159].  
Adipocyte dysfunction is associated with activation of proinflammatory signalling pathways 
and secretion of proinflammatory cytokines (TNFα, IL-6, IL-1β) and chemokines (MIF and 
MCP-1) [153, 160]. Kanda et al [160] have shown that  MCP-1 expression and secretion in 
adipocytes plays an important role in the  inflammatory  process. Using genetically modified 
mouse models that present either loss or gain of MCP-1 expression, they have shown that 
adipose tissue induced expression of MCP-1 transgene was sufficient to induce macrophage 
infiltration and insulin resistance in mice. Furthermore, they have shown that following 
disruption of the MCP- gene these effects were reverted suggesting that MCP-1 is directly 
involved in macrophage recruitment and inflammation in the adipose tissue. Adipocyte 
apoptosis or necrosis resulting from lipid overload was also associated with macrophage 
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recruitment into the adipose tissue. Cinti et al [161] have shown that in advanced obesity 
macrophages surround the necrotic adipocytes in crown-like structures, fuse to phagocytose 
the residual lipid droplet and form a large lipid-laden multinucleated syncytia specific for 
tissular chronic inflammation. These observations are supported also by evidence of 
increased macrophage recruitment in the adipose tissue in transgenic models of lipoatrophy 
[162] or adipocyte inducible apoptosis [163]. 
Another important aspect of macrophage infiltration is the phenotypic switch of 
macrophages from a “alternative activated” phenotype (M 2) that secretes anti-inflammatory 
cytokines such as IL-10, to a “classically activated” phenotype (M 1) which secretes 
proinflammatory cytokines such as IL-1, IL-6, TNF α and MCP-1 [164]. Though both types 
of macrophages are normally resident in the tissue, the M 1/M 2 ratio is very small in normal 
conditions, with the M 2 population being predominant. This is due to the different functions 
of the two types of macrophages: the M 2 macrophages are involved in general adipose tissue 
remodelling and secrete anti-inflammatory and angiogenic factors [165] while M 1 have a 
predominantly inflammatory function, secreting high levels of proinflammatory cytokine, 
ROS and NO [164]. In high fat diet and obesity, the M 1/M 2 ratio has been shown to switch 
towards the M 1 population [154]. Due to the proinflammatory phenotype of M 1 this switch 
in polarisation is correlated with systemic inflammation and insulin resistance [164, 166]. 
These observations are sustained by evidence showing that deletion of M 1 marker genes 
such as TNF α [167] or C-C motif chemokine receptor 2 (CCR 2) [168] resulted in 
normalisation of insulin sensitivity. Exercise training in mice with high fat-induced obesity 
[169] and gastric surgery in humans [170] have been also shown to promote the M 1 to M 2 
shift, consolidating the evidence showing the role of adipose tissue expansion and insulin 
resistance in obesity and the macrophage polarisation. 
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Increased fatty acids released from dysfunctional adipocytes also contribute to macrophage 
infiltration. Accumulation of intracellular FAs can act as ligands for the tool-like receptor 4 
(TLR4) in the plasma membrane of macrophages and activate the classical inflammatory 
response leading to proinflammatory cytokine secretion and signalling for macrophage 
recruitment [171-173].  
 
Vascular remodelling in obesity 
Most of the organs in the healthy human body stop growing in adult life and thus the vascular 
network remains quiescent after the body reaches maturity [174]. The adipose tissue, due to 
its plasticity and dynamics under different nutritional conditions, retains the capacity of 
blood vessel formation (angiogenesis) throughout the entire life [149]. The angiogenic 
capacity is essential for the tissue in assuring the necessary nutrient and O2 supply, hormonal 
regulation, molecular signalling and general homeostasis. Thus, it can be affirmed that 
angiogenesis represents a rate-limiting factor of adipose tissue expansion [175]. Though 
during tissue remodelling in development, adipogenesis and angiogenesis are temporally and 
spatially coupled [176], in obesity ,during the tissue rapid expansion the angiogenic process 
seems to be slower than the rate of adipose remodelling [177]. Blood flow studies in obese 
vs lean rats showed that the blood supply remained similar in both lean and obese animals 
independent of the size of the adipose tissue[177]. This suggests that the blood flow per 
adipocyte declines with obesity leading to possible nutrient and O2 deficits. Both 
preadipocytes and adipocytes are known to secrete pro-angiogenic factors such as basic 
fibroblast growth factor (bFGF) and vascular endothelial growth factors (VEGF) [149]. 
These factors are induced by various stimuli, with leptin and adiponectin levels being some 
of the most important in adipose tissue remodelling [178]. In obesity, angiogenesis induction 
is multifactorial. Claffey et al [179] showed that VEGFA mRNA and protein are expressed 
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in a differentiation-dependent manner in 3T3-F442A adipocytes suggesting that increased 
differentiation of preadipocytes in obesity could indirectly lead to angiogenesis induction. 
Furthermore, the rapid overexpansion of the adipose tissue can lead to low blood supply in 
distal adipocyte clusters, exposing the cells to hypoxia and nutrient starvation[180, 181]. 
HIF-1α is an oxygen-sensing transcription factor induced by hypoxia and the key regulator 
of oxygen homeostasis in the cell [182]. In normoxic conditions HIF-1α is hydroxylated by 
prolylhydrolase enzymes in the presence of oxygen and subjected to degradation. In hypoxia, 
due to inactivation of the hydrolase enzymes, An increase in HIF-1α protein expression in 
adipocytes is increased and was shown to induce VEGFA mRNA contributing to the 
angiogenic signalling [183]. In addition, VEGFA expression has been shown to be induced 
by various proinflammatory cytokines such as TNF α, IL-1β, and IL-6 [184] secreted by 
both dysfunctional adipocytes and infiltrating macrophages. 
 
Adipose tissue inflammation in obesity 
Accumulating evidence show that chronic inflammation plays a crucial role in the 
pathogenesis of obesity-related insulin resistance [157, 185] and metabolic dysfunction 
[151] and it is one of the first responses of the adipose tissue to adipocyte lipid overloading. 
The first evidence of inflammation in obese adipose tissue was brought by Hotamisligil et 
al [186] who showed increased expression and production of TNF α in adipose tissue of 
obese mice compared with lean controls. Since then increasing number of studies confirmed 
the up-regulation of genes encoding inflammatory factors and increased secretion of 
cytokines and chemokines in the enlarged adipocyte [70, 155]. It is considered that adipocyte 
lipid overloading represents the first step in the inflammatory drift in obesity [70, 187]. 
Increased metabolic burden of the cell leads to cellular stress and subsequent activation of 
proinflammatory pathways that induce synthesis and secretion of proinflammatory cytokines 
School of Biological and Biomedical Sciences Chapter 1 
 
52 
 
(TNF α, IL-6, IL-1β) and chemokines (MCP-1 and MIF). Accumulation of proinflammatory 
cytokines and chemokines in the intracellular space and the capillary blood flow leads to 
recruitment of macrophages in the affected tissue. The process is augmented also by 
increased adipocyte apoptosis in the tissue as result of progressive cellular stress and 
dysfunction [161]. Macrophage infiltration and polarisation from the adaptative M 2 type to 
the proinflammatory M 1 type is increasing the local inflammatory status via increased 
secretion of proinflammatory molecules such as TNF α, IL-1β, IL-6, IL-12, and MCP-1. 
This increased inflammatory state recruits not only macrophages but also other immune cells 
as mast cells and natural killer T (NKT) cells [188] that contribute to the progress of 
inflammation via further secretion of proinflammatory factors. 
 
Molecular aspects of the inflammation in adipocytes 
At the molecular level, inflammation in adipocytes is mediated via two major pro-
inflammatory signalling pathways: nuclear factor κB (NFκB) and c-jun N-terminal kinase 
(JNK). Though in obesity both signalling pathways are activated by similar triggers, the 
downstream effects can vary. If NFκB activation leads mostly to proinflammatory cytokine 
secretion and can be involved in apoptosis induction, JNK activation is also a central player 
in insulin resistance induction in overloaded adipocytes. 
The NFκB pathway is one of the most important intracellular signalling pathways involved 
in the regulation of inflammation In mammals, NFkB represents a group of structurally 
related and evolutionarily conserved proteins with five members in mammals: Rel (c-Rel), 
RelA (p65), Rel B, NFkB1 and NFkB2 involved in key cellular responses that modulates the 
outcome of cells exposed to stress stimulation [189]. In normal physiological state, NF-κB 
(p65/p50 heterodimer) is maintained inactive in the cytoplasm by inhibitory subunit IκB. In 
the presence of inflammatory stimuli IκB is phosphorylated by the IκB kinase (IKK) 
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complex and subsequently degradated allowing NFκB to translocate  to the nucleus and 
induce transcription of numerous inflammatory genes such cytokines, immunoreceptors and 
adhesion molecules [190]. In mammalian cells, according to the activation pattern, there are 
two described NFκB pathways: the canonical (classical) pathway and the non-canonical 
(alternative) pathway [191]. Both pathways involve the IKK dependent phosphorylation of 
IκBα and translocation of the NFκB dimmers to the nucleus, the difference between the two 
pathways consisting of the catalytic IKK kinase that activates the pathway. The canonical 
pathway is the most commonly activated NFκB pathway and is depending on the activity of 
IKKβ and NEMO kinases of the IKK complex leading mainly to phosphorylation of IκBα 
and nuclear translocation of mostly p65-containing heterodimers [190]. This pathway is 
activated by ligands binding to cytokines receptors, antigen receptors and pattern-
recognition receptors and Toll-like receptor 4 (TLR 4) [190]. The non-canonical pathway is 
responsible for activation of p100/RelB complexes by the IKKα subunits of the IKK 
complex, partial processing and generation of p52-RelB complexes [190]. The non-
canonical pathway activation is involved in development of lymphoid organs and induced 
by specific members of the TNF cytokine family, such as CD40 ligand, lymphotoxin B and 
B cell activating factor (BAFF) and lymphotoxin-β [189]. 
JNK kinases family represents a group of mitogen-activated kinases (MAPKs) activated by 
a variety of exogenous stimuli such growth factors deprivation, FAs or TNFα treatments and 
UV irradiation and plays an important role in regulation of the inflammatory status of the 
cell. Initially identified as kinases that phosphorylate c-Jun at Ser-63 and Ser-73 [192], the 
group was shown to be able to bind as homo- and heterodimeric complexes to the 
transcription factor activating protein 1 (AP-1) [190] [193].  
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The JNK protein kinases are encoded by three genes: Jnk1, Jnk2 and Jnk 3, with Jnk1 and 
Jnk2 ubiquitously expressed and Jnk3 with an expression pattern limited to brain, heart and 
testis [194]. The transcripts derived from all three genes are subjected to two series of 
alternative splicing. The first alternative splicing can remove the C-terminal domain leading 
to formation of different size isoforms with unknown functional significance leads to 
isoforms. The second one is restricted to the Jnk1 and Jnk2 genes and involves the selection 
of one of two alternative exons that encodes part of the kinase domain and influences the 
substrate specificity of the JNK isoforms to bind to substrates [194]. Via activation of the 
AP-1 complex, JNK signalling is involved in regulation of important cellular processes 
including inflammation, proliferation and apoptosis [195]. 
Both canonical NFκB and JNK pathway activation have been described in the adipose tissue 
of obese animals in response to various obesity-related triggers such as increased levels of 
FAs, cytokines and nutrient and energy starvation. The pathways can also be induced by 
cellular stress components such as ROS and are mainly involved in the initiation and 
expansion of inflammation [151, 196, 197].  
FAs have been described to be one of the most important factors contributing to adipocyte 
dysfunction in obesity. High concentrations of FAs have been shown to activate the 
proinflammatory pathways in two ways: a direct one involving TLR4 downstream signalling 
and an indirect one via induction of cellular stress and subsequent activation of the 
inflammatory NFκB and JNK. 
The direct pathway including activation of  TLR 4 was recently described after numerous 
observations indicating expression of the receptor on the adipocyte membrane [198] and 
activation of the receptor by FA binding, though normally the receptor  is an innate immune 
system receptor activated by LPS binding [171, 173, 199]. The signalling cascade activated 
by FA binding to TLR 4 includes recruitment of the adaptor protein myeloid differentiation 
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factor 88 (MyD88) to the Toll/IL-1 receptor (TIR) domain of the receptor and activation of 
downstream signalling cascade leading to proinflammatory pathways activation [200] 
(Figure 4). 
 
Figure 1.4.  Fatty acids-induced direct activation of JNK and NFκB pathways in adipocytes 
(modified after Akira et al [201])  
 
 Numerous studies have shown alsoa possible involvement of TLR 2 in direct induction of 
inflammatory pathways by FAs but the role of TLR 2 is still not clear. Similar to TLR 4, 
TLR2 has been identified on the membrane of adipocytes [199] and is known to be activated 
primarily by cytokines but also by FAs and other lipid molecules [202]. TLR 2 expression 
was shown to be increased in WAT and muscle of diet-induced obese mice inhibition of 
TLR 2 was associated with decreased inflammation and improved insulin signalling [203]. 
Also, it was reported that activated TLR 2 interacts with the CD 36 transporter of FAs [204] 
and TLR2 knockdown has been associated with reduced adiposity [205] supporting its 
possible role in FA’s activation of proinflammatory pathways. There is no direct evidence 
though for its involvement in the FA-induced inflammation in adipocytes it’s activation of 
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proinflammatory pathways being more related to the binding of inflammatory cytokines, 
especially TNF α [199]. 
Indirect activation of the proinflammatory pathways by FAs is mediated by lipid 
accumulation, metabolic burden and cellular stress induction (mitochondrial and 
endoplasmic reticulum stress) [206-208]. Accumulation of DAG and ceramide in obese 
adipocytes was shown to induce NFκB and JNK pathways via PKC θ activation [209]. 
Increased concentrations of FA have been shown to induce oxidative stress via NADPH 
oxidase activation [208] and accumulation of oxygen species (ROS) leads to activation of 
proinflammatory signalling pathways.. Increased catabolism in the mitochondria of 
hypertrophic adipocytes leads also to oxidative stress and production of free radicals [210] 
while metabolic induced ER stress represents also a source of  ROS induction via PDI 
activity[211]. Thus, ER stress induction  contributes to inflammatory state via the PERK- 
eIF2α- Iκβ pathway [212] or IRE1- TRAF2 -IKK [213] for NFκB and IRE1α- TRAF2- JNK 
pathway [214] described in detail in the subchapter dedicated to ER (section 1.2.2.1) 
 
Figure 1.5.  Indirect FAs-induced activation of JNK and NFκB pathways in obese adipocytes 
(modified after Gao et al  [209]) 
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Another important factor involved in activation of the proinflammatory pathways is the 
accumulation of inflammatory cytokines in the adipose tissue and their autocrine and 
paracrine actions. Macrophage infiltration and activation in the adipose tissue leads to 
increased proinflammatory cytokine secretion including TNF α, IL-6 and IL-1β. Similar 
cytokines are secreted also by the dysfunctional adipocytes as a response to both metabolic 
inflammation and the macrophage cytokine action. The inflammatory response becomes a 
vicious cycle: the cells secrete proinflammatory cytokines as a result of the inflammatory 
signalling and the secreted molecules trigger an inflammatory response in both a paracrine 
and autocrine way. Thus, the initial inflammation becomes a self-sustaining and expanding 
process involving both the adipocytes as the macrophages and other immune cells in the 
tissue. The inflammatory response in adipocytes induced by the increased levels of cytokines 
is mediated mostly via the TNF α receptor 1 (TNFR 1), TLR 2 and TLR 4. TNFR activation 
and downstream induction of NFκB and JNK pathways is mediated via TNF receptor-
associated factor 2 (TRAF 2)/cIAP protein complex, the cIAP proteins being mediators of 
the anti-apoptotic TNF α signalling [215] (Figure 6). 
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Figure 1.6. TNFα inductions of JNK and NFκB via TNF receptor (modified after Faustman et 
al [216]) 
 
 
The interleukin 1 receptor 1 (IL-1R1) involvement in inflammation in adipocytes is still 
under debate as numerous studies have revealed increased expression and secretion of 
interleukin-1 receptor agonist (IL-1Ra) in the adipose tissue of obese individuals [217]. The 
IL-1Ra is a member of IL-1 family that binds to IL-1 receptor without inducing a cellular 
response and thus having antagonizing effect with IL-1α and IL-1β [218] 
Hypoxia was shown also to contribute to the activation of the two inflammatory signalling 
pathways. Culver et al [219] have demonstrated that hypoxia activates NFκB via 
calcium/calmodulin-dependent kinase 2 (CaMK2)- TAK1- IKK pathway while Koong and 
collaborators [220] shown that activation can also be mediated by phosphorylation at a 
tyrosine residue on IκBα but through an IKK-independent mechanism. Activation of ER 
stress in hypoxic conditions is another mechanism of hypoxia for inflammatory pathways 
induction as previously described in this subchapter. 
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1.2.2.1. Endoplasmic reticulum stress in obesity 
 
The endoplasmic reticulum (ER) is a cytoplasmic membranous network of branching tubules 
and flattened sacs that is present in all eukaryotic cells. It is the principal site of lipid and 
protein biosynthesis and together with the Golgi apparatus it facilitates the transport and 
release of correctly folded proteins to their proper target sites [221]. It also represents the 
cellular Ca2+ storage organ and key organelle involved in detoxification of xenobiotics. 
Nascent polypeptides translated by the ribosomes are directed to the ER luminal space for 
proper folding. Within the ER lumen chaperone proteins as binding protein 1 (BiP or 
GRP78), calnexin and calreticulin assist the proper folding of nascent proteins and prevent 
the aggregation of unfolded or misfolded proteins [150]. The correctly folded proteins are 
then transported to the Golgi apparatus for final modification and then to their cellular 
destination. Unfolded or misfolded proteins are retained in the ER and then retrotranslocated 
to the cytosol by the machinery of ER-associated degradation (ERAD) and degraded by the 
proteasome [222]. 
In physiological states when the cellular demand for protein synthesis exceeds the capacity 
of the folding apparatus of the ER and the ERAD machinery, unfolded or misfolded proteins 
accumulate in the ER lumen leading to a condition referred to as ER stress. To prevent such 
accumulation of unfolded proteins and to ensure a high fidelity in protein folding, eukaryotic 
cells have evolved a self-defence mechanism - the unfolded protein response (UPR) [221-
223]. 
The UPR consists of five adaptative mechanisms that work together to ensure the return of 
the ER to its normal physiological state: (1) attenuation of protein synthesis which prevents 
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any further accumulation of unfolded proteins; (2) up-regulation of ER chaperone gene 
expression to increase the folding capacity and (3) increased phospholipid synthesis to 
expand the ER; (4) transcriptional induction of genes encoding the ERAD component to 
increase the rate of unfolded protein degradation and (5) induction of apoptosis to safely 
dispose of cells injured by ER stress and to ensure the survival of the organism [222]. 
In mammalian cells the UPR signalling cascades are initiated by three ER transmembrane 
protein sensors: PERK (double-stranded RNA-dependent protein kinase (PKR)-like ER 
kinase), IRE1 (inositol requiring 1) and ATF6 (activating transcription factor 6) (Figure 1.7). 
 
 
Figure 1.7. The UPR response pathways (modified after Schroeder et al [224]) 
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PERK 
 
PERK is an ER type I transmembrane protein serine/threonine protein kinase that has a 
luminal domain which acts as a sensor for unfolded proteins, a transmembrane domain 
enclosed in the ER membrane and a cytosolic domain that transmits signals to downstream 
effectors [224]. In an inactive state the luminal domain of the protein is associated with the 
ER chaperone BiP [225](reference). BiP release due to the accumulation of unfolded 
proteins leads to activation through oligomerisation and autophosphorylation [225]. Once 
activated, PERK phosphorylates substrate proteins such as eIF2α (eukaryotic initiation 
factor 2 α) and the transcription factor Nrf2 [nuclear factor (erythroid-derived 2)like-2] [150, 
222, 226]. eIF2α is the α subunit of the heterotrimeric eukaryotic translation initiation factor 
eIF2. Phosphorylation of eIF2α at serine 51 leads to general attenuation of translation which 
represents the first step in preventing further protein loading of the ER [227] and induces 
clearance of short-lived proteins. Interestingly, the phosphorylation of eIF2α up-regulates 
the ATF4 transcription factor through preferential mRNA translation [222, 228]. This escape 
from translational attenuation is due to a mechanism referred to as reinitiation after a short 
upstream open reading frame (uORF) and is based on the existence of one or more short 
uORFs in the 5’-UTR region of the mRNA. In normal conditions when eIF2α is active 
(unphosphorylated) the ribosome first binds to a 5’-cap structure, slides on the ATF4 mRNA 
in 5’ to 3’ direction and starts translation at the first small ORFs. After reaching the stop 
codon the ribosome detaches from the RNA before the ATF4 ORF can be translated. This 
process is repeated at each following uORF. By contrast, in ER stress when eIF2α is 
inactivated (phosphorylated), the translation rarely starts at the small uORFs. The ribosome 
scans further through the mRNA and through the last uORF resulting in initiation of 
translation at the ATF4 ORF (Figure 1.8) [222, 228-230]. 
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Figure 1.8. Escape mechanism of ATF4 mRNA from translational repression mediated by 
eIF2α phosphorylation (modified after Yoshida et al [222]) 
 
 
Translation of ATF4 is an important step in deciding cell fate as a result of endoplasmic 
reticulum stress. This is reflected by the main target genes of ATF4. Once translated, ATF4 
translocates to the nucleus and induces expression of genes such as ERO1 (ER oxidation 1) 
involved in disulphide bond formation in the protein folding process, CHOP (C/EBP 
homologous protein) involved in apoptosis, and GADD34 (growth arrest and DNA damage-
inducible protein) that limits the inhibitory effect of PERK activation on eIF2α [224] ATF4 
is also required for expression of genes involved in amino acid transport, glutathione 
biosynthesis and resistance to oxidative stress [226]. 
Beside eIF2α, PERK also phosphorylates Nrf2, a transcription factor that acts as a crucial 
regulator of cellular redox homeostasis through its capacity to induce expression of enzymes 
such glutathione S-transferase, NAD(P)H:quinine oxidoreductase and γ-glutamylcysteine 
synthetase which contributes to clearance of oxygen reactive species [223, 229]. 
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IRE1 
 
IRE1, the second sensor in the ER membrane, is a serine/threonine protein kinase 
endoribonuclease that, similarly to PERK, consists of an ER luminal domain, a 
transmembrane domain and two cytosolic domains: a kinase domain and a endoribonuclease 
domain [229, 231]. The protein is highly conserved in all eukaryotes and in mammals is 
present in two copies: IRE1α and IRE1β. IRE1α is a ubiquitous protein. Deletion of IRE1α 
results in an embryonic lethal phenotype in mice [232]. IRE1β expression is limited to the 
epithelial cells of the gastrointestinal tract. Knock-out of IRE1β induces a viable but 
susceptible to colitis phenotype in mice [233]. 
The inactive state of IRE1 is also maintained by binding of BiP to the luminal domain. 
Release of BiP protein in ER stress leads to IRE1 homooligomerization. Close contacts 
between two cytosolic domains result in trans-autophosphorylation and activation of the 
ribonuclease domain [231]. The activated IRE1α ribonuclease domain cleaves the 
constitutively transcribed XBP1 (X box protein 1) pre-mRNA into mature mRNA by un 
unconventional splicing mechanism [222]. XBP1 mRNA has two conserved overlapping 
ORFs. On activation of the UPR, IRE1α removes a 26 nucleotide intron from unspliced 
XBP1 mRNA, which leads to a translational frame shift and produces a fusion protein 
encoded from the two ORFs. The new carboxyl-terminus of the product from spliced XBP1 
mRNA (XBP1s) converts XBP1u (the product from the unspliced mRNA) into a potent active 
transcription factor [229] (Figure 1.9) 
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Figure 1.9. XBP1 mRNA splicing (modified after Lee et al. 2008) 
 
The XBP1s transcription factor then translocates into the nucleus and activates the 
transcription of ERAD component genes such as EDEM (endoplasmic reticulum 
degradation enhancing α-mannoside-like protein), HRD1 (HMG-CoA reductase degradation 
protein) and genes for ER chaperones such BiP and PDI-P5 involved in the quality control 
of protein folding in the ER. Thus, IRE1α promotes adaptation via XBP1s [222]. 
Another important aspect of atypical splicing of XBP1 is the cellular compartment where the 
mRNA is processed. Conventional splicing takes place in the nucleus whereas XBP1 splicing 
takes place in the cytoplasm [234]. The biological significance of cytoplasmic splicing is 
that pre-mRNA used for translation in the cytoplasm can be spliced when it is necessary to 
change the nature of the protein translated from the mRNA in response to extracellular or 
intracellular signalling. This is not the case of nuclear splicing were cleaved mRNA once 
exported cannot be modified again so another pre-mRNA must be de novo transcribed and 
spliced. Recently it was shown that XBP1u encoded in XBP1 pre-mRNA is a negative 
feedback regulator of XBP1s [234]. Thus, in the case of XBP1, pre-mRNA and mature 
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mRNA encode negative and positive regulators, and their expression is switched by 
cytoplasmic splicing in response to the situation in the ER [222] [233]. 
In mammals, besides the role in XBP1 mRNA processing, IRE1α has additional functions in 
cell signalling. Recent evidence suggests that the activated kinase domain of IRE1α binds to 
the adaptor protein TNFR-associated factor 2 (TRAF 2) triggering activation of the apoptosis 
signal-regulating kinase 1 (ASK1) and c-Jun-N terminal kinase (JNK) pathway [232]. IRE1α 
is also involved in modulation of “alarm genes” such p38 MAPK [235] and NFκB pathway 
[213] possibly by binding of the non-catalytic region of a tyrosine kinase adaptor protein 
(Nck) and the protein complex IKK/TRAF2. Thus, IRE1α is involved in both protection via 
adaptation through XBP1 splicing, and cellular injury via JNK, p38 MAPK and NFκB 
activation processes triggered by endoplasmic reticulum stress. 
 
 
ATF6 
 
ATF6, the third ER membrane stress sensor, is a type II transmembrane protein containing 
an ER luminal domain responsible for sensing unfolded proteins and two cytosolic domains: 
a DNA-binding domain containing a basic-leucine zipper (bZIP) motif and a transcriptional 
activation domain [222]. 
In mammals, there are two homologous proteins, ATF6α and β. Both are expressed 
ubiquitously and with similar functions [236]. In the absence of ER stress, the ATF6 luminal 
domain is bound to the BiP chaperone that inhibits translocation of ATF6 to the Golgi 
apparatus. Accumulation of unfolded proteins in the ER lumen leads to dissociation of BiP 
from the complex and translocation of ATF6 to the Golgi apparatus [226]. Here ATF6 is 
sequentially cleaved by two proteases: site 1 protease (S1P) that cleaves in the luminal 
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domain and the metalloprotease site 2 protease (S2P) that cleaves the N-terminal membrane-
anchored fragment of ATF 6 [224, 226]. This proteolytic activation process takes place in 
the membrane of the Golgi apparatus and is called regulated intramembrane proteolysis 
(RIP). The same mechanism is responsible also for cleavage of sterol response element-
binding proteins (SREBPs) which are activated when cholesterol is depleted [237]. SREBPs 
act as regulators of sterol biosynthesis. In the case of ATF6 cleavage, the proteolytic 
reactions release the cytosolic N-terminal region encoding the bZIP transcription factor. 
Once translocated to the nucleus, this active transcription factor binds to a cis-acting element, 
the ER stress response element (ERSE) and together with nuclear factor Y (NF-Y) induces 
the transcription of ER chaperone genes such BiP, GRP/94 and calreticulin [221, 222, 229]. 
Nevertheless, if the unfolded protein burden exceeds the ER capacity to adapt, ATF6 
cleavage can induce activation of ER-associated degradation process (ERAD) proteins and 
also of pro-apoptotic CHOP [221]. 
  
 
ER stress and inflammation 
 
Increasing number of studies suggest that the signalling pathways in the UPR and 
inflammation are connected through various mechanisms including production of ROS, 
release of Ca2+ from the ER, activation of the proinflammatory NFκB and JNK signalling 
pathways and induction of an acute-phase response [221]. Prolonged activation of the UPR 
could lead to accumulation of ROS as a result of UPR-stimulated up-regulation of chaperone 
proteins involved in disulfide bond formation in the ER lumen [150]. The enzyme 
responsible for this process is ER oxidoreductin 1 (ERO1) [229] protein that perform redox 
reactions using molecular oxygen as the final electron acceptor [150]. Accumulation of ROS 
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during ER stress can become toxic and initiate an inflammatory response. In order to limit 
this possible ROS toxicity the cells have evolved an antioxidant response involving Nrf2 
activation regulated by the PERK signalling pathway. This adaptative mechanism allows the 
cell to reduce the increasing toxic ROS and prevent a further toxic burden on the cell. In 
progressive chronic induction of ER stress ROS accumulation can exceed the buffering 
induced by Nrf2 and result in activation of the proinflammatory NFκB pathway, a key 
regulator in the onset of inflammation [221]. There are a few proposed mechanisms for ER 
stress-associated NFκB activation. The first one is related to ROS accumulation as a result 
of excessive protein folding and involves the ER enzymes responsible for disulphide bond 
formation and ERO1 that use molecular oxygen as a terminal electron acceptor in their redox 
reactions [238]. Additional oxidative stress can also result from the depletion of reduced 
glutathione consumed in reactions that reduce unstable and improperly formed disulphide 
bonds. Therefore, an increase in the protein-folding load in the ER can lead to accumulation 
of ROS and initiate an inflammatory response. 
The second proposed mechanism is activation of NFκB as a result of ER stress-mediated 
leakage of calcium into the cytosol [239]. Pahl et al [240] showed that ER overload leads to 
increased efflux of Ca2+ into the cytosol and subsequent generation of intermediate reactive 
oxygen species (ROI). Experiments showed that NFκB induction by ER stress is prevented 
by pre-incubation of cells with intracellular Ca2+ chelators and antioxidants suggesting that 
both these signals are required for NFκB activation in response to ER stress [240] 
The third mechanism proposed is that UPR response per se can directly promote NFκB 
activation through PERK-induced eIF2α phosphorylation. Unlike canonical signalling 
pathways that promote IκB phosphorylation and degradation, eIF2α phosphorylation is not 
affecting the phosphorylation status of IκB but, due to general attenuation of translation 
induce proteasomal degradation of the kinase whose half-life is relative short and release of 
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the proinflammatory NFκB complex [241]. This effect has been observed in cells treated 
with ER stress-inducing reagents and in UV-irradiated cells, both of which activate the 
PERK pathway. Also recent studies found that ER stress-mediated NFκB activation is 
attenuated both in perk-/- and cells bearing two mutant allele of EIF2A in which serine 51 
(the substrate of the stress-inducible kinases) has been mutated to an alanine suggesting an 
important regulatory role of eIF2α phosphorylation in NFκB activation under stress 
conditions [242]. 
The last mechanism proposed for NFκB activation in response to ER stress involves the 
IRE1α signalling pathway. ER stress-induced trans-autophosphorylation of IRE1α  was 
proposed to induce conformational changes in the cytosolic domain of the protein that allows 
the binding of the adaptor protein TRAF2 [232]. The IRE1α-TRAF2 complex recruits IκB 
kinase (IKK) that phosphorylates IκB leading to proteasomal degradation of the inhibitory 
IκB subunit α and NFκB translocation to the nucleus [213]. Though described here, the 
mechanism is still not fully understood and needs further investigation. A similar mechanism 
was proposed also for JNK activation. Activation of JNK in response to ER stress is mediated 
also by formation of IRE1-TRAF2 complex, as shown in studies using truncated TRAF2 in 
the N-terminal RING effector domain that leads to inhibition of JNK activation in response 
to ER stress signals and by experimental evidence that showed that JNK activation in 
response to ER-stress is impaired in mouse embryonic fibroblasts that lack IRE1α [232]. 
Recently it has been indicated that the UPR response can also induce inflammation by up-
regulation of an acute-phase response through an ER-resident transcription factor CREBH 
in the liver [243]. CREBH is an ATF6 homologous protein expressed in hepatocytes and 
highly induced by inflammatory cytokines. In ER stress, CREBH is activated by 
translocation to the Golgi complex where it is cleaved by S1P and S2P. An N-terminal 
fragment of CREBH is released into the cytosol and translocates to the nucleus inducing 
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transcription of acute phase genes such serum amyloid P component (SAP) and C-reactive 
protein (CRP) [232, 243]. 
 
 
ER stress induced inflammation and insulin resistance in obesity 
 
In the last decade an increased number of studies suggest a positive association between ER 
stress, inflammation and insulin resistance in obesity, mainly through UPR-induced 
activation of pro-inflammatory signalling pathways such JNK and NFκB [221]. In response 
to metabolic dysfunction, IRE1α activation as result of ER stress leads to conformational 
changes in the cytosolic domain that allows recruitment of adaptor protein TRAF 2 and 
activates inflammatory MAP kinases JNK and IKK. IKK activation induces IκB 
phosphorylation and degradation, leading to NFκB translocation to the nucleus and 
transcriptional activation of proinflammatory genes [213]. JNK activation on the other side 
induces serine phosphorylation of insulin receptor-1 substrate (IRS-1) inhibiting 
phosphorylation of tyrosine residues and functional activation of the receptor [244]. Also, 
activation of JNK leads to phosphorylation of activator protein-1 (AP-1) and transcription 
of proinflammatory genes. This mechanism is supported by data showing that tissue specific 
deletion of JNK1 in adipose tissue decreased IL-6 expression in adipose tissue and improved 
hepatic insulin sensitivity in mice fed a high fat diet [245]. These observations suggest that 
IRE1α could be the link between ER stress and JNK activation leading to increased cellular 
inflammation and insulin resistance. Consistent with this model is also the observation that 
mice lacking one allele of XBP1 (xbp1+/- mice) display increased activation of PERK, IRE1α, 
JNK and dysregulated phosphorylation of IRS-1 when fed a high-fat diet [221]. In addition, 
activation of PERK and IRE1α could lead to NFκB activation via IκB phosphorylation and 
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attenuation of general translation, leading to increased transcription of proinflammatory 
genes. Similar activation was found in the case of hepatocytes [246, 247], cardiomyoblasts, 
pancreatic β-cells [248, 249], macrophages and 3T3 L1 preadipocytes [221, 250] incubated 
with free fatty acids or cholesterol. Although the mechanisms by which the FAs are inducing 
ER stress are still unknown, there is an increased amount of data suggesting that high levels 
of saturated fatty acids (SFA) induce activation of the UPR and subsequently activation of 
proinflammatory pathways including NFκB and JNK. This activation leads to insulin 
resistance either via direct inhibition of insulin receptor Tyr phosphorylation through the 
IRE1-TRAF2-JNK pathway [251] or to increased expression of proinflammatory cytokines 
through the PERK- eIF2α-IκB-NFκB pathway [34, 224]. Attenuation of FA-induced ER 
stress by chemical chaperones effectively reduced FA-induced expression of 
proinflammatory cytokines and improved insulin signalling which was accompanied by 
reduced IKKβ and JNK phosphorylation [206]. Also activation of the UPR in response to 
FAs increases the expression of the ER chaperone BiP and by its interaction with Akt, 
decreases phosphorylation of Ser-473 and general Akt phosphorylation leading to impaired 
insulin signaling [252]. By inhibition of general translation ER stress decrease the total level 
of Akt leading to subsequent decreased insulin signalling [253]. 
Recent evidence shows also that inflammatory cytokines produced by hypertrophic 
adipocytes or macrophages recruited into inflamed adipose tissue [254], can itself elicit ER 
stress in L929 cells and hepatocytes [243, 255] suggesting that UPR activation triggers a 
self-sustaining vicious inflammatory cycle in adipose tissue leading to peripheral insulin re-
sistance, adverse effects on the cardiovascular system and type II diabetes. Several studies 
have documented a role of proinflammatory cytokines such as TNFα, IL-6 and IL-1β in 
insulin resistance in both rodents and human subjects [213, 256-260]. TNFα exposure has 
been shown to induce insulin resistance by both inactivation of the insulin receptor as a 
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consequence of increase Ser 307 phosphorylation of IRS-1 through JNK activation [261, 
262] and down-regulation of IRS-1 and GLUT 4 gene expression and decrease GLUT 4 
mRNA stability [263, 264]. IL-6 on the other hand have been reported to modulate the 
insulin signaling pathway in tissue specific manner: it transiently activate SOCS-3 and 
induces a reduction in IRS-1 phosphorylation and PI3K activation in hepatocytes [265] and 
reduced expression of IRS-1, GLUT4 genes decreasing insulin-stimulating transport of 
glucose in adipocytes. 
 
Although in the last years considerable progress has been made towards understanding the 
molecular events that underlie the pathological onset and progress of obesity, many 
mechanisms involved remain still unknown. The adipose tissue and mainly the adipocyte 
dysfunction have been shown to play a central role in the development of the condition 
leading to lipotoxicity, inflammation and insulin resistance. Though increasing data have 
shown involvement of various mechanisms in the cellular dysfunction, little is known about 
the factors that trigger the dysfunction. 
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1.3. Aims and objectives 
 
 
In the last years, multiple pieces of evidence have shown that ER stress induction in the 
adipose tissue [266] and mainly in the adipocytes from obese subjects (or mice) [267, 268] 
mediates part of the inflammatory response and insulin resistance in dysfunctional cells, 
contributing to the pathological onset and progression of obesity. Although the molecular 
events that ER stress coordinates have been extensively studied, the physiological triggers 
of this ER stress are still unknown. In order to answer this question, the aim of my thesis 
was to investigate whether physiological alterations in obesity, such as elevated plasma fatty 
acids, cholesterol levels, inflammation and adipose tissue remodelling can induce ER stress 
in adipocytes.  
 
Therefore, the objectives of this thesis can be summarised as follows: 
 
 To characterise whether high concentrations of saturated fatty acids commonly found 
in obese individuals are inducing ER stress in obesity (Chapter 4). Recent evidence 
have showed that exposure to high concentrations of fatty acids, especially palmitate, 
leads to development of ER stress in different cell lines such as preadipocytes [221, 
250], β-pancreatic cells [248, 249], and hepatocytes [246, 247]  
 
 To investigate if hypercholesterolemia, another hallmark of obesity and a major risk 
factor for development of cardiovascular and metabolic diseases [269] is able to 
induce UPR in adipocytes (Chapter 5). High cholesterol concentrations were shown 
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to induce ER stress in macrophages [270] and smooth muscle cells [271] but there 
are no studies investigating the effect on adipocytes. 
 
 To investigate if increased levels of proinflammatory cytokines as TNF α, IL-6 and 
IL-1β can induce ER stress in adipocytes (Chapter 6). These cytokines  commonly 
found in the blood of obese patients are the most abundant cytokines in the 
dysfunctional adipose tissue and have been shown to induce UPR in hepatocytes 
[255] and β-cells [272-274].  
 
 To study if glucose starvation can represent a trigger for ER stress in adipocytes 
(Chapter 7). Adipose tissue remodelling has been shown to play a central role in 
obesity dysfunction due to formation of low vascularised areas as result of rapid 
overexpansion. The low nutrient intake have been associated with cellular 
dysfunction and especially ER stress in cancer cells [275] and β-pancreatic cells 
[276] but few data are known about the effect on adipocytes. 
 
 To investigate if hypoxia can induce UPR in adipocytes (Chapter 8).            Adipose 
tissue remodelling and low vascularisation affect not only the nutrient supply of the 
adipocyte but also the O2 intake. Hypoxia has been previously shown to induce 
inflammation [277, 278] and insulin resistance [279, 280] in adipocytes But the 
mechanisms underlying these effects are still not fully understood.  
 
The summary of my thesis aim and objectives are represented in the flow chart below 
(Figure 1.10) 
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Figure 1.10. The flow chart of the pathological progress of obesity in the 
adipose tissue with proposed stages of ER stress induction in response obesity-
related factors investigated in the study
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2.1. Materials 
 
2.1.1. General chemicals 
 
Table 2.1. Chemicals. 
Chemical Company and catalogue number (cat. 
no.) 
3-Isobutyl-l-methylxanthine (IBMX) Sigma-Aldrich, # I5879 
37% (w/v) formaldehyde Fisher Scientific, #P/0840/53 
Agarose (electrophoresis grade) Bioline, BIO-41025 
Acetic acid (HOAc) Fisher Scientific, A/0360/PB17 
Bovine serum albumin Sigma-Aldrich, # A2153 
Bovine serum albumin, fatty acid free Sigma-Aldrich, # A3803 
β-Mercaptoethanol Sigma-Aldrich, M6250 
Bromophenol blue Sigma-Aldrich, #11439 
Complete mini protease inhibitors Roche, #11836 153 001 
Coomassie Brilliant Blue R Sigma-Aldrich, # B0149 
Diethyl pyrocarbonate (DEPC) Acros Organics, # A0300574 
Dexamethasone Sigma-Aldrich, # D4902 
Dimethyl sulphoxide Sigma-Aldrich, #D5879 
Ethylenediamine tetraacetic acid  
(EDTA) 
Fisher Scientific, # D/0700/53 
Ethanol Fisher Scientific, # E/0650DF/25 
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Ethidium Bromide (10 mg/ml) Sigma-Aldrich, # E1510 
Glycerol Fisher Scientific, # G/0650/17 
Glycine Fisher Scientific,# BP381-1 
Hydrochloric acid Fisher Scientific, # H/1100/PB17 
Insulin from bovine pancreas Sigma-Aldrich, # I0516 
Interleukin 1β Thermo Fisher, # RIL1B1 
Interleukin 6 Life Technologies, # PHC0066 
Methanol Fisher Scientific, # M/4000/PC17 
Native human acetylated LDL AbD Serotec, # 5685-3404 
Nile red Sigma-Aldrich, # N3013 
Nonidet-P40 Fluka, #74385 
Oil red O Sigma-Aldrich, # O0625 
Palmitic acid Sigma-Aldrich, # P5585 
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich, # P1585 
Propanol Fisher Scientific, # P/7490/17 
Potassium chloride  Fisher Scientific, # P/4240/53  
Potassium dehydrogenate phosphate  Fisher Scientific, # 7778-77-0  
Ponceau S Sigma-Aldrich, #P3504 
Sodium chloride Fisher Scientific, # S/3120/65 
Sodium deoxycholate Sigma-Aldrich, # D6750 
Sodium dodecyl sulphate (SDS) Fisher Scientific, # BPE116-500 
Sodium hydroxide Fisher Scientific, # S/4920/53 
Thapsigargin Sigma-Aldrich, # T9033 
Thiazolyl blue tetrazolium bromide (MTT) Sigma- Aldrich, # M5655 
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N-[4-(2-chlorophenyl)-6,7-dimethyl-3-
quinolinyl]-N'-(2,4-difluorophenyl)-urea (TMP-
153) 
Enzo Life Sciences, # BML-EI317-0020 
TNF α (human) Cell Signaling Technology, # 8902 
Tris (hydroxymethyl) methylamine (Tris) Fisher Scientific, # T/3710/60 
Triton X-100 Sigma-Aldrich, # 282103 
Tunicamycin Merck Millipore, Calbiochem, # 645380 
Tween®20 Sigma-Aldrich, # P1379 
 
 
2.1.2. Tissue culture reagents 
 
All reagents used for cell culture were sterile-filtered and only opened under sterile conditions in 
a microbiological safety cabinet. For prepared solutions, filter sterilisation was carried out using 
a 0.2 µm sterile filter and syringe. 
Table 2.2. List of reagents used in tissue culture work. 
Name Company and catalogue number (cat. no.) 
0.25% Trypsin-EDTA solution Sigma-Aldrich, # T4049 
DMEM high glucose, with phenol red Sigma-Aldrich, # D5671  
DMEM high glucose, w/o phenol red ThermoFisher, # 31053-028  
DMEM w/o glucose, with phenol red Thermo Fisher, # 11966025 
DMEM high glucose, w/o L-glutamine w/o 
sodium pyruvate 
Biosera, # LM-D1112/500 
Dulbecco's phosphate buffered saline Biosera, # LM-S2041-1000 D857 
Fetal bovine serum Biosera, # S1830 
School of Biological and Biomedical Sciences Chapter 2 
 
79 
 
Fetal calf serum Biosera, CA-115 
L-Glutamine Biosera, # G7513 
Penicillin-streptomycin, solution (10,000 U 
penicillin and 10 mg streptomycin/ml)  
Sigma-Aldrich, # P4333 
RPMI 1640 Sigma-Aldrich, #R0883 
Trypan blue solution (0.4% w/v) Sigma-Aldrich, # T8154 
 
 
2.1.3. Enzymes and antibodies 
 
Table 2.3.1.  List of enzymes used in the study. 
Enzyme Company, catalogue number (cat. no.) 
GoTaq® DNA polymerase Promega, # M3001 
GoTaq® hot start polymerase Promega, # M5001 
Superscript® III reverse transcriptase Life Technologies, # 56575 
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Table 2.3.2.  List of antibodies used in the study. 
Primary antibody Dilution  Company, catalogue number 
(cat. no.) 
Anti-AKT 1:1000  Cell Signaling, # 4691 
Anti-β-actin 1:20000  Sigma-Aldrich, # A2228 
Anti-BiP 1:1000  Abcam, # ab-53068 
Anti-CHOP 1:1000  Cell Signaling, # 2895 
Anti-eIF2α 1:1000  Santa Cruz Biotechnology, # sc-
11386 
Anti-GAPDH 1:30000  Sigma-Aldrich, # G8795 
Anti-HIF 1α 1:500  R&D Systems, # AF1935 
Anti-JNK 1:1000  Cell Signaling, # 9252 
Anti-phospho-eIF2α 1:1000  Santa Cruz Biotechnology, # sc-
11386 
Anti-phospho S473-AKT 1:1000  Cell Signaling, # 4060 
Anti-phospho-JNK 1:1000  Cell Signaling, # 4668 
Secondary antibodies Dilution  Company, catalogue number 
(cat. no.) 
Goat anti-rabbit-IgG (H+L)-
horseradish peroxidase (HRP)-
conjugated secondary 
1: 20000  Cell Signaling, # 7074S 
Goat anti mouse IgG (H+L)-
HRP-conjugated antibody 
1: 20000  Thermo Fisher Scientific, # 31432 
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2.1.4. Commercially available kits 
 
Table 2.4. List of commercially available kits used in the study. 
Name Company and catalogue 
number (cat. no.) 
AmershamTM ECLTM Western blotting 
detection reagents 
GE Healthcare,  # RPN2009 
CriterionTM TGXTMprecast gels 4-20% BioRad, # 567-1094/95 
DCTM protein assay kit I BioRad, # 500-0111 
EZ-RNA kit Geneflow, # K1-0120 
geNorm 6 reference genes (mouse) PrimerDesign, # ge-SY-6 
Pierce® ECL plus Western blotting 
substrate 
ThermoScientific, # 32132 
Precision 2 x real-time PCR MasterMix 
with SYBR green 
PrimerDesign, Precision 
Precision FAST 2xreal-time PCR 
MasterMix with SYBR Green 
PrimerDesign, Precision-R 
RestoreTM Western Blot stripping buffer Thermo Scientific, # 21059 
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2.1.5. Oligodeoxynucleotides 
 
The oligodeoxynucleotides used in the study were synthesized by Sigma (liquid, 100 µM in 
water) or by Eurogentec Ltd (lyophilised). Lyophilised primers were resuspended in sterile 
water to a final concentration of 100 μM. All primers were stored at -20ºC. The 
oligonucleotides used in this study are listed in Table 2.5. 
Table 2.5. Oligonucleotides sequences. 
Name Purpose Sequence Annealing 
temperature
* (ºC) 
Oligonucleotides for Mus musculus genes  
H8477 
 
GPAT3 PCR and RT-qPCR, 
forward primer 
AGCCATTGTGGAGGATGAAG 
 
60 
H8478 GPAT3 PCR and RT-qPCR, 
reverse primer 
GGAAGCAATAGCGCACTAGG 
 
60 
H8677 
 
DGAT1 PCR and RT-qPCR, 
forward primer 
TCATGGAAGAAGGCTGAGGT 60 
H8678 DGAT1 PCR and RT-qPCR, 
reverse primer 
TCATGGAAGAAGGCTGAGGT 
 
60 
H8873 
 
PCYT1 PCR and RT-qPCR, 
forward primer 
TGGGAGTCTGCAGTGATGAG 
 
60 
H8668 
 
Pcyt1 PCR and RT-qPCR, 
reverse primer 
CTGCGTCCTTGATGTGCTTA 
 
60 
School of Biological and Biomedical Sciences Chapter 2 
 
83 
 
H8669 HIF1α PCR and RT-qPCR, 
forward primer 
TCCATGTGACCATGAGGAAA 
 
60 
H8771 HIF1α  PCR and RT-qPCR, 
reverse primer 
AAAAAGCTCCGCTGTGTGTT 
 
60 
H8744 
 
RESISTINPCR and RT-
qPCR, forward primer 
TGGCTCGTGGGACATTCGTG   
 
65 
H8745 RESISTIN  PCR and RT-
qPCR, reverse primer 
CCACGCTCACTTCCCCGACA 
 
65 
H8754 
 
MCP-1 PCR and RT-qPCR, 
forward primer 
CACCAGCACCAGCCAACTCT    
 
55 
H8755 MCP-1 PCR and RT-qPCR, 
reverse primer 
GCCGGCAACTGTGAACAGCA  
 
55 
H8756 
 
IL-6 PCR and RT-qPCR, 
forward primer 
ACAACCACGGCCTTCCCTAC 
 
65 
H8757 
 
IL-6 PCR and RT-qPCR, 
reverse primer 
ACAGGTCTGTTGGGAGTGGT  
 
65 
H8877 
 
TNFα PCR and RT-qPCR, 
forward primer 
AGCCGATGGGTTGTACCTTG 
 
60 
H8878 
 
TNFα  PCR and RT-qPCR, 
reverse primer 
ATAGCAAATCGGCTGACGGT 
 
60 
H8881 
 
Leptin PCR and RT-qPCR, 
forward primer 
TTTCACACACGCAGTCGGTA  
 
62 
H8882 
 
Leptin PCR and RT-qPCR, 
reverse primer 
GGGTGAAGCCCAGGAATGAA 
 
62 
School of Biological and Biomedical Sciences Chapter 2 
 
84 
 
H7961 XBP1 PCR, forward primer GATCCTGACGAGGTTCCAGA Touchdown 
PCR 
H7962 XBP1 PCR, reverse primer ACAGGGTCCAACTTGTCCAG Touchdown 
PCR 
H7994 ACTB PCR and RT-qPCR, 
forward primer 
AGCCATGTACGTAGCCATCC 55 
H7995 ACTB PCR and RT-qPCR, 
reverse primer 
CTCTCAGCTGTGGTGGTGAA 55 
H8553 BiP (HSPA5) RT-qPCR, 
forward primer 
TTCGTGTCTCCTCCTGAC 55 
H8554 BiP (HSPA5) RT-qPCR, 
reverse primer 
ACAGTGAACTTCATCATGCC 55 
H8660 VEGFA RT-qPCR, forward 
primer 
AGAGCAACATCACCATGCAG 55 
H8661 VEGFA RT-qPCR, reverse 
primer 
TTTGACCCTTTCCCTTTCCT 55 
H8736 ERDJ4 (DNAJB9) RT-qPCR, 
forward primer 
CTGTGGCCCTGACTTGGGTT 65 
H8737 ERDJ4 (DNAJB9) RT-qPCR, 
reverse primer 
AGGGGCAAACAGCCAAAAGC 65 
H8778 CHOP RT-qPCR, forward 
primer 
TCTTGAGCCTAACACGTCGAT 55 
H8779 CHOP RT-qPCR, reverse 
primer 
CGTGGACCAGGTTCTGCTTT 55 
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H8796 EDEM1 RT-qPCR, forward 
primer 
TGGAAAGCTTCTTTCTCAGC 55 
H8797 EDEM1 RT-qPCR, reverse 
primer 
ATTCCCGAAGACGTTTGTCC 55 
H9106 PERK RT-qPCR, forward 
primer 
CTCAAGTTTCCTCTACTGTTCAC
TC 
60 
H9107 PERK RT-qPCR, reverse 
primer 
GCTGTCTCAGAACCGTTTTCCC 
 
60 
H9110 IRE1α RT-qPCR, forward 
primer 
GCGCAAATTCAGAACCTACAAAG
G 
62 
H9111 IRE1α RT-qPCR, reverse 
primer 
GGAAGCGGGAAGTGAAGTAGC 62 
Oligonucleotides for Homo sapiens genes  
H8287 ACTB PCR, forward primer CTGAGCGTGGCTACTCCTTC 55 
H8288 ACTB PCR, reverse primer GGCATACAGGTCCTTCCTGA 55 
H8289 XBP1 PCR, forward primer GAGTTAAGACAGCGCTTGGG 59 
H8290 XBP1 PCR, reverse primer ACTGGGTCCAAGTTGTCCAG 59 
 
 The primers were designed using NCBI’s PrimerBlast software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) or Primer3 web tool using the parameters 
described by Santa Lucia et al [281]. The sequences were designed to have of 18-20 
nucleotides, a guanine-cytosine (GC) content of 45-60 % and melting temperature (Tm) 
between 55 and 66 ºC (with less than 2 degree difference in between the primers pair).  
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Primers for murine ACAT1 (acetyl-coenzyme A acetyltransferase 1), SCD1 (stearoyl-CoA 
desaturase 1), PLA1 (phospholipase A1), PLA2 (Phospholipase A2) and Pcyt2 (phosphate 
cytidyltransferase 2, ethanolamine) were ordered from Primer Design and the sequences are 
unknown. Murine GAPDH primers were included in the geNorm reference gene kit. 
 
 
2.1.6. Buffers and solutions 
 
All buffers and solutions were prepared using Nanopure H2O according to the recipes listed 
in table below. 
Table 2.6. Buffers and solutions used in the study. 
Buffer /Solution Composition Quantity Recipe 
DEPC-H2O 1 ml DEPC 1 l Add 1 ml DEPC to 1 l  
Nanopure H2O and stir 
vigorously for 30 min at room 
temperature.  
Autoclave the solution 
dNTPs, 2 mM 2 mM dATP 
2 mM dCTP 
2 mM dGTP 
2 mM dTTP 
1 mM Tris·HCl 
(pH 8.0) 
 
1 ml Add 10 μl 100 mM Tris·HCl 
(pH 8.0) in 910 μl H2O and mix 
the solution. Add the following 
to the solution: 20 μl 100 mM 
dATP, 20 μl 100 mM dCTP, 20 
μl 100 mM dGTP, and 20 μl 
100 mM dTTP. 
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EDTA, 0.5 M  
 
93.1 g 
Na2EDTA·2H2O 
 
500 ml Dissolve 93.1 g 
Na2EDTA·2H2O in ~ 350 ml 
H2O and adjust pH to 8.0 with 
10 M NaOH  
Add H2O to 500 ml and 
autoclave  
 
Isopropanol,          
60 % (v/v) 
100 % 
isopropanol 
 Mix 60 ml 100 % isopropanol 
with 40 ml H2O 
Oil red O stock 
solution 
250 mg Oil red O 
 
50 ml Dissolve 250mg Oil Red O in 
50 ml isopropanol by stirring 
continuously. Filter solution 
using a 0.45 µm filter and store 
at room temperature in a 
container protected from light.  
Oil red O working 
solution 
 50 ml Mix 30 ml Oil red O stock 
solution with 20 ml H2O. Filter 
solution through a 0.22µm filter 
and store at room temperature 
in a contained protected from 
light. The solution should be 
made prior to the experiment as 
it is stable for max 1 week. 
PBS, 10 X 
 
1.37 M NaCl 
 26.8 mM KCl  
4 l Add 320 g NaCl, 8 g KCl, 57.6 
g Na2HPO4 and 8 g KH2PO4 in 
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101.4 mM 
Na2HPO4  
14.7 mM KH2PO4  
3 l of H2O. Stir until fully 
dissolved and add distilled 
water up to 4 l. 
Ponceau Red S 
solution, 0.1% (w/v) 
 
0.1 % (w/v) 
Ponceau Red S  
20 % (v/v) acetic 
acid 
 
500 ml Mix 0.5g Ponceau Red S with 
25 ml acetic acid and add water 
up to 500 ml. Stir well 
RIPA buffer 
 
50 mM Tris·HCl, 
pH 8.0 
150 mM NaCl 
1 % (v/v) Triton 
X-100 
0.5 % (w/v) 
sodium 
deoxycholate 
0.1 % (w/v) SDS 
 
10 ml Add 5 ml 1M Tris·HCl pH 8.0, 
0.3 ml 5 M NaCl, 0.1 ml Triton 
X-100, 0.5 ml 10 % (w/v) 
sodium deoxycholate, and 0.1 
ml 10 % (w/v) SDS in 8.5 ml 
H2O. Mix well the solution and 
store at 4°C. 
SDS-PAGE sample 
buffer, 6 X 
350 mM Tris,  
(pH 6.8) 
30 % (v/v) 
glycerol 
10 % (w/v) SDS 
0.5 g/l 
bromophenol blue 
10 ml Dissolve 3.78 g glycerol, 1.00 g 
SDS, 500 μl 10 g/l 
bromophenol blue, 3.50 ml 1 M 
Tris·HCl pH 6.8 and 200 μl β-
mercaptoethanol in 
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2 % (v/v) β-
mercaptoethanol 
10 ml H2O on the shaker 
SDS-PAGE buffer, 
10 X 
1.92 M glycine 
0.248 M Tris 
10 g/l SDS 
1 l  Add 144.13 g glycine, 30.03 g 
Tris and 10.00 g SDS to 900 ml 
H2O. Once completely 
dissolved, add H2O to a final 
volume of 1 l 
Semi-dry transfer 
buffer, 10 X 
1 M Tris  
1.52 M glycine 
1 l Dissolve 121.1g Tris base and 
144.13g glycine in 600ml H2O 
and stir until fully 
dissolved.Add H2O up to1l.  
TAE, 50 X 2 M Tris·HOAc 
0.1 M EDTA 
pH ~ 8.5 
1 l Add 242 g Tris, 57.1 ml HOAc 
and 37.2 g Na2EDTA·2H2O to 
1 l H2O 
TBS, 10 X 200 mM Tris  
1.37 M NaCl 
1 l Dissolve 24.2g Tris base and 
80g NaCl in 600ml H2O and 
adjust the pH to 7.6 using HCl. 
Add H2O up to 1 l. 
TBST 
 
200 mM Tris  
1.37 M NaCl 
0.1% Tween 20 
1 l Add the 24.2 g Tris and 80g 
NaCl in 800 ml H2O and adjust 
the pH to 7.6 using HCl. Add 1 
ml Tween 20 mix and adjust to 
1 l with H2O.  
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TE (pH 8.0), 10 X 100 mM Tris·HCl 
(pH 8.0) 
10 mM EDTA 
4 l Add 400 ml 1 M Tris·HCl (pH 
8.0) and 80 ml 0.5 M EDTA in 
4l H2O. Autoclave the solution. 
Tris·HCl (pH 6.8),  
1 M  
 
1 M Tris  1 l Dissolve 121.14 g Tris in 800 
ml H2O and adjust the pH to 6.8 
with concentrated HCl. Add 
H2O to 1 l  
 
Tris·HCl (pH 8.0),  1 
M  
 
1M Tris  1l Dissolve 121.14 g Tris in 800 
ml H2O and adjust the pH to 8.0 
with conc. HCl. Add H2O to 1 
l. 
 
 
2.1.7. Special equipment 
 
Table 2.7 Special equipment used in the study 
Name Company Catalogue number (cat. no) 
BD FACS Calibur Flow 
Cytometer  
BD Biosciences 342975 
Bioruptor  Diagenode UCD-200TM-EX 
Counting chamber Marienfield Superior 0642010 
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Criterion TM cell BioRad 165-6001 
Galaxy R+ CO2 incubator RS Bioltech 170-300 PLUS 
Gel doc 1000 mini 
transilluminator 
BioRad # 400-0065 
Modular Incubator  Billups-Rotenberg MIC-101 
Mr FrostyTM Freezing 
Container 
Thermo Scientific 5100-0001 
PTC-200 Thermal Cycler MJ Research NA 
Rotor-gene 6000 Corbett Life Science 9001560 
 
 
 
 
2.1.8. Cell culture 
 
General guidelines: All cell cultures were handled in a tissue culture designated room. For 
cell handling, culture and treatments Class II (HEPA-filtered) biological safety cabinets were 
used and the cells were maintained in a 37ºC, 5% (v/v) CO2 and 95% air and humidity 
controlled incubator.  
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2.1.8.1. Cell lines 
 
2.1.8.1.1. 3T3-F442A cell line 
 
The 3T3-F442A [282, 283] murine preadipocytes used in this study were kindly provided 
by Prof. C. Hutchinson as subconfluent culture in Dulbecco’s modified Eagle’s medium 
(DMEM) 4.5 g/L D-glucose supplemented with 2 mM L-glutamine and 10% (v/v) fetal 
bovine serum.  
 
2.1.8.1.2. 3T3-L1 cell line 
 
The 3T3-L1[283, 284] murine preadipocytes used in this study were purchased from the 
ATCC collection (ATCC®-CL-173TM) and cultured as instructed in Dulbecco’s modified 
Eagle’s medium (DMEM) 4.5 g/L D-glucose supplemented with 2 mM L-glutamine and 10 
% bovine calf serum (complete growth medium).  
 
2.1.8.1.3. THP-1 cell line 
 
The THP-1 human monocytic cell line used in the study was kindly provided by Dr Adam 
Benham. The cells were cultured in RPMI-1640 growth medium supplemented with 2 mM 
L-glutamine and 10 % fetal bovine serum (complete growth medium).  
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2.2. Methods 
 
 
2.2.1. Tissue culture methods 
 
2.2.1.1. Subculture of adherent cell lines 
 
To subculture adherent cell lines, the cells were washed with sterile PBS and incubated with 
0.25 % trypsin-EDTA for 5 min at 37ºC in order to facilitate dispersion. After complete 
dispersion of the cells assessed by using an inverted microscope, serum supplemented 
growth medium was added (1:10 trypsin solution to medium ratio) to inactivate the trypsin. 
The cells were re-suspended and counted using a haemocytometer. In the counting process 
the number of viable cells was established using trypan blue exclusion protocol [285] and 
only the viable cell count was used for calculating the densities for the new cultures.  
 
2.2.1.2. Subculture of non-adherent cell lines  
 
For non-adherent cell lines (THP-1 cell line), the cell culture was gently mixed by pipetting 
up and down so that the cells will be evenly dispersed in the medium and viable cell density 
was measured using a haemocytometer and trypan blue dye. The culture was then 
centrifuged 5 minutes at 1200 rpm, room temperature (RT), and re-suspended in appropriate 
volume of fresh medium. 
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2.2.1.3. Counting cells using the haemocytometer 
 
In order to prepare subcultures with a desired cell density, the viable cells were counted 
before plating using a haemocytometer and trypan blue solution. Prior to counting, the 
haemocytometer and coverslip were cleaned with 70 % ethanol and the coverslip attached 
to the haemocytometer in order to form the counting chamber. A small volume of the mixed 
suspension (~50 µl) was then carefully placed in the haemocytometer chamber avoiding 
overfilling and cells were counted using the 10 X objective of the microscope. The cell 
counting was performed using the trypan blue staining protocol for viable cells [285, 286] 
and the haemocytometer instructions. 
 
2.2.1.4. Trypan blue staining 
 
The trypan blue staining procedure followed the protocol described by Freshney et al [285]. 
In short, 100 µl of cell suspension was mixed with a 0.4% (w/v) trypan blue solution in a 
ratio of 1:1 (v/v).10 µl of the mixed suspension was loaded in the haemocytometer counting 
chamber and the cells were counted starting from the upper left corner. An area of 1 mm2 
square was counted avoiding counting the same cell twice. Only unstained, viable cells were 
counted. The same procedure was followed for a second and third square and the average 
number of cells was calculated.  
 
The viable cell density per ml, the total number of viable cells and the viability percentage 
was determined using the following calculations: 
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No of cells per ml = the average count per square x dilution factor* x 104 ±,  
* dilution factor is the dilution factor of cell suspension in Trypan blue staining 
solution (in our case 2) 
± conversion factor to 1 ml 
 
Total no of cells = cells per ml x volume of original suspension 
 
Cell viability (%) = (total viable cells (unstained) ÷ total cells (stained and 
unstained)) x 100 
 
 
2.2.1.5. Cryopreservation 
 
For cryopreservation freezing medium consisting in 90 % (v/v) FBS and 10 % (v/v) DMSO 
was used. Usually 80 - 90 % confluent cultures were used for the procedure as the cell density 
will allow a high number of cells to be stored and the cells are still in their growth phase. 
The cells were washed with warm (37ºC) sterile PBS and incubated with 0.25 % trypsin – 
EDTA at 37ºC until full detachment from the plate. Cells were then re-suspended in growth 
medium and the cell density was assessed using a haemocytometer. Appropriate volume of 
freezing medium was used to re-suspend the cells in order to obtain a 1-1.5 ml suspension 
(1x 105 cells/ml) per cryotube. The cryotubes were placed in Mr FrostyTM Freezing 
container, and were stored over night at -80ºC. The second day the cryotubes were 
transferred in liquid nitrogen for long time storage. 
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For THP-1 cells cryopreservation the same protocol was used with the only difference that 
the trypsin incubation step was removed as the cells are growing in suspension. 
 
 
2.2.1.5. Revival of cryopreserved cells 
 
The cells were revived by placing the cryotube in a 37ºC water bath until the cell suspension 
was thawed. The suspension was then re-suspended in 10 ml of complete growth medium 
and incubated for at least 2 days in a 37ºC, 95 % air and 5 % CO2 incubator before changing 
the medium. 
 
 
2.2.1.6. Adipocyte in vitro differentiation  
 
 For in vitro differentiation, the 3T3-F442A and 3T3-L1 murine preadipocytes were 
maintained in DMEM supplemented with 4.5 g/l D-glucose, 2 mM L-glutamine and 10 % 
(v/v) fetal bovine serum (FBS) until confluency. This step was shown to be extremely 
important due to a previously shown property of these cells to induce spontaneous growth 
arrest and differentiation upon very high density [283, 287].  
Two days post confluency the medium was replaced with an induction medium containing 
complete growth medium supplemented with 1 μg/ml insulin, 0.5 mM IBMX, and 0.25 μM 
dexamethasone. The cells were maintained in this induction medium for three days and then 
for two more days in medium containing 1 μg/ml insulin. On day 5 of differentiation, the 
medium was replaced with complete growth medium and maintained for another 7 days, 
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while replacing the medium every 3 days. Adipocytes differentiation was assessed after 12 
days of differentiation by staining with Oil red O or nile red as described below. 
 
 
2.2.1.7. Oil Red O staining of neutral lipids  
 
The Oil Red O staining of in vitro differentiated adipocytes was used as a method to evaluate 
the degree of differentiation of the cells 12 days after induction using an previously 
established protocol [288] 
 
Reagents:  3.7 % (w/v) formaldehyde; 1 X sterile PBS; Oil Red O working solution (see 
Table 3.6); 60 % isopropanol. 
 
Protocol 
 In vitro differentiated adipocytes as previously described were washed with warm PBS and 
incubated for 5 min with 3.7 % (w/v) formaldehyde. The formaldehyde was then replaced 
with fresh 3.7 % (w/v) formaldehyde and incubated for another hour to assure an optimal 
fixation of the cells. During the incubation the plates were wrapped in parafilm to prevent 
drying and covered with aluminum foil to protect from light. After incubation, the cells 
were washed with 60 % (v/v) isopropanol and left to dry completely. Oil red O working 
solution was added to each well and cells were incubated for 10 min at room temperature. 
The cells were washed four times with H2O and photographed using a Nikon camera 
attached to the microscope. 
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2.2.1.8. Nile red fluorescent staining of lipids 
 
Nile red fluorescent staining method was used to determine the percentage of differentiation 
in the 12 days in vitro differentiated adipocyte culture.  
 
Reagents: Nile red working solution (100 ng/ml in PBS); 1 X sterile PBS 
 
Protocol 
In vitro differentiated adipocytes in day 12 of differentiation were trypsinised as previously 
described in section 2.2.1.1., re-suspended in fresh medium and then centrifuged for 5 
minutes at 1200 g, RT. Cells were then re-suspended in sterile PBS and nile red working 
solution was added in a 1:100 ratio (100 ng/ml final concentration in PBS). The suspension 
was then incubated for 5 min at RT, protected by light. After the incubation, the cells were 
centrifugated again for 5 min at 1200 g and washed once with fresh PBS to eliminate the 
excess dye. Cells were then re-suspended in fresh sterile PBS and immediately analysed by 
flow cytometry on a BD FACSCalibur Flow Cytometer at a low flow rate. 
        
 
2.2.1.9. Flow cytometry 
 
In the study, the nile red fluorescent staining of neutral lipids was used for characterisation 
of ~ 50,000 gated events/ sample with regard to size, granularity and fluorescence. Gates 
were set in order to exclude cellular debris and differentiate in between the two populations 
based on cell size (FCS) and cell granularity (SSC). Nile red fluorescence was excited at 488 
nm and its fluorescence emission collected using the FL-1 (530/30 nm) band pass filter. The 
instrument settings used in the study are presented below. 
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 For 3T3 F442A cells  
Forward scatter (FSC , for cell size) – E-1 (lin, Amp gain = 4.50), 
Side scatter (SSC, for granularity) – 280 V (lin, Amp gain = 1.00), 
  Fluorescence (FL1) – 275 V (log, Amp gain = 1.00).  
                                     
 For 3T3-L1 cells    
Forward scatter (FSC, for cell size) – E-1 (lin, Amp gain = 4.50), 
  Side scatter (SSC, for granularity) – 326 V (lin, Amp gain = 1.00), 
  Fluorescence filter (FL1) – 275 V (log, Amp gain = 1.00).  
 
Data were analysed in WinMDI 2.9 and graphs prepared in GraphPad Prism 6.04 (GraphPad 
Software). Three biological replicates were analysed for each sample. 
 
 
2.2.1.10. THP-1 in vitro differentiation 
 
The THP-1 monocytes were in vitro differentiated into macrophages by incubation with 50 
nM phorbol-12-myristate 13-acetate (PMA) for 3 d, followed by 1 d incubation in growth 
medium [289]. The degree of differentiation of the cultures was visually assessed due to the 
adherent phenotype of differentiated macrophages. Renewal of the medium allowed that 
only the adherent differentiated macrophages were kept for the study. 
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2.2.2. Cell treatments 
 
 
2.2.2.1. Palmitic acid treatment 
 
In vitro differentiated 3T3-F442A and 3T3-L1 adipocytes were serum-starved overnight in 
DMEM containing 4.5 g/l D-glucose and 2 mM L-glutamine and then incubated in serum-
free medium containing 2 % (w/v) fatty acid-free BSA and 0.05 - 1 mM palmitic acid. 
Palmitic acid to fatty acid-free BSA complexes were prepared as follows: the acid was 
dissolved in ethanol and diluted 1:100 in DMEM containing 4.5 g/l D-glucose and 2 % (w/v) 
fatty acid-free BSA. The solution containing the complexes was made fresh before the 
experiments and sterile filtered before addition to the cells. Control cells received ethanol 
diluted 1:100 into DMEM containing 4.5 g/l D-glucose and 2 % (w/v) fatty acid-free BSA. 
For the experiments investigating the effect of palmitic acid on insulin signalling in 
adipocytes and preadipocytes, the cells were incubated for 48 h with the treatment previously 
described before stimulation with 100 nM insulin for 15 min. 
 
 
2.2.2.2. Cholesterol treatment 
 
In vitro differentiated adipocytes were incubated for 48 hours in DMEM containing 4.5 g/l 
D-glucose, 2 mM L-glutamine and 100 μg/ml human acetylated LDL (AcLDL) in the 
presence or absence of the acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor TMP-153 
at a final concentration of 0.6 μM [290]. The same treatment was used on differentiated THP 
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cells but due to previously described induction of apoptosis in response to the cholesterol 
treatment [291], the incubation was limited to 16 h . 
 
2.2.2.3. Proinflammatory cytokine treatments 
 
In vitro differentiated adipocytes were incubated with 0 - 200 ng/ml tumour necrosis factor 
alpha (TNFα), interleukin 1 beta (IL-1β) or interleukin 6 (IL-6) for 0 - 24 hours in serum 
free DMEM 4.5 g/l D-glucose supplemented with 2 mM L-glutamine. 
For experiments investigating the biological activity of the proinflammatory cytokines, 
preadipocytes were incubated for short periods of time (0 - 30 min) with 25 ng/ml TNF-α, 
200 ng/ml IL-1β or 200 ng/ml IL-6. 
 
 
2.2.2.4. D-Glucose starvation 
 
For glucose starvation experiments, in vitro differentiated adipocytes were incubated for    6 
- 48 hours in DMEM with or without D-glucose and supplemented with 2 mM L-glutamine. 
 
 
2.2.2.5. Hypoxia treatment 
 
Day 12 differentiated adipocytes were placed in a sealed hypoxia chamber and flushed with 
a pre-analysed gas mixture of 0.5 % (v/v) O2, 5 % (v/v) CO2 and nitrogen (BOC Industrial 
Gases), at a flow rate of 25 l/min for 5 min to completely replace air inside with the gas 
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mixture (time for complete replacement of air as recommended by the manufacturer). The 
modular chamber was then incubated at 37ºC for 0-8 hours. 
 
 
2.2.2.6. Cell viability assay 
 
The MTT assay protocol used in the present study was previously described by Tim 
Mosmann [292] and it is presented below. 
Reagents: Phenol red free complete culture medium; isopropanol containing 4 mM HCl and 
0.1% (v/v) Nonidet P-40 
 
Protocol 
After the desired treatment, the cells were incubated with 0.5 g/l MTT in phenol-red free 
medium for 4 h at 37°C, in order to allow formation of the insoluble purple formazan 
crystals. After 4 h the medium was discarded and the crystals were dissolved using 
isopropanol containing 4 mM HCl and 0.1% (v/v) Nonidet P-40. Absorbance of the obtained 
formazan solution was then read at 590 nm with a reference at 620 nm. The absorbance was 
expressed as the ratio of the absorbance at 590 nm to the absorbance at 620 nm. 
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2.3. Molecular methods 
 
2.3.1. RNA extraction 
 
Reagents: EZ RNA kit (Geneflow), ice-cold 100% isopropanol, 70% ethanol, DEPC water 
 
Protocol 
RNA from cells was isolated using the EZ RNA kit according to the manufacturer’s 
instructions. Briefly, the cells were washed with sterile PBS and lysed directly in the culture 
dish using 0.5 ml denaturing solution containing guanidine thiocyanate (reagent A in kit). 
The lysates were homogenised by pipetting the solution up and down a few times and were 
incubated for 5 min at room temperature. Lysates were then transferred into 1.5 ml tubes and 
0.5 ml extraction solution containing phenol-chloroform mix (reagent B in kit) was added. 
The tubes were shaken vigorously for 15 s and incubated at room temperature for 10 min. 
Samples were then centrifuged for 15 min at 12,000 g, 4ºC allowing formation of two phases: 
an aqueous upper phase that contains the RNA and an organic phase that contains the 
proteins and other cell components. The aqueous upper phase was transferred to a new tube 
and 0.5 ml ice-cold isopropanol was added to precipitate the RNA. The phase and 
isopropanol solution were mixed well by inverting the tube a few times and then incubated 
over night at -20ºC to allow the RNA to precipitate. Next day the samples were centrifuged 
for 10 min at 12,000 g, 4ºC and the supernatant was discarded. The pellet obtained was 
washed with 1 ml 75 % ethanol and centrifuged again for 5 min at 7,500 g, 4ºC. The 
supernatant was then removed and the pellet (RNA) was left to dry at room temperature for 
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10 min in order for the ethanol to completely evaporate. The RNA was then re-suspended in 
30 µl DEPC-treated water and samples were stored at -80ºC. 
 
 
2.3.2. RNA concentration quantification 
 
The RNA concentration in the samples was assessed using an UV spectrophotometer. 
Each sample was diluted in DEPC-treated water in a ratio 1:50, and loaded in duplicate on 
an UV microtiter plate. The absorbance was measured at 230 nm (A230 for phenolic 
contaminants), 260 nm (A260 for nucleic acids) and 280 nm (A280 for protein contamination) 
in order to establish the concentration and purity of the RNA for each sample. The 
concentration of RNA was calculated using SoftMax Pro software, against a control made 
out of DEPC-treated water only. The purity of the RNA isolated was established using the  
ratios A260/A230 (~2), A260/A280 (~1.8).  
 
 
2.3.2. Reverse transcription 
 
The RNA obtained was reverse transcribed in a two steps reaction using SuperScriptIII 
Reverse Transcriptase (Invitrogen) and following the manufacturer’s instructions. First 
strand cDNA synthesis was prepared in 20 µl total reaction volume in a nuclease-free tube 
as described below. 
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Table 2.8. Reverse transcription reaction reagents and conditions 
Component / concentration Volume (µl per sample) 
oligo(dT)15,   50 µM 1.0 
RNA, 5 µg Calculated from concentration 
dNTPs mix , 10mM 1.0 
H2O Up to 13 µl 
  
The components were mixed and incubated at 65°C for 5 minutes then placed on ice for 1 
min. The following components were added to the reaction mix: 
 
Component / concentration Volume (µl per sample) 
1st Strand Buffer, 5X 4.0 
DTT, 0.1M 1.0 
RNaseOUT RNase Inhibitor, 40U/µL 1.0 
SuperScript Reverse Transcriptase    
(Invitrogen), 200U/ml 
1.0 
 
The components were vortexed and heated to 50°C for 1 h followed by inactivation of the 
reverse transcriptase by heating to 70°C for 15 min. The cDNA obtained was stored at 4°C 
and used for the PCR and QPCR reactions. 
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2.3.3. Polymerase chain reaction (PCR) 
 
Taq polymerase was used as a polymerase for β-actin amplification and Hot Start Taq 
polymerase, a modified Taq polymerase that is inactive at temperatures below 45ºC was 
used to investigate genes with lower expression.  
 
 
Table 2.9.  The general protocol of the PCR reaction  
Component / concentration Volume (µl per sample) 
Green GoTaq flexi buffer, 5X 5 
MgCl2, 25 mM  1.5 
dNTPs  mix, 2 mM 1.25 
Forward primer,10 µM 2.5 
Reverse primer, 10 µM 2.5 
cDNA 1.25 
GoTaq (Hot Start) polymerase, 5U/µl 0.25 
Sterile H2O 10.75 
Total volume 25 
 
The fragments were amplified in a thermal cycler (PTC-200 Thermal cycler, MJ Research) 
using the following conditions: 
 
Step Temperature (ºC) Time (seconds) No of cycles 
Initial denaturation 94 120 1 
Denaturation 94 60  
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Annealing As presented in 
table 2.5 
30  
35 
Extension 72 30 
Final extension 72 300 1 
 
 
 
Table 2.10.  PCR conditions for of XBP1 mRNA splicing 
Step Temperature (ºC) Time (seconds) No of cycles 
Initial denaturation 95 300  
 
22 
Denaturation 94 30 
Annealing 72 30 
Decrease annealing temperature by 1.0°C each cycle 
Extension 72 15  
 
35 
Denaturation 94 30 
Annealing 50 30 
Extension 72 15 
Final extension 72 420 1 
 
2.3.4. Preparation of agarose gels 
 
The amplification products were run on an agarose gel in order to be investigated. Briefly, 
1.5 g of agarose powder were mixed with 150 ml Tris-acetic acid-EDTA (TAE) buffer (1 % 
(w/v) agarose gel) and heated until the agarose was completely dissolved. The homogenised 
solution was then left to cool down until the solution was < 40ºC. 7 µl 10 mg/ml ethidium 
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bromide was then added and the solution was mixed thoroughly. The solution was poured in 
the agarose gel caster and left at room temperature until complete polymerisation. The gel 
was then submersed in 1 X TAE running buffer and the samples were run at a voltage of 2 
V/cm2. 
For XBP1 PCR products, due to the small difference in between the spliced and unspliced 
forms, the agarose gel used was 2 % (w/v) agarose in TAE buffer. 
The gels were visualised in UV on a Gel Doc 1000 mini trans-illuminator and pictures were 
saved for further analysis. The images were quantified using Image J software and the 
percentage of splicing was calculated as described below. 
 
2.3.5. Analysis of DNA samples on agarose gels 
 
The percentage of XBP1 splicing was calculated by dividing the signal for spliced XBP1 
cDNA by the sum of the signals for spliced and un-spliced XBP1 mRNAs. 
 
2.3.6. Quantitative  PCR (qRT-PCR) 
 
For the quantitative PCR (qRT-PCR) reactions, various kits were used during the study: 
2xqPCR MasterMix (Primer Design), FAST 2xqPCR MasterMix (PrimerDesign) and qRT-
PCR MasterMix (Promega), according to the manufacturer instructions. For all the kits, the 
detection was made on an Rotor-Gene thermo cycler (Corbett) using SYBR Green 
fluorescent dye and 40 amplification cycles. 
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Table 2.11. Reaction mix per sample using 2xqPCR MasterMix or FAST 2xqPCR 
MasterMix (Primer Design) 
Component / concentration Volume (µl per sample) 
(FAST) 2xqPCR Master Mix 10 
Forward primer, 10 µM 0.6 
Reverse primer, 10 µM 0.6 
cDNA     (1:100 input cDNA from RT-
PCR) 
5 
Sterile   H2O 3.8 
Total volume 20 
For primer pairs designed by Primer Design, the primer mixed added was 1 µl/sample and 
water was adjusted to a final volume of 20 µl. 
 
Table 2.12. Cycling conditions for 2xqPCR Master Mix 
Step Temperature (ºC) Time (seconds) No of cycles 
Initial denaturation 95 600 1 
Denaturation 95 15  
 
40 
Annealing As presented in 
table 2.5 
30 
Extension 72 20 
Final extension 72 300 1 
Melting curve 55-95 N/A  
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Table 2.13.  Cycling conditions for FAST 2xqPCR Master Mix 
Step Temperature (ºC) Time (seconds) No of cycles 
Initial denaturation 94 300 1 
Denaturation 94 15  
 
40 
Annealing 55 20 
Extension 72 30 
Final extension 72 300 1 
Melting curve 55-95 N/A  
 
For all protocols amplification of a single qRT-PCR product was confirmed by recording 
the melting curves after each run. All amplification efficiencies were > 0.9. Calculation of 
CT values (number of cycles required for the fluorescent signal to cross the threshold) was 
done with the RotorGene software using a manually set threshold. Each qRT-PCR 
experiment was repeated 3 times with independent biological samples. All qRT-PCR 
reactions were investigated using technical triplicate also in order to account for pipetting 
errors. 
Relative quantitation of gene expression was used to quantify the difference in the expression 
of specific target gene between different samples. All values were normalised to β-actin 
housekeeping gene (reference gene) expression. Calculations were made using comparative 
Ct method [293]: 
 
ΔCT= ΔCTtarget - ΔCTreference 
            ΔΔCT= ΔCT target -ΔCTcontrol 
Ratio gene in sample vs gene in control = 2
- ΔΔCT 
where  
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CT target = CT value of the gene of interest in treated 
CT reference = CT value of the housekeeping gene; 
            CT control = CT value of the gene of interest in untreated sample  
 
 
 
2.4. Biochemical methods 
 
 
2.4.1. Protein extraction 
 
In order to analyse the protein expression profile in treated and un-treated cells, cell lysates 
were obtained. For adherent cell the reagents and protocol used were the following: 
 
Reagents: Ice-cold RIPA buffer [50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5 % (w/v) 
sodium deoxycholate, 0.1 % (v/v) Triton X-100, 0.1 % (w/v) SDS]; protease and 
phosphatase inhibitors (Roche); ice-cold 1 X PBS 
 
Protocol 
Cells were washed 3 times with 4ºC 1X PBS and incubated with ice-cold RIPA buffer 
containing protease and phosphatase inhibitors. The culture was homogenised in the lysis 
buffer directly in the culture plate using the pipette tip or a cell scraper, and the lysate was 
transferred into 1.5 ml tubes and incubated for 10 min on ice to allow complete lysis. For 
differentiated adipocytes, in order to decrease their viscosity the lysates were briefly 
sonicated for 5 minutes using Bioruptor (Diagenode) at high power, with 10 s sonication 
bursts and 30 s pause intervals in between, according to the manufacturer instruction, Lysates 
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were then centrifuged for 5 minutes at 13,000 g, 4ºC in order to sediment the cell debris and 
separate the aqueous fraction containing the proteins. The supernatant was transferred to a 
fresh tube and the protein content was quantified using the DC Protein Assay kit (Lowry 
based method) according to the manufacturer instructions. After protein quantitation, the 
samples were stored for short term at -20ºC and for long term at -80ºC. 
 
 
2.4.2. Protein quantification 
 
Protein content of the lysates was quantified using DC Protein Assay according to the 
manufacturer instructions. In short, cell lysates were diluted 1:5 in distilled H2O and 5 µl of 
the diluted lysate was loaded into a clean, dry microtiter plate. The lysate was then mixed 
with 25 µl reagent S+A mix (1:50 ratio reagent S to reagent A) and 200 µl reagent B. Similar 
to the samples, 5 µl of known BSA dilutions (0 to 2 mg/ml) used as standards were loaded 
onto the plate and mixed with the reaction reagents. All standards and samples were loaded 
in duplicate to minimise the possible pipetting errors. The plate was then incubated at RT, 
on a horizontal shaker for 15 minutes and the absorbance was read at 750 nm using a plate 
reader. A standard curve was made using the BSA standards readings and used for the sample 
protein concentrations.  
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2.4.3. Western Blotting 
 
 
2.4.3.1. SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis)  
BioRad SDS-PAGE system and the 4-20% Criterion TGX precasted gels were used in the 
study according to the manufacturer instructions. 
 
Reagents: 6XSDS-PAGE loading buffer; SDS-PAGE running buffer 4-20% Criterion TGX 
precast gels; prestained protein molecular marker  
 
 
Protocol 
The gel system was prepared according to the instructions and the wells of the precast gels 
were washed with the SDS-PAGE running buffer. For each sample 50 µg protein lysate was 
mixed with 6 X SDS-PAGE sample buffer and incubated for 5 min at 100ºC. Samples were 
then left to cool down at room temperature and loaded into the wells of the precast gel along 
with the prestained protein ladder. The gel was run at 240 V  for ~ 30 min, until the 
bromphenol blue front in the sample loading buffer reached the bottom of the gel. The gel 
was then removed from the system and placed in TBST for few minutes. 
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2.4.3.2. Semi-dry transfer 
 
In order to use immunological detection of investigated proteins, the proteins on the SDS-
PAGE gel were transferred to a 0.45 µm polyvinylidene fluoride (PVDF) membrane that can 
be subjected to antibody incubation. The transfer was made using a semi-dry transfer system 
according to the manufacturer instructions. 
 
Reagents: Semi-dry transfer buffer containing 5% (v/v) methanol; PVDF membrane; 
Whatman paper 
 
Protocol 
The PVDF membrane cut to the size of the gel was incubated for 1 minute in 100 % 
methanol. All the components of the semi-dry (PVDF membrane, SDS-PAGE gel and 8 
Whatman papers) were then incubated for 10 minutes in 1X semi-dry transfer buffer 
containing 5 % methanol, on a shaking platform. Once the components were equilibrated in 
transfer buffer, the gel sandwich was assembled as following: 4 Whatman papers, the PVDF 
membrane, the SDS-PAGE gel, 4 Whatman papers, and the excess transfer buffer was 
removed. The transfer was made in a semi-dry unit at 2-3 mA /cm2 for 70 minutes. 
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2.4.3.3. Ponceau S staining 
 
Reagents:  0.1% (w/v) Ponceau Red S solution in 5% acetic acid; TBST; H2O 
 
Protocol 
In order to evaluate if the protein transfer was efficient, the PVDF membrane was incubated 
immediately after the transfer in TBST for 10 minutes and then in 0.1% (w/v) Ponceau Red 
S solution in 5% acetic acid for another 10 minutes. The membrane was then washed with 
H2O until the excess of the dye was removed allowing visualisation of the protein bands. 
After assessing the transfer efficiency, the membrane was washed several times in TBST in 
order to remove the Ponceau staining solution and was prepared for immunoblotting. 
 
 
2.4.3.4. Immunoblotting 
 
Reagents: TBST buffer; 5 % (w/v) skimmed milk in TBST; 5 % (w/v) BSA in TBST; 
antibodies (dilution as presented in table 2.3.2) Pierce ECL/ ECL Plus substrate; 
photographic film (CL-X PosureTM film, cat. no. 34091, Thermo Fisher Scientific) 
 
Protocol 
The PVDF membrane from the semi-dry transfer was incubated for 1 h in 5 % skimmed milk 
in TBST and then washed 5 times x 5 min with TBST. After the washing steps, the 
membrane was incubated with the desired primary antibody diluted as previously described 
in 5 % (w/v) skimmed milk in TBST or 5 % (w/v) BSA in TBST (for phosphorylated 
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proteins) over night at 4ºC, on a shaker. The next day, the membrane was washed 5 times x 
5 min with TBST and incubated with the secondary antibody (HRP-linked) diluted 1:20,000 
in 5 % (w/v) skimmed milk in TBST for 1 hour at room temperature, on a shaker. After the 
incubation, the membrane was washed again 5 times x 5 min with TBST and incubated with 
the chemiluminiscent ECL or ECL Plus substrate for 5 min in the dark. The excess of 
chemiluminiscent reagent was then removed and the membrane was placed in a cassette and 
exposed to a photographic film for appropriate lengths of time (1-10 min). The film was 
developed using an X-ray film developing machine according to the manufacturer’s 
instructions. 
 
 
2.4.3.5. Quantification of Western blotting bands 
 
In order to quantify the bands resulted from the chemiluminiscent reaction between the HRP 
linked to the secondary antibody and the ECL substrate, the developed films were scanned 
on a CanoScan LiDE 600F scanner (Canon) and saved as tiff. files. The bands were 
quantitated using ImageJ as described under the heading “Gels Submenu” on the ImageJ 
web site (http://rsb.info.nih.gov/ij/docs/menus/analyze.html#plot).  
In order to correct for differences in loading between individual lanes, the peak intensities 
for the used primary antibody were then divided by the peak intensities obtained with the 
antibody for the loading control in the corresponding lane. All loading control-corrected 
peak intensities obtained for one Western blot were then expressed relative to the loading 
control-corrected peak intensity of the 0 h sample. 
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Similarly, the GelDoc images of XBP1 splicing were quantitated using ImageJ and following 
a similar protocol with the protein bands quantification. The percentage of splicing was 
calculated as described in subchapter 2.3.5.
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CHAPTER 3 
 
ADYPOCYTE IN VITRO DIFFERENTIATION 
 
 
 
 
 
 
 
 
 
 
 
  
 
School of Biological and Biomedical Sciences Chapter 3 
 
119 
 
Obesity is the most common nutritional disorder in the developed world and a risk factor for 
associated diseases like type 2 diabetes mellitus, cardiovascular diseases and hypertension. 
As a key regulator of metabolic homeostasis the adipose tissue represents the main tissue 
affected by the pathological conditions in obesity. Though the cellular composition of the 
adipose tissue includes a variety of cell types as preadipocytes, adipocytes, macrophages and 
endothelial cells [46], alteration of adipocyte homeostasis has been shown to be the main 
cause of tissue dysfunction [149]. 
The aim of my study is to investigate whether physiological alterations in obesity, such as 
elevated plasma fatty acids, cholesterol levels, adipose tissue inflammation or remodelling 
can induce an endoplasmic reticulum stress response in adipocytes contributing to the 
lipotoxic and inflammatory drift of adipose tissue in obesity. In order to accomplish this aim, 
the first step was to obtain a cellular model of adipocytes that can be subjected to treatments 
without the interference from other tissue-related factors. For this, two established murine 
preadipocytes cell lines, 3T3-F442A and 3T3-L1 were selected due to previously described 
capacity to in vitro differentiate into adipocytes under controlled conditions [282, 294] Both 
cell lines originated from the 3T3 fibroblast cell line obtained by Todaro et al [295] from 
disaggregated Swiss mouse embryos. They are spontaneously immortalised lines capable of 
differentiating into adipocytes in vitro or in vivo [283]. The difference between the two cell 
lines resides in the ability to undergo adipose differentiation in the presence of serum 
adipogenic factors or growth hormones [294]. Compared to the L1 line, the F442A line 
presents a higher capacity of cell adipogenic cluster formation [283] and differentiation 
[296] under hormonal induction, the cell line  being considered more “committed” to the 
adipogenic differentiation than the L1 line. 
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Due to their properties, both cell lines have been extensively used in studies investigating 
adipocyte physiology and pathology related to metabolic diseases. The in vitro 
differentiation process using adipogenic factors have been thoroughly described [297, 298]. 
In this study, both 3T3-F442A and 3T3-L1 cell lines were grown to confluency and 
maintained 2 d post confluency to induce cell growth arrest needed for differentiation 
induction as described by Green et al [287]. The cells were then differentiated for 12 d using 
an adipogenic cocktail according to the protocol described in the Materials and Methods 
chapter. Differentiation of the cells was assessed using lipid staining methods as cytoplasmic 
accumulation of lipid droplets has been previously shown to be increased directly 
proportional to the extent of adipocyte differentiation. Two lipid staining methods were used 
in the study: Oil red O staining that allowed a qualitative evaluation of the differentiation 
process and Nile red fluorescent staining using flow cytometry that allowed a quantitative 
evaluation of lipid accumulation. All experiments were done using adipocytes in day 12 of 
differentiation. 
Microscopic evaluation of adipocyte differentiation after 12 d of induction using Oil red O 
staining revealed an increased accumulation of lipid droplets in the cells subjected to the 
adipogenic cocktail compared to the ones that did not receive the cocktail (Figure 3.1). 
 
    
Figure 3.1. Oil Red O staining of neutral lipids in in vitro differentiated 3T3-F442A adipocytes 
(A) Preadipocytes, 20X, (B) adipocytes day 12, 20X, and (C) adipocytes day 12, 10X. 
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The results show that the differentiation protocol used did induce accumulation of lipid 
droplets in 80 - 90 % of the cell population in 3T3- F442A cells as previously described 
[299, 300]. In order to accurately establish the percentage of cells presenting lipid droplets, 
the quantitative flow cytometry method using the fluorescent lipid probe nile red [301] was 
used. The flow cytometry experiments were set to investigate 50,000 cells/sample, 
comparing preadipocytes with adipocytes in day 12 of differentiation. Unstained 
preadipocytes and adipocytes were used as experimental controls for cell autofluorescence 
and gates were set in order to exclude cellular debris. Nile red fluorescence was used as an 
indicator of intracellular lipid accumulation. 
Investigation of fluorescence in preadipocytes and adipocytes differentiated for 12 d 
revealed a mean fluorescence increase of 3.2 ± 0.2 fold upon differentiation of 3T3-L1 cells 
(Figure 3.2 A). For 3T3-F442A cells two distinguishable fluorescent populations were 
observed after 12 d, exhibiting 2.9 ± 0.1 fold and 25 ± 2 fold increase in nile red fluorescence 
compared to undifferentiated (0 d) cells (Figure 3.2 B). 
Figure 3.2. Nile red staining of lipids in adipocyte differentiation. Nile red fluorescence of (A) 
3T3-L1 and (B) 3T3-F442A cells on day 0 (dark grey line) and 12 of differentiation (black line). The 
light grey line represents the autofluorescence of cells differentiated for 12 d without incubation with 
nile red. For each sample 50,000 gated cells were analysed. Results are representative for three 
biological repeats.  
A B 
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Quantitation of the nile red fluorescence data by constructing the probability distribution for 
the increase in nile red fluorescence upon differentiation and the constraint that the 
fluorescence of adipocytes has to be greater by at least two standard deviations then the mean 
nile red fluorescence of undifferentiated cells revealed that 72 ± 3 % of the 3T3-L1 and 80 
± 1 % of the 3T3-F442A cells acquired a lipid-loaded phenotype. 
In order to better characterise the adipocyte-like phenotype of the increased fluorescent 
populations observed at day 12, I further looked for other parameters that could be used to 
discriminate between the undifferentiated and differentiated populations. The differentiation 
process has been previously shown to induce changes in the cellular phenotype due to 
accumulation of lipids in the cytoplasm [287]. These changes affect the size and granularity 
of the cell [302] and thus, the two parameters can be used in flow cytometry and plotted as 
side scatter (SSC-H) for granularity and forward scatter (FSC-H) for cell size. Investigation 
of the two parameters revealed increases in both the granularity and size of adipocytes 
(Figure 3.3 B, D) compared to preadipocytes (Figure 3.3 A, C) suggesting the previous 
described increased lipid accumulation in the cells [287, 302]. 
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Figure 3.3. Dot plots of the side scatter (SSC-H) versus the forward scatter (FSC-H) for (A, B) 
3T3-L1 and (C, D) 3T3-F442A cells before (A, C) and 12 d after induction of adipogenic 
differentiation (B, D). Black dots are within the gated population that was analysed, grey dots are 
outside the gated population. The same gate was used to analyse all samples. 
 
Further analysis to establish if there is a correlation between granularity (SSC-H) and 
fluorescence indicated a positive association between the two parameters, with a higher 
fluorescence in the population presenting increased SSC-H (≥ 300 A.U.) compared to the 
population with lower SSC-H (< 300 A.U.) (Figure 3.4 A, B). 
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Figure 3.4. Increased nile red fluorescence correlates with granularity in differentiated 3T3-
F442A adipocytes. (A) Dot plot of the Nile red fluorescence versus the side scatter SSC-H. The 
population with a nile red fluorescence of ≥ 300 arbitrary units (A.U.) represented by black dots, the 
population with a nile red fluorescence of < 300 A.U. by grey dots. (B) The histogram of the side 
scatter reveals that the population with a Nile red fluorescence of ≥ 300 A.U. displays increased side 
scatter. 
 
Taken together, the data obtained suggest that, according to the correlated increase in size, 
granularity and fluorescence, the majority of the 3T3-L1 and 3T3-F442A cells at d 12 after 
the adipogenic induction have accumulated lipids presenting an adipocyte-like phenotype.  
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Discussion 
 
The aim of this chapter was to investigate the degree of differentiation of both 3T3-F442A 
and 3T3-L1 cell lines exposed to adipogenic cocktail for 12 days as described in Material 
and methods chapter. Oil red O staining of neutral lipids revealed an 80 - 90 % increase in 
lipid accumulation upon differentiation (Figure 3.1), but the inherent difficulty of assigning 
lipid droplets to cells in this method precludes a quantitative analysis. To circumvent this 
problem flow cytometry using the fluorescent dye nile red was used and the cells were 
investigated using three previously established parameters for adipocyte differentiation: 
fluorescence, size and granularity [301-303]. Data obtained showed that 72 % of the L1 and 
80 % of the F442A cells displayed increased lipid content after 12 d of differentiation (Figure 
3.2). Both differentiated populations also showed an increase in granularity (Figure 3.3) and 
fluorescence (Figure 3.4). These results are comparable with previously data from Rubin et 
al  [300] that showed a 80 - 90% differentiation of the 3T3-L1 population in response to a 
similar adipogenic stimulation. Their assessment of differentiation was also based on light 
microscopy observations of Oil red O stained cells but also on the measurement of 
triacylglycerol content of the heterogeneous differentiated population by extraction via 
saponification. The measurement of the percentage of differentiated cells by oil red O 
staining was similar to the ones I obtained using the same method and can be considered 
comparable to the 72 - 80 % differentiation rate I obtained using nile red fluorescent staining 
and flow cytometry as the method is much more accurate and quantitative. 
An ~3 fold increase in nile red fluorescence in both 3T3-L1 and 3T3-F442A differentiated 
adipocytes is similar to the one obtained by Schaedlich et al [304] in adipogenic 
differentiation of the murine stem cell line CGR8. The increased fold fluorescence in F442A 
adipocytes can be explained by increased susceptibility of this cell line to differentiation 
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compared to the L1 line [296]. The observation of a second differentiated population in the 
F442A cell line that presents higher fluorescence and granularity (Figure 3.1 B and 3.4) is 
also in agreement with previous reports [305, 306]. Le et al [305] described heterogeneity 
in 3T3 cell populations in response to hormone stimulation during adipogenic 
differentiation. Their study showed that expression of adipogenic markers such as 
peroxisome proliferator-activated receptor γ (PPAR γ), CCAAT enhancer binding protein α 
(C/EBP α) and adipocyte protein 2 (aP2) is not sufficient for induction of the lipid-laden 
phenotype of adipocytes. In order for the cells to accumulate lipids, hormones as insulin, 
growth hormones or PPARγ ligands (thiazolidinediones, eg. Dexamethasone) are essential 
for lipid metabolism-related protein induction. The cell-to-cell variability and asynchrony in 
the response to these factors is responsible for the heterogeneity of the population in 
differentiation. Their observations are sustained also by Loo et al [306] that showed 
heterogeneity in the differentiating process, with multiple populations different both at 
molecular levels (expression of PPAR γ, perilipin A, C/EBP α) and phenotypic level (size 
of lipid droplets) in response to the adipogenic cocktail. Their study showed also formation 
of a small but highly differentiated population exhibiting numerous large lipid droplets that 
accumulate increased fluorescence similar to the one I have obtained. As the F442A cell line 
was shown to present a higher sensitivity to hormonal induction of adipogenesis [296] and 
considering the number of investigated cells per experiment, this could explain why the two 
distinct populations can be observed in the F442A compared to the L1. Experiments using 
fluorescence-activated cell sorting (FACS) and molecular analysis of the cells forming this 
population could provide more insight on the nature of this heterogeneity in the population.  
My results indicate that the established in vitro differentiation treatment is inducing a change 
of the cell phenotype towards a lipid-laden one for 70 - 80 % of the 3T3-L1 and 3T3-F442A 
cell populations after 12 d of adipogenic induction. Taking into consideration the 
School of Biological and Biomedical Sciences Chapter 3 
 
127 
 
observations made by Le et al [305] showing correspondence in increased lipid droplets 
accumulation, size and granularity of the cell and expression of adipogenic gene markers , 
my results suggest that the populations obtained are differentiated adipocytes.
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CHAPTER 4 
 
HIGH CONCENTRATIONS OF THE SATURATED FATTY ACID 
PALMITIC ACID DO NOT INDUCE ENDOPLASMIC RETICULUM 
STRESS IN IN VITRO DIFFERENTIATED ADIPOCYTES 
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Excess nutrient intake, elevated saturated fatty acids (SFA) and cholesterol blood levels 
commonly found in obese individuals have been previously linked to the profound 
physiological and metabolical alterations in adipocytes [157, 307-310]. Cellular 
hypertrophy, hyperplasia, mitochondrial and endoplasmic reticulum stress are some of the 
main phenotypical and physiological changes that occur in the adipose tissue during the 
onset of obesity. Obesity is the leading risk factor for type 2 diabetes, cardiovascular diseases 
and hypertension [2, 34] and it was linked to ER stress, inflammation and insulin resistance 
in adipose tissue [151, 251, 311]. Recent studies have shown that exposure to high 
concentrations of fatty acids, especially palmitate, leads to development of ER stress in 
different cell lines such as preadipocytes [221, 250], pancreatic β cells [248, 249], podocytes 
[312] and hepatocytes [246, 247] but the physiological factors leading to ER stress and 
activation of the UPR in obese adipocytes are not well characterised. In order to investigate 
the role of high concentrations of saturated fatty acids in activation of the UPR in adipocytes, 
the results in this chapter address the following questions: 
 
1. Do high concentrations of saturated fatty acids induce ER stress in adipocytes? 
 
2. Is the differentiation process from preadipocytes to adipocyte affecting the cellular 
response to saturated free fatty acids? 
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4.1. The saturated fatty acid palmitic acid does not induce endoplasmic reticulum 
stress in adipocytes 
 
In order to investigate the role of SFA in induction of ER stress in adipocytes, I evaluated 
the effect of palmitic acid on in vitro differentiated 3T3-F442A and 3T3-L1 cells. Palmitic 
acid was chosen for these experiments as it represents the most prevalent SFA in the normal 
diet [313] and also the most abundant SFA in circulating plasma [314, 315]. Moreover, 
palmitic acid has been shown to be the SFA with the highest cell toxicity due to the fact that 
acid represents a poor substrate for lipid metabolism and can represent a precursor for 
lipotoxic ceramide formation. The range of concentrations used in the experiment was in the 
physiological range reported for rodents and humans [314, 316]. 
The cells were maintained in serum free medium over night to avoid SFA contamination 
from serum and incubated with increasing concentrations (0 - 1 mM) of Palmitic acid 
complexed to fatty acid-free bovine serum albumin (BSA) for up to 48 h. Ethanol was used 
as no SFA: BSA control treatment as the alcohol served as solvent for the palmitic acid 
preparations. As a positive control for UPR induction 1 µM thapsigargin was used, as the 
compound is known to induce ER stress by depleting ER luminal Ca2+ stores [317].  
Previous reports have indicated that high concentrations of palmitic acid can lead to 
apoptosis via lipotoxicity or induction of increased oxidative stress in preadipocytes [268], 
hepatocytes [247, 318] or pancreatic β-cells after 24 h treatment [319-322]. In order to ensure 
that the results obtained are determined by ER stress induction only, I first evaluated the 
effect of the proposed palmitic acid concentrations on cell viability. An MTT assay was used 
to assess cell viability for up to 48 h incubation with the treatment. Palmitic acid did not 
affect the viability of the 3T3-F442A adipocytes over a period of up to 48 h (Figure 4.1.1 
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and data not shown), while incubation with 1 μM thapsigargin decreased viability by ~37 % 
compared to the control. 
 
 
Figure 4.1.1.  High concentrations of palmitic acid do not affect adipocyte viability. MTT assay 
on in vitro differentiated 3T3-F442A adipocytes incubated for 48 h with the indicated concentrations 
of BSA-complexed palmitic acid. 1 μM thapsigargin (Tg) was used as a positive control for induction 
of ER stress. Thapsigargin (Tg) - treated samples were compared to untreated (0) samples using a 
two-tailed, unpaired t-test. 
 
 
In order to investigate the role of palmitate on ER stress induction, protein and mRNA levels 
for UPR markers were investigated. The activity of the PERK signalling branch of the UPR 
was assessed by Western blotting for CHOP protein, while activation of IRE1α was 
monitored by measuring the percentage of XBP1 mRNA splicing.  
Incubation of 3T3-F442A adipocytes for 6 - 8 h with increasing concentrations of palmitic 
acid did not show an quantifiable elevation of CHOP protein levels (Figure 4.1.2 A, B) or 
induce detectable levels of XBP1 mRNA splicing (Figure 4.1.2 C, D) for any of the 
concentrations used. 
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Figure 4.1.2. Palmitic acid does not induce CHOP protein expression (A, B) or XBP1 splicing 
(C, D) in 3T3-F442A adipocytes after short term exposure. (A, C) 6 h incubation; (B, D) 8 h 
incubation; Relative (rel.) CHOP signals were corrected for the loading control GAPDH and the 
results from the quantitation are shown below the image. XBP1 splicing was corrected for β-actin 
mRNA expression and the percentage of spliced XBP1 mRNA is indicated below the image as % 
splicing; 1 μM thapsigargin (Tg) was used as a positive control for induction of ER stress; Images 
presented are representative for three independent biological repeats of the experiment. 
Abbreviations: u – unspliced XBP1 mRNA, s – spliced XBP1 mRNA. 
 
 
 
 
Previous data from the literature indicate UPR activation in response to prolonged exposure 
(up to 24 h) to high concentrations of saturated fatty acids in variuos cell lines [221, 268, 
312]. As the adipocyte main function represents lipids storage and trafficking, I decided to 
continue the investigatigation of palmitic acid high concentrations role on ER stress 
induction at longer time points than previously seen in other cell lines, respectively up to 48 
h. Western blots analysis for CHOP protein expression in 3T3-F442A adipocytes incubated 
with palmitic acid for 12 or 24 h did not show any induction of the PERK branch of the UPR 
(Figure 4.1.3 A, B), results supported also by the lack of XBP1 mRNA splicingby IRE1α  in 
response to any of the concentrations of palmitate tested at any of the times investigated 
(Figure 4.1.3 C, D). 
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Figure 4.1.3. Palmitic acid does not induce CHOP (A, B) or XBP1 splicing (C, D) in adipocytes 
after long term exposure. (A, C) 12 h and (B, D) 24 h exposure of 3T3-F442A adipocytes to various 
concentrations of palmitic acid. The images shown are representative for three independent 
biological repeats of the experiment. 
 
 
 
Similar results were obtained after incubation with the SFA: BSA complex for 48 h (Figure 
4.1.4 A, C). 
In order to exclude the possibility that the results shown in Figures 4.1.2 - 4.1.4 are cell line 
specific, the 48 h incubation was repeated using the 3T3-L1 in vitro differentiated adipocytes 
(Figure 4.1.4 B, D). The results suggest that palmitic acid does not induce CHOP expression 
or XBP1 splicing in any of the tested in vitro differentiated adipocytes, at any concentration 
and time point tested (Figure 4.1.4). 
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Figure 4.1.4. Palmitate does not induce CHOP protein expression or XBP1 splicing in 
adipocytes. (A, B) CHOP expression in in vitro differentiated (A) 3T3-F442A adipocytes and (B) 
3T3-L1 adipocytes exposed to the indicated concentrations of palmitate complexed to BSA for 48 h. 
Relative (rel.) CHOP signals were corrected for the loading controls GAPDH or ACTB. (C, D) XBP1 
splicing in in vitro differentiated (C) 3T3-F442A adipocytes and (D) 3T3-L1 adipocytes incubated 
for 48 h with the indicated concentrations of BSA-complexed palmitate. Images are representative 
for three biological repeats of the experiment. 
 
 
 
 In order to further validate the effect of high concentrations of palmitic acid on ER stress 
induction and consolidate the results obtained so far, I investigated also the mRNA levels 
for ER stress responsive genes such as HSPA5 (BiP), GADD153 (CHOP) and ERDJ4 which 
are markers of downstream UPR activation [221, 224, 225, 268]. HSPA5 encodes BiP 
(binding protein or GRP78), one of the most important ER chaperones involved in the proper 
folding of nascent proteins and prevention of aggregation of un- or misfolded proteins in the 
ER lumen that leads to activation of UPR [224, 247]. GADD153 encodes CHOP (C/EBP 
homologous protein) protein, a bZIP transcription factor situated downstream in the PERK 
pathway. CHOP is induced early during ER stress [323] and its expression is maintained 
stable during activation of the UPR, making it a useful indicator of ER stress induction [224, 
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225]. ERDJ4 encodes the DNAJ-like ERdj4 protein, an ER chaperone that acts as a co-factor 
for BiP in the ER-associated degradation of unfolded proteins [324]. All three genes have 
been previously shown to be highly induced by ER stress and play a key role in the outcome 
of the UPR, cell survival or apoptosis [224, 249, 323]. Expression levels of these genes were 
evaluated by quantitative PCR (RT-qPCR) in 3T3-F442A and 3T3-L1 adipocytes incubated 
for 48 h with increasing concentrations of palmitic acid. The high physiological 
concentrations of palmitate used in the experiments did not elevate the mRNA levels for any 
of the genes of interest: BiP (HSPA5, Figure 4.1.5 A), CHOP (GADD153, Figure 4.1.5 B) 
or ERDJ4 (Figure 4.1.5 C) especially when compared to the large increases in mRNA levels 
of these genes in thapsigargin-treated adipocytes. 
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Figure 4.1.5. Palmitate does not induce BiP, CHOP, or ERDJ4 transcription in adipocytes. (A, 
B) BiP mRNA, (C, D) CHOP mRNA, and (E, F) ERDJ4 mRNA levels in in vitro differentiated (A, 
C, E) 3T3-F442A and (B, D, F) 3T3-L1 adipocytes incubated for 48 h with the indicated 
concentrations of BSA-complexed palmitate. The differences in BiP mRNA (p = 0.10 for 3T3-F442A 
adipocytes and p = 0.34 for 3T3-L1 adipocytes), CHOP mRNA (p = 0.11 for 3T3-F442A adipocytes 
and p = 0.41 for 3T3-L1 adipocytes), and ERDJ4 mRNA (p = 0.48 for 3T3-F442A adipocytes and p 
= 0.41 for 3T3-L1 adipocytes) levels in the untreated and palmitate treated samples are not 
statistically significant. p values were calculated using ANOVA test and comparing treated and 
untreated samples after three biological repeats of the experiment. Thapsigargin-treated samples 
were compared to untreated samples using a two-tailed, paired t-test. 
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Taken together, the results presented in Figures 4.1.1 - 4.1.5 indicate that high concentrations 
of the SFA palmitic acid do not induce ER stress in adipocytes in vitro. 
In order to make sure that the results were not artefacts resulting from technical problems 
regarding the palmitate:BSA complex formation, the complex biological activity was tested. 
Preadipocytes previously described in the literature to develop ER stress in response to high 
concentrations of palmitate [221] were incubated with the palmitate:BSA complexes  (0 – 
750 µM) for 6 - 24 hours [268] and ER stress was investigated via the XBP1 splicing assay. 
The results presented in Figure 4.1.6 A, B indicated that palmitate concentrations  ≥ 500 µM 
induce XBP1 splicing starting 12 h, with even lower concentrations inducing XBP1 splicing 
at higher time incubations (24 h). These data suggest that the palmitic acid-BSA complexes 
used in my experiments can induce ER stress as previously described in the literature and 
the results obtained in mature adipocytes are not a consequence of a technical problem. 
 
 
Figure 4.1.6. High concentrations of palmitic acid induce XBP1 splicing in 3T3-F442A 
preadipocytes. XBP1 mRNA splicing in preadipocytes incubated for (A) 12 h and (B) 24 h with the 
indicated concentrations of palmitic acid; percentage of spliced (s) vs unspliced (u) XBP1 mRNA is 
indicated as % splicing. Images are representative for three biological repeats of the experiment. 
 
 
 
Previous studies have suggested a positive association between ER stress and insulin 
resistance mainly through UPR-induced activation of proinflammatory signalling pathways 
such c-jun N-terminal kinase (JNK) and NFκB [206, 246, 247, 250, 311, 325, 326]. Ozcan 
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et al [311] and Karaskov et al [248] showed that chronic elevation of SFA characterising the 
obese status induces ER stress leading to JNK activation and impaired insulin signaling. The 
main proposed mechanism is that JNK activation in response to ER stress induces serine 
phosphorylation of IRS-1, making the substrate protein IRS-1 a poor substrate for the insulin 
receptor (IR). This results in reduced thyrosine activation of IRS-1 in response to IR 
activation and decreased insulin signaling transduction upon receptor stimulation  [244, 252, 
327]. Serine phosphorylation of IRS-1 also inhibits IRS-1/PI3-kinase interaction that is 
essential for insulin downstream signalling resulting furthermore in decreased signalling 
[328]. A second proposed mechanism is that upon stimuli or stresses, Akt activity can be 
modulated via interaction with cytosolic chaperones and in the case of ER stress via 
interaction with the chaperone BiP (GRP78) [252]. Whyle BiP is primarily an ER protein, it 
was shown that it can localise also at the plasma membrane under pathological conditions 
[329, 330] or in the cytosol, as GRP78va. The cytosolic form is results from alternative 
splicing (retention of intron 1) and is lacking the ER signalling peptide [331]. UPR activation 
induces BiP up-regulation and promotes the interaction between BiP and Akt that leads to 
inhibition of serine 473 (S473) phosphorylation in Akt and subsequently decreases its 
activity. Also, by inhibiting general translation ER stress decreases Akt levels leading to 
impaired insulin signaling and insulin resistance [253].  
To investigate whether high concentrations of the SFA palmitic acid can affect insulin 
signaling in adipocytes, the murine 3T3-F442A adipocytes were preincubated overnight 
with the established concentrations of palmitatic acid and then incubated with 100 nM 
insulin for 15 min to stimulate the insulin signalling pathway. Akt phosphorylation at S473 
and was investigated as a marker of impaired insulin signaling. 
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Figure 4.1.7. Palmitate does not inhibit insulin signalling in 3T3-F442A adipocytes. AKT S473 
phosphorylation in serum-starved adipocytes incubated for 48 h with the indicated concentrations of 
BSA-complexed palmitic acid before stimulation with 100 nM insulin for 15 min. Phosphorylation 
of AKT at S473 (pS473-AKT) and total AKT levels were determined by Western blotting. Relative 
pS473-AKT signals were corrected to total AKT and values are presented below the pS473-AKT 
image. Actin (ACTB) was used as loading control. The image shown is representative for three 
independent biological repeats of the experiment. 
 
 
The SFA palmitic acid did not inhibit insulin-stimulated AKT  S473 phosphorylation in 3T3-
F442A adipocytes as shown in Figure 4.1.7, which is consistent with several other reports 
[332-336], although it did induce a reduction of the AKT serine residue phosphorylation in 
preadipocytes even at lower concentrations (up to 0.75 mM palmitic acid) (Figure 4.1.8). 
 
 
Fig 4.1.8. Palmitate inhibits insulin signalling in 3T3-F442A preadipocytes. AKT S473 
phosphorylation in serum-starved preadipocytes incubated for 48 h with up to 0.75 mM BSA-
complexed palmitic acid before stimulation with 100 nM insulin for 15 min. Relative pS473-AKT 
signals were corrected to total AKT and values are presented below the pS473-AKT image. The 
image presented is representative for three independent biological repeats of the experiment. 
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In conclusion, high concentrations of palmitic acid were not able to induce ER stress PERK 
pathway as shown via CHOP protein and mRNA levels investigation in Figures 4.1.2 to 
4.1.4 (A,B) and 4.1.5 (B, C). Similar lack of induction was observed also for IRE1α pathway 
as none of the investigated downstream effectors HSPA5 (BiP), ERDJ4 mRNA (Figure 4.1.5 
A,B, E, F) or XBP1 mRNA splicing were induced. Taken together the results indicate that 
none of the investigated UPR pathways showed activation in response to high concentrations 
of palmitic acid in in vitro differentiated adipocytes. 
Investigation of ER stress-induced insulin signalling alterations via AKT S473 
phosphorylation as previoulsy described [248, 268, 311, 337], failed also to reveal any 
evidence that palmitic acid is able to induce ER stress in adipocytes or decreased insulin 
signalling.  
In conclusion, my results indicate that high concentrations of the SFA palmitic acid do not 
induce an UPR in adipocytes even after up to 48 h incubation.  
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4.2. The cellular specialisation of adipocytes in lipid storage and metabolism may 
provide a protection mechanism against SFA-induced ER stress 
 
 
Adipocytes represent the key modulator of lipid storage and metabolism in the body. In 
normal physiological states, during feeding, excess energy intake is stored in adipocytes in 
the form of triacylglycerol (TAG) and cholesteryl esters (CE) in lipid droplets. Postprandial 
or during fasting, adipocytes release lipids into the blood stream as free fatty acids (FA) and 
glycerol in order to meet the energy requirements of peripheral tissues. Excess accumulation 
of lipids in other tissues leads to lipotoxicity, inflammation and insulin resistance [34, 151]. 
This suggests that the high specialisation of adipocytes in lipid synthesis and breakdown 
may protect these cells against lipid injury. Taking into consideration the results presented 
in the first part of this chapter and the previously known data of ER stress induction by high 
levels of SFA in preadipocytes [268] and other cell lines [247, 248, 268, 318, 338], I 
hypothesised that cell specific mechanism(s) that protect adipocytes against SFA-induced 
injury exist. In order to identify possible components of this mechanism (s), I decided to 
investigate: (1) the basal mRNA levels of ER stress sensors in adipocytes vs preadipocytes 
and (2) the mRNA expression levels of several enzymes involved in SFA metabolism in 
adipocytes versus preadipocytes, respectively involved in TAG and phospholipid (PL) 
biosynthesis (described in detail in the Introduction chapter). 
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4.2.1 ER sensing protein basal levels are not involved in adipocyte protection 
mechanisms against SFA-induced ER stress 
 
I have previously provided evidence that high concentrations of palmitic acid could not 
induce PERK (CHOP protein and mRNA expression) or IRE1α (XBP1 mRNA splicing) 
pathways in adipocytes at any of the concentrations or time points investigated. Also, I have 
shown in Figure 4.6 that preadipocytes do exhibit XBP1 splicing in response to palmitate 
similar to the previously published data by Guo et al [268] showing induction of both PERK 
and IRE1α pathways in response to SFA treatments. As the difference between the adipocyte 
and preadipocytes is based on the molecular and physiological changes during the 
differentiation process, I decided to investigate first if the basal levels of ER stress sensor 
proteins can be affected by this process. Increased basal levels of PERK or IRE1α in 
adipocytes vs preadipocytes could explain the protection against the SFA-induced ER stress 
investigated.  
In order to investigate if this hypothetical mechanism is true, PERK and IRE1α mRNA levels 
were quantified via RT-qPCR and compared in adipocytes vs. preadipocytes. 
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Figure 4.2.1. IRE1a and PERK mRNA in preadipocytes and in vitro differentiated adipocytes. 
(A) 3T3-F442A cells and (B) 3T3-L1 cells were differentiated for 12 d. mRNA levels were 
determined by RT-qPCR and standardised to ACTB. A two-tailed, unpaired t-test was used to 
compare the expression level in differentiated cells to the expression level in undifferentiated cells. 
Results are representative for three biological repeats of the experiment. 
 
Results presented in Figure 4.2.1 panel A show a 40 ± 5 % decrease in IRE1α mRNA and a 
50 ± 10 % increase in PERK levels in 3T3-F442A adipocytes vs preadipocytes. In 3T3-L1 
cells no significant differences were observed in basal mRNA in adipocytes vs preadipocytes 
for IRE1α and respectively PERK. 
The variation observed in the 3T3-F442A cells needs further addressing, as if the decrease 
in IRE1α mRNA basal levels observed is true, then the 3T3-F442A adipocytes should be 
more prone to develop ER stress and I have shown that it is not the case (Figures 4.1.2 to 
4.1.4 C, D). Also, PERK mRNA levels do show a high increase but due to the large error bar 
the results are not statistically significant suggesting most probably technical variability in 
sample preparation. More repeats of the experiments are necessary in order to establish if 
the PERK mRNA basal levels are indeed increased in adipocytes vs preadipocytes in 3T3-
F442A cell line and if this could contribute to the protection against SFA-induced ER stress. 
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The results obtained in the 3T3-L1 cell line showed no significant differences in the basal 
mRNA levels of the ER sensor proteins in adipocytes vs preadipocytes suggesting that the 
gene expression of the two investigated proteins is not part of the adipocyte protection 
mechanism hypothesised. Future repeats of the experiment in 3T3-F442A cells will provide 
more evidence if the gene expression for the two sensors is indeed altered by the 
differentiation process or the results obtained so far are generated by technical errors. 
 
 
4.2.2. Changes in mRNA levels for enzymes involved in SFA metabolism during the 
differentiation process could confer protection against lipotoxicity in adipocytes 
 
In adipocytes, the two major pathways involved in dietary SFA metabolism are represented 
by the TAG and phospholipids (PL) biosynthesis pathways. TAG biosynthesis allows the 
SFA to be stored in lipid droplets until physiologically demanded. TAGs represent the main 
cellular energy source. The phospholipid biosynthesis pathway leads to formation of 
phospholipids, essential components of biological membranes and cellular signalling. 
In order to investigate if alteration of mRNA levels for enzymes involved in these pathways 
is conferring protection against dietary-induced SFA lipotoxicity in adipocytes, mRNA 
levels for some of the main enzymes involved in TAG and PL formation were investigated 
in adipocytes and preadipocytes. 
One of the first steps in dietary SFA metabolism in the cell is desaturation to 
monounsaturated fatty acids (MUFA), which are the main components of PL, TAG and 
cholesterol esters [100, 112, 339]. This step is catalysed by stearoyl-CoA desaturase 1 
(SCD1), a Δ9 desaturase localised in the endoplasmic reticulum. In order to investigate if the 
desaturation capacity of the cell could be involved in the SFA-related injury, mRNA 
expression levels for SCD1 desaturase were investigated in adipocytes vs preadipocytes. 
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Results shown in Figure 4.2.2 indicated a 4 ± 0.5 fold increase in SCD1 desaturase mRNA 
levels in adipocytes suggesting that cellular specialisation of adipocytes during 
differentiation is indeed affecting their desaturation capacity.  
 
Figure 4.2.2. Basal levels of stearoyl-CoA desaturase 1 (SCD1) mRNA are increased in 
adipocytes versus preadipocytes. [P] preadipocytes versus [A] adipocytes. * p < 0.05 , where the p 
value was obtained using a two-tailed paired t test. Results are representative for three biological 
results of the experiment. 
 
For the TAG biosynthesis pathway, GPAT3 which catalyses acylation and formation of 1-
acylglycerol-3-phosphate, lipin 1 which is a member of the PAP family involved in 
dephosphorylation of 1,2-diacylglycerol-3-phosphate to the intermediate 1,2-diacylglycerol 
and DGAT1 enzyme that catalyses acylation of 1,2-DAG to TAG mRNA levels were 
studied. Basal mRNA expression for all the investigated genes was shown to be significantly 
increased in adipocytes vs preadipocytes: GPAT3 expression by 24 ± 2 fold, lipin 1 by 3 ± 
0.5 fold and DGAT1 by 20 ± 2 fold, suggesting that adipocytes have indeed a higher basal 
expression of genes involved in SFA metabolism and TAG synthesis as hypothesised (Figure 
4.2.3 A-C) 
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Figure 4.2.3. Basal levels of enzymes involved in TAG biosynthesis are increased in adipocytes 
versus preadipocytes. RT-qPCR results for genes involved in TAG formation, (A) GPAT3 mRNA, 
*p < 0.001, (B) Lipin 1 mRNA, *p < 0.05, (C) DGAT1 mRNA, *p <0.05 in adipocytes [A] versus 
preadipocytes [P]. p values was obtained using a two-tailed paired t test. The results are 
representative of three biological repeats of the experiment. 
 
 
For the PL biosynthesis pathway, CTP: phosphocholine cytidylyltransferase (CT), the rate-
limiting enzyme of the CDP-choline pathway that leads to phosphatidylcholine (PC) 
formation and CTP: phosphoethanolamine cytidylyltransferase (ET) and the enzyme 
involved in phosphatidylethanolamine (PE) synthesis were chosen to be investigated in my 
study. mRNA levels for CT and respectively ET genes were investigated via RT-qPCR. The 
CT mRNA expression revealed a 5 ± 0.5 fold decrease in adipocytes compared to 
preadipocytes (Figure 4.2.4 A) while ET mRNA levels increased by 5 ± 1 fold ( Figure 4.2.4 
B) suggesting a possible shift in the PL biosynthesis ratio in differentiated adipocytes. 
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Figure 4.2.4. Basal levels of enzymes involved in PL biosynthesis in adipocytes versus 
preadipocytes. RT-qPCR results for mRNA levels of enzymes involved in PL formation (A) CT 
mRNA, *p<0.005, (B) ET mRNA, *p<0.05 in adipocytes versus preadipocytes. p values were 
obtained using a two-tailed paired t test. Results are representative for three biological repeats of the 
experiment. 
 
 
Taken together my results show up-regulation of all the investigated genes involved in TAG 
biosynthesis, SFA desaturation and phosphatidylethanolamine synthesis suggesting that 
adipocyte differentiation process may protect the cells against SFA injury via up-regulation 
of lipid metabolism enzymes and storage of excess lipids. 
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Discussion 
 
The SFA palmitic acid does not induce endoplasmic reticulum stress in adipocytes 
 
The first aim of this study was to investigate whether high concentrations of the SFA acid 
are inducing ER stress in adipocytes. Previously it has been described that high 
concentrations of SFAs are able to activate the UPR in preadipocytes [221, 250], β pancreatic 
cells [248, 249], podocytes [312] and hepatocytes [246, 247] but limited data [266, 340] are 
available for adipocytes, the key players in obesity and metabolic diseases.  
In the present chapter I have investigated the effect of up to 1 mM palmitic acid on in vitro 
differentiated 3T3-F442A and 3T3-L1 adipocytes, after short (0-8 h) or long (12-48 h) term 
incubations. Assessment of ER stress markers CHOP protein and XBP1 mRNA splicing 
induction in response the SFA palmitic acid indicate that the SFA treatment was not able to 
induce either of the markers at any of the time points and concentrations investigated (Figure 
4.1.2 to 4.1.4). Furthermore there was no evidence for increases in the basal mRNA levels 
for the ER stress-responsive genes encoding for BiP, CHOP and ERDJ4 (Figure 4.1.5).  As 
no evidence of UPR was found in any of my experiments, in order to avoid possible negative 
results due to technical errors, I have also investigated if the palmitic acid: BSA complexes 
used in the cell treatment were able to induce ER stress in other cell lines as previously 
reported. For these experiments, 3T3-F442A preadipocytes were used as they were 
previously described by Guo et. al [268] to show ER stress induction in response to palmitic 
acid: BSA treatment. Induction of XBP1 mRNA splicing in preadipocytes as shown in Figure 
4.1.6 indicated that the designed treatment is biologically active but it does not induce ER 
stress in adipocytes. 
Insulin resistance has been previously linked to ER stress in hepatocyte [332] via activation 
of proinflammatory pathways JNK or NFκB [244, 248, 251, 311, 332, 341]. As my results 
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showed no indication of ER stress induction, I have also investigated if palmitic acid is 
affecting insulin signalling in adipocytes. My results presented in Figure 4.1.7 show that that 
none of the SFA concentrations used was able to induce AKT S473 phosphorylation in 
adipocytes after 48 h incubation. SFA treatment control experiments in preadipocytes 
showed abolishment of AKT S473 phosphorylation in response to insulin stimulation at 
lower concentrations of palmitic acid (0.75mM) (Figure 4.1.8) as previously reported [268]. 
These results suggest that high concentrations of SFA palmitic acid do not induce ER stress 
or insulin resistance in adipocytes even after long term (48 h) incubation. 
My results differ from ones previously presented by other groups but the studies vary greatly 
in the choice of the SFA or SFA mixes used and the adipocyte differentiation protocols. In 
2007 Jiao et al.[342], using in vitro differentiated 3T3-L1 cells and mouse primary 
adipocytes, reported rapid induction (1-3 h incubation) of ER stress and possible insulin 
resistance in response to 0.5 mM mixture of SFAs. These results contradict not only my 
observations (Figure 4.1.2 to 4.1.5, and 4.1.7) but also several other papers investigating 
different FA role in ER stress induction. This is due to the fact that the SFA mix used was 
composed of  myristic, lauric, arachidonic, oleic, and linoleic acids and previous studies have 
shown that unsaturated fatty acids oleic and linoleic acid protect cells from the negative 
effects of SFAs [343-348] while that the medium-chain fatty acids lauric and myristic acid 
do not induce insulin resistance [334]. Although the mix used by the group did not contain 
palmitic acid, palmitate is considered the most common saturated fatty acid reported to 
induce cell injury [320, 349] and I did not see any induction of ER stress markers or 
inhibition of AKT phosphorylation previously shown also by other groups [334]. A possible 
explanation for the results obtained by Jiao et al could be that the FA mixture used contains 
a high concentration of arachidonic acid (AA) and this could induce an intracellular Ca2+ 
mobilisation from the ER compartment towards the cytoplasm, as previously shown [350, 
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351]. Although AA represents one of the major components of plasma membrane 
phospholipids, 10 µM AA has been shown to induce Ca2+ mobilisation after few minutes 
incubation with a maximal effect after 30 min incubation [350]. Ca2+ release from the ER in 
response to 25 µM AA have been shown to also induce c-jun mRNA up-regulation (after 3 
h incubation) and JNK phosphorylation [351]. These time points coincide with the induction 
of ER stress markers and JNK phosphorylation that Jiao et al describe in their study. PERK 
and IRE1α phosphorylation were shown to reach a peak at 30 min incubation, being 
maintained for up to 3 h. This overlap in the time of AA induced Ca2+ mobilisation from the 
ER and the time of ER stress markers  induction suggests that AA-induced Ca2+ mobilisation 
from the ER could be the cause of ER stress.  
Another study that reported SFA-induced ER stress comes from Kawasaki et al. [266] that 
reported  induction of ER stress in 3T3-L1 adipocytes treated with 50 μg/ml of a free fatty 
acid mixture derived from human serum. Although the group showed induction mRNA 
levels for most of the ER-stress related genes (Bip, Chop, Edem, Erdj4, Atf4), the 
concentration used in the study is much lower than the one I have used in my experiments 
and the ones used in most of the published data related to FA effects in various cell lines (21, 
22, 24, 93). Also, the described induction of ER stress in response to the FA mixture is very 
rapid (4 h) surpassing even the induction I could see in preadipocytes incubated with higher 
concentrations of palmitic acid (Figure 4.1.6). This contradiction between my results and 
their data could come from the difference in the SFA used, similar to the discrepancy 
observed in report to the data presented by Jiao et al [342], but the small concentration of 
fatty acid mixture used suggest also that compounds other than the SFAs present in the fatty 
acid mixture used by Kawasaki et al. seem to be causing ER stress in adipocytes. 
Koh et al.[352] and Jeon et al.[340] have reported induction of eIF2α phosphorylation and  
downstream ATF3 mRNA after 24 h incubation of 3T3-L1 adipocytes with 0.5 mM palmitic 
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acid. As eIF2α can be phosphorylated by other protein kinases that are not related to ER 
stress [353] and the groups did not show any other marker of ER stress induced, I concluded 
that the results obtained are not the result of ER stress as I could not see any induction of 
PERK-eIF2α downstream CHOP protein (Figure 4.1.1-4.1.4. A, B),  XBP1 mRNA splicing 
4.1.2 C, D and 4.1.3 C, D) or mRNA for ER-stress related genes in response to even higher 
concentration of palmitic acid and for longer exposure. 
 
 
The specialisation of adipocytes in lipid storage and metabolism may provide a 
protective mechanism against SFA-induced ER stress 
 
The results discussed in the first part of this chapter indicate that high concentrations of the 
SFA palmitic acid do not induce ER stress or insulin resistance at any of the concentrations 
and time points used in the study. Palmitic acid is known to be able to induce ER stress in 
preadipocytes [268] and I have previously shown this effect in my results (Figure 4.1.6). 
This has raised the question of why the adipocytes are not injured. In order to find an answer 
to this question, I hypothesised the existence of a cell specific mechanism that protects 
adipocytes against SFA-induced ER stress. As the differential response to SFAs was 
observed after the differentiation process and it is known that adipocytes become highly 
specialised in lipid metabolism and storage [207], I decided to investigate two possible 
mechanisms that could protect the cell: (1) alteration in basal expression levels for genes 
encoding for ER-sensor proteins and (2) up-regulation of genes encoding for enzymes 
involved in SFA intracellular metabolism.  
My results indicated no significant differences in the basal levels of PERK or IRE1α genes 
in adipocytes vs preadipocytes in 3T3-L1 cell line though the results obtained in the F442A 
line need further investigation to ensure the validity of the results (Figure 4.2.1). If the 
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variation between the basal mRNA levels of the two ER stress sensors in the F442A line will 
be proved to be correct and if the imbalance can be translated at protein level, this would 
suggest a cell line-specific unbalanced UPR response that could include different 
mechanisms of response to cellular stress and injury. If the results obtained are the 
consequence of technical errors in sample preparation then the results will be expected to be 
similar to the ones obtained in the L1 line. This would suggest that the basal level of genes 
for ER stress main sensor protein is not the reason behind the protection of adipocyte against 
lipotoxicity.  
Investigation of the second proposed mechanism, revealed an up-regulation in mRNA levels 
for genes encoding for enzymes involved in desaturation (Figure 4.2.2), TAG biosynthesis 
(4.2.3) and PL-related ET gene (Figure 4.2.4 B) suggesting that this could be the protection 
mechanism against SFA-induced ER stress in adipocytes. This conclusion is in part sustained 
by recent evidence in the literature indicating key roles for SCD1 in protection against SFA-
induced cell injury (SFAs accumulation and toxicity) in various cell lines such as β-cells 
[354-357], hepatocytes [358], human epithelial cells [359], human cancer cells [360], and 
adipocytes [106]. The mechanisms by which SCD1 levels are protecting against lipotoxicity 
are various. Collins et al. [106] show that in adipocytes SFA are inducing up-regulation of 
de novo lipogenesis and coordinate the up-regulation of elongation and desaturation 
pathways for disposal of saturated fatty acids and production of monosaturated fatty acids 
(MUFA) in order to protect the cells from saturated fatty acids toxicity. Dietary SFA such 
as palmitate and stearic acid have been shown to be substrates for SCD 1 [354, 356, 361] 
leading to formation of palmitoleate and oleate. Ariyama et al. [359] and Miyazaki et al. 
[362] show that SCD1 knockdown decreases cellular MUFA and consequently increased 
SFA/MUFA ratio in membrane PLs leading to UPR induction in vitro and respectively in 
vivo, thus indicating the role of SCD1 in maintaining cell membrane fluidity and increase 
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cell survival in response to increase SFA intake. Up-regulation of TAG biosynthesis 
enzymes correlates positively with formation and enlargement of lipid droplets in 
adipocytes, the storage capacity of the cell not allowing accumulation of FAs that can cause 
cellular toxicity. Increased PL synthesis is also correlated with homeostasis of cellular 
membranes (plasma membrane, ER and mitochondrial) and lipid droplet membrane 
formation [363-365]. 
Listenberger et al [366] showed that overexpression of SCD1 in CHO cells increases 
exogenous palmitate delivery to the TAG pool and protects against palmitate-induced 
lipoxicity. SCD1 overexpression was directly correlated with increased desaturation of 
exogenous palmitic acid and also with increased deposition of palmitic acid in the TAG pool. 
Using deuterated palmitate, the group shows that in scd1 overexpressing cells, the TAG 
fraction contains over 71 % of the deuterated fatty acid, 4.6 fold more than normal CHO 
cells. Interestingly, only ~ 25 % of the deuterated palmitate in TAG pool was associated with 
C16:1 while the majority was stored as saturated fatty acid. These data suggest that in case 
of increased unsaturated FAs levels in the cell due to the enzyme overexpression, SCD1 can 
facilitate storage of the saturated FAs in the lipid droplet. Furthermore, the group brings 
evidence that resistance to palmitate-induced apoptosis is correlated in a dose-dependent 
manner with SCD1 expression. They show that 25RA cells that have increased expression 
of SCD1 (induced by overexpression of SREBP) but not as much as the SCD1 CHO cells 
are moderately resistant to palmitate-induced lipotoxic cell death while the SCD1 cells are 
completely protected. Furthermore, the study also establishes a correlation between TAG 
synthesis and palmitate and oleate induced lipotoxic apoptosis. Using DGAT1-/- fibroblasts 
they show that the deficient cells are similarly sensitive to palmitate as the WT but they 
exhibit apoptosis also in incubations with oleate whereas the WT cells exhibit only increased 
TAG synthesis. Taken together theses results show that the role of SCD1 and TAG 
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biosynthesis in SFA-induced injury is essential. Scd1 not only protects the cell against 
palmitate toxicity but is actively involved in both desaturation and storage of the SFA. 
These results are in agreement with the hypothesis I formulated from my observations. 
During my PhD I have also designed genetic aproaches using lentiviral transduction in order 
to knockdown or over-express SCD1 and DGAT1 in adipocytes and preadipocytes in order 
to establish a clear correlation between the TAG synthesis and the protection against the 
palmitate toxicity. Due to technical problems though these experiments were not started. 
Further studies using the already set up lentiviral system will be able to show if indeed, up-
regulation of the enzymes involved in TAG synthesis represents the adipocyte protection 
mechanism against palmitate lipotoxicity. 
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CHAPTER 5 
 
INCREASED CONCENTRATIONS OF CHOLESTEROL DO NOT 
INDUCE UPR IN ADIPOCYTES 
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The results described in Chapter 4 provide evidence that obesity-related high concentrations 
of SFA are not able to induce ER stress in adipocytes. In this chapter I have continued to 
investigate other lipid factors in the obese individuals’ blood that may affect homeostasis 
and lead to organelle dysfunction in adipocytes. 
Hypercholesterolemia, or high blood cholesterol concentrations, is one of the hallmarks of 
obesity [269, 367, 368] and a major risk factors in development of cardiovascular and 
metabolic diseases [369-371]. In the adipose tissue, the second major tissue involved in 
cholesterol metabolism after the liver, excess cholesterol was shown to lead to abnormal 
cellular cholesterol distribution and organelle dysfunction [308, 372, 373] but the 
mechanisms involved are not fully elucidated. Recent studies have linked high cholesterol 
concentrations with mitochondrial and ER stress in macrophages [270, 374, 375] and smooth 
muscle cells [271]. The present chapter is investigating whether high concentrations of 
cholesterol are inducing the UPR in adipocytes and thus contributing to cellular dysfunction. 
 
 
5.1. High cholesterol concentrations are not able to induce ER stress in adipocytes 
 
Accumulation of excess unesterified (free) cholesterol (FC) in the cell has been previously 
shown to be cytotoxic due to an increased imbalance in the FC: phospholipid ratio in the 
cellular membrane leading to membrane rigidity and alteration of lipid raft dynamics [376]. 
This FC-induced cytotoxicity was described especially in cells that exhibit a low endogenous 
cholesterol biogenesis and rely on exogenous sources, such as adipocytes [377-379]. In 
humans, adipose tissue contains the largest pool of free cholesterol in the body, which is 
estimated at 25% of total body cholesterol [380, 381]. This amount of free cholesterol 
doubles in obese individuals [378, 382]. In the normal physiological state, most of the free 
cholesterol uptaken by the adipocytes is stored as cholesteryl esters in the lipid droplet but 
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during excess hyperlipidemic intake, the cell becomes overloaded with FC and this could 
lead to organelle dysfunction and cellular stress. 
In order to investigate the role of high concentrations of cholesterol on ER stress induction 
in adipocytes, in vitro differentiated 3T3-F442A and 3T3-L1 adipocytes were incubated for 
48 h with 100 µg/ml acetylated low density lipoprotein (AcLDL). UPR activation was 
assessed at the protein level - CHOP expression by Western blotting, and at the mRNA level 
- XBP1 splicing by PCR (Figure 5.1.1). My results showed that AcLDL did not elevate of 
CHOP protein expression (Figure 5.1 A, B) or induce XBP1 mRNA splicing (Figure 5.1.1 
C, D). 
One of the mechanisms involved in limitation of cellular FC-induced toxicity in adipocytes 
is cholesterol esterification that allows storage of cholesterol in the lipid droplets. This 
esterification is catalysed by  the ER membrane acyl-coenzyme A: cholesterol 
acyltransferase (ACAT) enzyme [383], [384]. Inhibition of ACAT1 activity has been shown 
to increase the FC overloading in macrophages and muscle cells [271, 374, 383, 385] and 
has been associated with obesity and type 2 diabetes [386]. In order to investigate if ACAT 
activity is protecting against cholesterol overloading-induced ER stress in adipocytes, I have 
chemically inhibited esterification of cholesterol using the ACAT1 inhibitor TMP-153 
[290]. Inhibition of ACAT with TMP-153 in the presence or absence of AcLDL did not 
induce elevation of CHOP protein levels or induce XBP1 mRNA suggesting that cholesterol 
does not induce ER stress in adipocytes independently of the ACAT enzyme activity (Figure 
5.1.1). 
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Figure 5.1.1. High cholesterol concentrations do not induce CHOP expression or XBP1 
splicing in adipocytes (A, B) CHOP protein levels and (C, D) XBP1 splicing in in vitro 
differentiated (A, C) 3T3-F442A and (B, D) 3T3-L1 adipocytes incubated for 48 h with 100 µg/ml 
human acetylated LDL (AcLDL), AcLDL and 0.6 μM of the ACAT inhibitor TMP-153, 0.6 μM 
TMP-153, 1.0 μM Tg, or left untreated (‘-‘). The average and standard error of three independent 
experiments are shown in the bar graphs. Differences in CHOP protein levels between the untreated 
sample and the samples treated with AcLDL, AcLDL and 0.6 μM TMP-153, and 0.6 μM TMP-153 
are not statistically significant (p = 0.26 for 3T3-F442A adipocytes and p = 0.35 for 3T3-L1 
adipocytes in a repeated measures ANOVA test assuming equal variabilities of the differences). 
 
 
To further validate these results, the next step was to investigate the mRNA levels of genes 
encoding for ER chaperones BiP and CHOP proteins in response to high concentrations of 
AcLDL. mRNA levels were quantitated using RT-QPCR and were normalised to β-actin 
mRNA. Results presented in Figure 5.1.2 show that cholesterol did not induce BiP or CHOP 
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m RNA levels in the presence or absence of ACAT1 inhibitor TMP-153 suggesting again 
that cholesterol does not induce ER stress in adipocytes. 
 
 
 
Figure 5.1.2. Cholesterol loading does not induce BiP or CHOP transcription in adipocytes.(A, 
B) BiP mRNA and (C, D) CHOP mRNA levels in in vitro differentiated (A, C) 3T3-F442A and (B, 
D) 3T3-L1 adipocytes incubated for 48 h with human acetylated LDL (AcLDL), AcLDL and 0.6 μM 
TMP-153, 0.6 μM TMP-153, 1.0 μM Tg, or left untreated (‘-‘). The average and standard error of 
three independent experiments are shown. Differences are not statistically significant (BiP mRNA: 
p = 0.34 for 3T3-F442A adipocytes and p = 0.11 for 3T3-L1 adipocytes; CHOP mRNA: p = 0.09 for 
3T3-F442A adipocytes and p = 0.11 for 3T3-L1 adipocytes). p values were obtained from a repeated 
measures ANOVA test comparing the samples treated to the untreated (-) samples and assuming 
equal variabilities of the differences. Thapsigargin-treated samples were compared to untreated 
samples using a two-tailed, unpaired t-test. 
 
 
In order to verify if my designed AcLDL treatment can induce ER stress, in vitro 
differentiated THP-1 macrophages were incubated with AcLDL for 16 h in the presence or 
absence of the ACAT inhibitor TMP-153. The macrophage cell line was chosen for this 
experiment due to previous data in the literature describing the THP-1 cells as prone to 
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develop ER stress in response to cholesterol overloading [291, 387]. The 16 h time point 
chosen was also in agreement with previous publications indicating elevation in apoptosis 
markers in macrophages after 18 h incubation with 100 µg/ml of acLDL [291, 374]. 
Evaluation of UPR induction was assessed as XBP1 mRNA splicing and showed induction 
of splicing in both the presence and absence of the ACAT inhibitor TMP-153 (Figure 5.1.3). 
These results proved that the treatment used in the study is biologically active and has similar 
effects with the previous reported ones, supporting the validity of my findings. 
 
 
Figure 5.1.3. Cholesterol induces XBP1 mRNA splicing in in vitro differentiated THP-1 
macrophages. Cells were incubated for 16 h with either 100 µg/ml AcLDL , AcLDL and 0.6 µM 
TMP-153, 0.6 µM TMP-153 alone, 1.0 μM Tg or left untreated (‘-‘). Image presented is 
representative for three biological repeats of the experiment. 
 
 
Taken together, my results indicate that high concentrations of cholesterol, although able to 
induce UPR in other cell lines (Figure 5.1.3 and ref [291, 374, 375]) are not able to induce 
ER stress in adipocytes. 
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Discussion 
 
 
High plasma levels of cholesterol have been associated with obesity and cellular dysfunction. 
Accumulation of FC in various cell lines has been shown to result in plasma membrane 
stiffness [388, 389], formation of cholesterol needle-shaped crystals that damage organelle 
structure [390], accumulation of cytotoxic oxysterols [376], and activation of apoptotic 
pathways [385]. Recently, several groups have linked cholesterol overloading with ER stress 
both in vitro [270, 271, 374, 375] and in vivo [374] but few studies have investigated its 
effect in adipocytes, the only cells capable of storing large amounts of lipids in the organism 
and one of the main affected cell types in obesity. 
In order to assess the impact of cholesterol overloading in adipocytes, I have investigated 
whether high concentrations of AcLDL can induce ER stress in in vitro differentiated 
adipocytes. My results indicate that in both 3T3-F442A and 3T3-L1 adipocytes treatment 
with high concentrations of cholesterol was not able to induce any of the UPR pathways 
investigated: CHOP protein and mRNA expression (Figure 5.1.1 A, B) (Figure 5.1.2 C, D) 
for PERK and XBP1 mRNA splicing (Figure 5.1.1 C, D) or BiP mRNA (Figure 5.1.2 A, B) 
for IRE1α. These results suggest that high cholesterol concentrations do not induce ER stress 
in adipocytes.  
My conclusion differ from the data reported by Chen et al [391] that shows induction of BiP 
and CHOP protein expression in response to increased concentrations of oxidised LDL 
(OxLDL) in 3T3-L1 adipocytes. The results though cannot be fully compared as the 
cholesterol-modified form used is different. Though both forms of LDL have similar cellular 
uptake [392], due to the presence of both oxidised protein and lipids, OxLDL can have 
multiple effects including impaired degradation [393-396] and enhanced inflammatory 
stimulation [395, 397, 398]. Also, the plasma AcLDL form is very reduced in vivo compared 
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to OxLDL, but used as a cholesterol substitute in in vitro experiments due to increased 
cellular uptake compared to the native form [399] and in order to specifically avoid cellular 
effects resulted from the oxidised components of molecule [400]. The in vivo oxidation of 
LDL was shown to be the results of various enzymes including NADPH oxidase, 15-
lipoxygenase, myeloperoxidase and mitochondrial electron transport system enzymes [399] 
and takes place mainly in the vascular wall. The biological effects are though strongly 
influenced by the modification of the component proteins and lipids, with the degree of 
oxidation strongly influencing the cellular effects of the altered lipoprotein [401]. Even mild 
oxidation of LDL-coating phospholipids was shown to induce activation of proinflammatory 
pathways in vascular cells [401] and oxidative stress in endothelial cells [402, 403], human 
fibroblasts [404] and rat neurons [405]. Increasing degrees of oxidation were shown to be 
associated with increased biological cytotoxic effects leading to apoptosis in macrophages 
via activation of caspase-3 [406]. As my results did not show any induction of UPR markers 
at protein or mRNA level, and considering the above presented differences in the two 
modified forms of LDL, I consider that the ER stress induction showed by Chen et al [391] 
may be the result of the effect of oxidised components of LDL and not the cholesterol 
overloading.  
As cholesterol loading did not show any effect on UPR induction in adipocytes, I have also 
investigated if cholesterol esterification via ACAT activity is the mechanism that protects 
adipocytes against this lipid overloading injury. Chemically-induced increase in intracellular 
FC levels via inhibition of ACAT1 using TMP-153 [290] revealed no changes in the UPR 
status in any of the cell lines investigated suggesting the existence of possible ACAT-
independent cell-specific protection mechanisms against FC lipotoxicity in adipocytes. One 
of these mechanisms could be originating from lipid storage in adipocytes and metabolic 
functions of adipocytes. Previous studies have suggested that adipocytes are not only able to 
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store increased amounts of cholesterol, but they also use more FC in order to maintain the 
homeostasis and functionality of the lipid droplet (LD) [407, 408]. Therefore, adipocytes 
present an increased utilisation of uptaken cholesterol. LD biogenesis, though not fully 
understood, has been described as formation of neutral lipids within the ER membrane that 
leads to distension of the membrane and budding of LDs surrounded by a single ER-derived 
monolayer rich in FC and phosphatidylcholine [408-410]. Zechner et al [407] provided 
evidence that adipocyte differentiation, respectively LD formation, is linked to increased FC 
cellular storage. Similarly, Prattes et al. [411] have shown that expansion of the TAG pool 
is associated with increased cholesterol storage in both cholesteryl esters and FC form, with 
FC localised mainly in the LD membrane. Both studies have brought evidence that support 
the hypothesis that in case of cholesterol overloading the adipocyte can direct the FC into 
two possible pathways: esterification and storage in the pre-existing LD and incorporation 
into membranes of the new or enlarged LD. Up-regulation and increased translocation of the 
cholesterol trafficking protein caveolin 1 [412] to the surface of lipid droplets in response to 
cholesterol overloading [413] brings more evidence that this model may reflect the 
physiological response of the adipocyte to cholesterol overloading. Future experiments are 
needed though in order to provide better insight into this proposed protection mechanism. 
Due to time limitations, these questions could not be answered in my study but future 
investigations looking at the cellular fate of cholesterol taken-up by adipocytes will provide 
further insight if LD membrane biogenesis is indeed involved in protection against lipid-
injury along with the increased storage capacity.  In depth evidence are also needed to 
exclude the possibility that TMP-153 may not fully inhibit the ACAT enzymatic activity in 
adipocytes. Previous studies have indicated that TMP-153 concentrations similar to the one 
used in my treatments inhibit cholesterol esterification in other cell lines such as human 
colonic carcinoma LS180 (half maximal inhibitory concentration, IC50 = 150 nM) and human 
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hepatoma Hep G2 cells (IC50 = 330 nM) [414] or reduce plasma cholesterol in various 
animals such as hamsters and rats, with an IC50 of 5-10 nM [290]. This suggests that the 0.6 
µM TMP-153 chosen for my experiments should be able to inhibit ACAT esterase activity 
and increase intracellular FC levels. However, more evidences are needed in order to reach 
this conclusion. These could be provided by constructing a TMP-153 dose-response curve 
in adipocytes in order to establish the exact IC50 needed to inhibit ACAT activity. 
Experiments using fluorescent labelled LDL could also elucidate the fate of the uptaken 
cholesterol in adipocytes via fluorescent microscopy while lipid extraction and fractionation 
by thin-layer chromatography could give an indication if the cholesterol is indeed stored in 
the lipid droplets as cholesteryl esters or used in membrane composition.
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CHAPTER 6 
 
THE PROINFLAMMATORY CYTOKINES TNF ALPHA, IL-6 AND IL-1 BETA DO 
NOT INDUCE AN UPR IN VITRO DIFFERENTIATED ADIPOCYTES 
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In the last decade, a number of studies have indicated that obesity is associated with chronic, 
low grade inflammation. It is characterized by abnormal cytokine production, increased 
acute-phase reactants, and activation of inflammatory signalling pathways [186]. A very 
important feature of this obesity-related inflammatory response is that it appears to be 
triggered and to reside predominantly in the adipose tissue [151, 415] due to two major 
events: macrophage infiltration and activation [153, 416], and dysfunctional hypertrophied 
adipocyte secretion of proinflammatory adipokines [155, 417]. Accumulation of 
proinflammatory cytokines in adipose tissue has been shown to contribute to a self-
sustaining vicious inflammatory cycle leading to cellular dysfunction and obesity-related 
insulin resistance [418-421] but the molecular mechanisms involved are not yet fully 
understood. Recent data have shown that inflammatory cytokines such as TNFα, IL-6 and 
IL-1β elicit ER stress in L929 cells [255] hepatocytes and β-cells [272-274] and that 
activation of the UPR leads to subsequent activation of proinflammatory pathways [422, 
423] and insulin resistance [167, 424-426]. Thus, I decided to investigate if proinflammatory 
cytokines in adipose tissue (TNFα, IL-6 and IL-β) can induce ER stress in adipocytes 
contributing to or directly inducing cellular dysfunction. 
 
6.1. TNFα does not induce ER stress in adipocytes 
 
TNFα is a dual proinflammatory cytokine involved in both host protective immune responses 
against infectious pathogens and in host damage in sepsis, tumour cachexia and autoimmune 
diseases [427, 428]. Due to its dual role, abnormal expression of TNFα has been extensively 
studied and has been linked to various immunological diseases. Recently, besides its immune 
roles, it has been shown that TNFα plays an important role in lipid [429-431] and glucose 
metabolism [418, 432, 433]. Kern et al.[434] and Hotamisligil et al. [424] have shown that, 
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though TNFα is mainly secreted by activated macrophages, the adipose tissue represents also 
a signifiant source of endogenous TNFα and that, its expression is elevated in this tissue in 
obesity in both human and animal models. Abnormal elevated TNFα levels in adipose tissue 
have been suggested to be the key mediator of insulin resistance via various mechanisms 
including: alteration in expression of glucose transporter 4 (GLUT4) gene [432, 433], 
inhibition of tyrosine phosphorylation of insulin receptor substrate 1(IRS-1) [418] and 
induction of oxidative stress [435-437]. It was shown to play an important role in inhibition 
of preadipocyte differentiation via down-regulation of adipogenic transcription factors such 
as PPARγ and C/EBPα and C/EBPδ [438-440], thus limiting the possibility of enhanced 
lipid clearance via storage of lipids in  mature adipocyte in case of excess intake. Recently 
high concentrations of TNFα  have been shown to activate the UPR in L929 cells [255], 
hepatocytes [441] and pancreatic β-cell [422]. Considering the fact that ER stress is known 
to mediate inflammation and insulin resistance in response to cellular dysfunction and the 
previous provided evidence of UPR induction in response to elevated TNFα, I decided to 
investigate the possibility that ER stress is the mediator of TNFα effects in obese 
dysfunctional adipocytes. In order to answer this objective, in vitro differentiated 3T3-
F442A and 3T3-L1 adipocytes were exposed to 0-25 ng/ml TNFα for 0-24 h. Markers of ER 
stress were investigated at  protein (CHOP expression) and  mRNA level (XBP1 mRNA 
splicing). 
UPR induction in response to TNFα treatment was initially investigated during short-term 
exposure (0-6 h) as TNFα activation of proinflammatory molecular pathways is known to 
be rapid and transient. Also, Xue et al.[441] have described a possible transient activation 
of ATF6 and XBP1 splicing induction in adipocytes after 4 h incubation with TNFα. My 
results, though, did not reveal any induction of any of the investigated UPR markers: CHOP 
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protein expression (Figure 6.1.1 A-C) or XBP1mRNA splicing (Figure 6.1.1 D-F) at any of 
the time points or the TNFα concentrations investigated. 
 
  
Figure 6.1.1. TNFα does not induce CHOP protein expression or XBP1 splicing in adipocytes 
after short time incubation. (A-C) CHOP protein expression, (D-F) XBP1 mRNA splicing in in 
vitro differentiated adipocytes incubated for (A, D) 2 h; (B, E) 4 h and (C, F) 6 h with the indicated 
concentrations of TNFα. Images are representative for three biological repeats of the experiments. 
  
In order to further investigate if TNFα is involved in ER stress induction in adipocytes, the 
experiments were continued by exposing the in vitro differentiated cells to TNFα for longer 
periods of time (24 h) and higher concentrations of TNFα (25 ng/ml). 
To avoid false results due to apoptosis resulted from TNFα-induced ROS accumulation as 
described in various cell lines [442, 443], before investigating the ER stress induction, the 
viability of the TNF treated cells was assessed using an MTT assay. The results shown in 
Figure 6.1.2 indicate that the concentrations used did not affect the cell viability even after 
24 h incubation with TNFα. 
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Figure 6.1.2. TNFα does not affect viability of adipocytes. MTT assay of in vitro differentiated 
adipocytes incubated with 0-25 ng/ml TNFα for 24 h. Tg, 1 µM thapsigargin. Differences between 
TNFα treated and untreated samples are not significant. * p < 0.05 for Tg compared to control “0”. 
A repetead measures ANOVA test was used to compare treated and untreated samples. The data 
shown are representative for three biological repeats of the experiment. 
 
The 24 h incubation of adipocytes with up to 25 ng/ml TNFα revealed that TNFα was not 
able to induce XBP1 mRNA splicing (Figure 6.1.3) even at higher concentrations. 
 
 
Figure 6.1.3. High concentrations of TNFα do not induce XBP1 mRNA splicing in adipocytes. 
XBP1 splicing in in vitro differentiated 3T3-F442A adipocytes incubated with the indicated 
concentrations of TNFα for 24 h.  The results are representative for three biological repeats of the 
experiment. 
 
In order to validate the TNF α activity, induction of JNK MAPK kinase was investigated as 
previously described in the literature [192, 444-446]. Preadipocytes were incubated with 25 
ng/ml TNFα for 30 min and JNK phsophorylation was assessed via Western blotting. TNFα 
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strongly induced JNK phosphorylation in preadipocytes as presented in Figure 6.1.4  
suggesting that the TNFα used in the experiment is active. 
 
Figure 6.1.4. TNFα treatment induces JNK phosphorylation in preadipocytes. 3T3-F442A 
preadipocytes were incubated with 25 ng/ml TNFα for 30 min and JNK phosphorylation was 
assessed by Western blotting. Image is representative for three biological repeats of the experiment 
 
Taken together, the absence of induction of any of the UPR markers investigated at protein 
level (CHOP) or mRNA level (XBP1) after short or long term incubation and for any of the 
investigated TNFα concentrations suggest that the cytokine does induce ER stress in in vitro 
differentiated 3T3-F442A and 3T3-L1 adipocytes. 
 
 
 
 
 
 
 
 
 
School of Biological and Biomedical Sciences Chapter 6 
 
171 
 
6.2. The proinflammatory cytokines IL-6 and IL-1β do not induce ER stress in 
adipocytes 
 
In part 1 of this chapter I have shown that high concentrations of the proinflammatory 
cytokine TNFα do not induce ER stress in in vitro differentiated 3T3-F442A and 3T3-L1 
adipocytes. To further characterise the role of inflammation in ER stress induction in obesity, 
I continued my study with the investigation of two other possible cytokines involved in the 
adipose tissue proinflammatory process and known to be elevated in obese individuals: IL-
6 [155, 417] and IL-1β [447]. Both interleukins are mediators of inflammatory responses 
and have been linked to insulin resistance in vitro and in vivo [417, 426, 448]. Also, 
circulating levels of IL-6 have been positively correlated with increase in the body mass 
index (BMI) [449] and general expansion and dysfunction of adipose tissue [450].  
To study whether these two proinflammatory cytokines induce ER stress in adipocytes, I 
exposed in vitro differentiated 3T3-F442A adipocytes to various concentrations (0 – 200 
ng/ml) of IL-6 or IL-1β for up to 24 h. The concentration range chosen for the experiment is 
higher than the circulating levels found in the blood of obese subjects (e.g. for BMI > 35, ~ 
8 pg/ml IL-6 [451]) but within the concentrations used for in vitro models of obesity [452, 
453]. 
Incubation for 24 h with high concentrations of IL-6 or IL-1β failed to induce XBP1 mRNA 
splicing in adipocytes as presented in Figure 6.2.1. 
 
 
 
School of Biological and Biomedical Sciences Chapter 6 
 
172 
 
 
Figure 6.2.1. The proinflammatory cytokines IL-6 and IL-1β do not induce ER stress in 
adipocytes. XBP1 mRNA splicing in in vitro differentiated 3T3-F442A adipocytes incubated for 24 
h with the indicated concentrations of (A) IL-6 and (B) IL-1β. Results are representative for three 
biological repeats of the experiment. 
 
To validate the activity of the two cytokines used, JNK activation was assessed in 
preadipocytes, in response to 200 ng/ml IL-6 or IL-1β. Short time incubation (0-30 min) of 
the cells in the presence of the cytokines preparations strongly induced JNK phosphorylation 
as shown in Figure 6.2.2 suggesting that the previous obtained results showing no induction 
of XBP1 mRNA in response to the cytokine treatment are not the results of technical errors. 
 
Figure 6.2.2. IL-6 and IL-1β induce JNK phosphorylation in 3T3-F442A preadipocytes. JNK 
phosphorylation in 3T3-F442A preadipocytes incubated for the indicated times with (A) 200 ng/ml 
IL-6 or (B) 200 ng/ml IL-1β. Results are representative for two biological results of the experiment. 
 
Taken together, my results suggest that the proinflammatory cytokines IL-6 and IL-1β, 
similar to TNFα, do not induce ER stress in in vitro differentiated 3T3-F442A and –L1 
adipocytes. 
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Discussion 
 
TNFα does not induce ER stress in adipocytes 
 
My results revealed no induction of any of the UPR markers for any of the time points or 
concentrations investigated suggesting that TNFα does not induce ER stress in in vitro 
differentiated  3T3 F442A or 3T3 L-1 adipocytes. My conclusions differ from the one drawn 
by Koh et al [352] that showed XBP1 splicing and phosphorylation of eIF2α protein in 
response to TNFα treatment in adipocytes. This study shows that TNFα effects are mediated 
mainly via TNFα-induced down-regulation of mitochondrial biogenesis and mitochondrial 
injury rather than via direct ER stress activation. This suggests a possible connection but not 
a causal role for TNFα in UPR induction. As I could not see any ER stress induction in 
response to TNFα, I concluded that the experimental results obtained by Koh et al may be 
induced by other mechanisms than the UPR that were not fully described or investigated in 
the study. Besides down-regulation of mitochondrial biogenesis, there are two other 
mechanisms proposed for induction of UPR by TNFα. The first one is related to the TNFα- 
induced ROS formation [441], while the second is proposing that TNFα could induce ER 
stress via up-regulation of proinflammatory cytokines and increased ER burden.  
In respect for the first mechanism proposed, Xue et al [441] study showed that TNFα  
activates ER stress pathways in a ROS-dependent fashion in L929 murine fibrosarcoma 
cells. They also show that the induction is very specific to the TNFα- induced ROS as 
oxidative stress inducers such as H2O2 and arsenite could not induce UPR though they were 
able to induce phosphorylation of eIF2α. Although the mechanism by which TNFα-induced 
ROS is activating the UPR is not fully addressed, the group proposed that BiP protein may 
play an important role in TNFα-mediated induction of ER stress. They hypothesise that 
increased formation of ROS in response to TNFα stimulation could dissociate BiP protein 
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from PERK and IRE1α and this dissociation would indirectly induce activation of the 
pathways via autophosphorylation. Though this proposed mechanism may be correct, there 
are still questions that can be raised from the data shown. For example, the TNFα-ROS-
eIF2α signal transduction was not affected by PERK knock-down suggesting that another 
kinase may be responsible for the effects on the eIF2α transcription factor. This hypothesis 
is also supported by Denis et al [454] that show that TNFα was able to induce transient 
phosphorylation of PERK and IRE1α in hypothalamus but without activation of downstream 
effectors, suggesting that TNFα alone may not sufficient to induce ER stress. Also, the ER 
stress induction shown by Xue and collaborators [441] may be cell specific as L929 cells are 
known to be more sensitive to TNFα cytotoxicity [455, 456]. As I did not observe induction 
of any investigated ER stress markers, I believe that the observations and the mechanism 
proposed by [441] could be cell specific and resulted from an increased sensitivity of the cell 
line to TNFα.  
Considering the second proposed mechanism of TNFα- induced ER stress, there is no 
evidence so far of a direct effect of TNFα-related transcriptional induction and increased 
protein folding burden in the ER. Although TNFα induces increased synthesis of 
proinflammatory cytokines [457] and pro-apoptotic molecules [458], it does also inhibit 
transcription of genes encoding for proteins involved in insulin signalling pathway [167], 
glucose [459] and FA transport [460], insulin-sensitising adipokines [461] and antioxidant 
enzymes [462]. Thus, the TNFα transcriptional regulation-induced protein burden 
mechanism is still under investigation. 
Taking into consideration that the previous evidence shown to support the role of TNFα in 
ER stress induction may be cell specific or correlative but not direct causal evidence, and 
the fact that I could not see any induction of UPR at any of the time points and concentrations 
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used, I concluded that TNFα is not able to induce ER stress in my proposed in vitro adipocyte 
model. 
 
The proinflammatory cytokines IL-6 and IL-1β do not induce ER stress in adipocytes 
 
My results showed in the second part of this chapter that both IL-6 (Figure 6.2.1 A ) and IL-
1β (Figure 6.2.1 B) do not induce ER stress in in vitro differentiated 3T3 F442A and L1 
adipocytes. As far as I am aware, this is the first study looking at the role of IL-6 and IL-1β 
in ER stress induction in adipocytes though an increasing number of data have shown their 
implications in insulin resistance and impaired glucose transport. There are only two studies 
that link the two cytokines to ER stress. The first one is coming from O’Neill et al [463] and 
is looking at the effect of the two cytokines on UPR induction in murine or human isolated 
pancreatic islets. Their results showed that overnight exposure of the islets to IL-6 and IL-β 
disrupt glucose-stimulated intracellular calcium response altering the Ca2+ homeostasis and 
inducing ER stress by limiting the intraluminal Ca2+ storage in a similar way to thapsigargin. 
Though the exact mechanism is still unknown, the effects were observed only when the 
cytokines were used simultaneous and not when the islets were incubated with each 
cytokine. Other observations in the study showed IL-6 does not seem to affect the islets 
function independently but its increasing the effects of IL-1β that is known to be increasingly 
detrimental to the β-cells [464]. This may suggest that the effects of the cytokine mix may 
be cell-specific due to increased sensitivity of the cells to IL-1β but further evidence is 
needed to confirm this hypothesis.   
The second is the study of Zhang et al [243] that also described a possible mechanism of 
UPR induction in response to IL-6 and IL-1β, involving endoplasmic reticulum CREBH 
activation but the results were shown to be tissue-specific and the UPR induction could be 
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seen only in the liver, in vivo, but not in in vitro cultured hepatocytes suggesting that the ER 
stress induction seen may not be the result of the proinflammatory cytokine treatment itself. 
As I could not see induction of UPR response for any of the investigated cytokines, I consider 
the results obtained by O’Neill et al [463] may be also cell specific although future 
experiments may need to be made in order to investigate if the cytokines cumulated effect 
could also induce ER stress in adipocytes. The existence of a previously demonstrated 
sensitivity of the β-cells to IL-1β suggests though that the observations may not be applyed 
to adipocytes and the effects are restricted to the β-cell line. 
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CHAPTER 7 
 
GLUCOSE STARVATION ACTIVATES THE UPR IN IN VITRO 
DIFFERENTIATED ADIPOCYTES 
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The adipose tissue is a highly active tissue subjected to continuous changes in size and 
composition throughout development and adult life [177]. This process of permanent 
remodelling is often discrete, reflecting the general turnover of adipose tissue cells in 
different depots and it is possible due to the high plasticity of the adipocytes and the well 
developed network of blood capillaries that ensure the cells an optimal exposure to nutrients 
and oxygen [176, 465]. In obesity, the remodelling process is pathologically accelerated and 
though it can be partially sustained by the hypertrophy and hyperplasia of the adipocytes, 
the angiogenesis process seems to be slower, the formation of new blood vessels acting as a 
limiting factor for the adipose tissue changes [154, 184]. Studies investigating the blood 
circulation have shown that the cardiac index and output remains constant in lean vs obese 
despite the different size of the adipose depots in both human and mice [177, 466] and that 
in obese subjects the postprandial blood flow per unit of adipocyte surface declines leading 
to suboptimal oxygen and nutrient delivery to the adipocytes [177, 467, 468]. In this context, 
the remodelling of the adipose tissue in obesity could be associated with nutrient starvation 
of cells in the newly over-expanded areas of the adipose tissue and this may contribute to 
cellular dysfunction and further metabolic implications. 
As previous studies have linked glucose starvation to ER stress in cancer cells [275] and β-
pancreatic cells [276], I have decided to investigate if the absence of glucose could also 
induce an UPR in adipocytes. In order to elucidate if glucose starvation can be one of the 
factors involved in ER stress induction, I incubated in vitro differentiated 3T3-F442A and 
3T3-L1 cells in the presence or absence of glucose and induction ER stress markers was 
assessed. Cells were incubated for 24 h with serum free medium supplemented with 2 mM 
L-glutamine as energy source [469, 470] but no glucose. Western blot analysis of CHOP 
protein expression after 24 h incubation revealed a potent induction of the protein in both  
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lines, with a 3 ± 1 fold increase in 3T3-F442A and a 5 ± 0.2 fold  increase in 3T3-L1 cells 
(Figure 7.1 A, B). Due to the fact that GAPDH expression is regulated by glucose [471], β-
actin was used as the loading control. 
 
 
 
Figure 7.1. Glucose starvation induces CHOP in adipocytes. (A) CHOP protein levels in in vitro 
differentiated 3T3 F442A and 3T3-L1 adipocytes maintained for 24 h in the presence of 4.5 g/l D-
glucose (“+ Glucose) or without glucose (“- Glucose). (B) Quantification of Western blots shown in 
panel (A). * p < 0.05, ** p < 0.005, with p values obtained using two-tailed, unpaired t-test. Images 
are representative for three biological repeats of the experiment. 
 
 
Investigation of XBP1 mRNA splicing revealed that induction of splicing in response to 
glucose starvation in 3T3-F442A in vitro differentiated adipocyte cell line. The induction 
started 12 h after glucose starvation when it recorded a 12 % splicing peak (Figure 7.2.A) 
and then decreased but maintained at 7 – 8 % splicing for up to 48 h (Figure 7.2 B). These 
data suggest that glucose starvation induces ER stress in in vitro differentiated 3T3-F442A 
and 3T3-L1 adipocytes. 
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Figure 7.2. Glucose starvation induces XBP1 mRNA splicing in adipocytes. In vitro 
differentiated adipocytes incubated with or without glucose (A) 3T3-F442A for 12 h; (B) 3T3-F442A 
(with or without Tg) and 3T3-L1 (without Tg) for 24 h; (C) 3T3-F442A for 48 h. Results are 
representative of three repeats of the experiments. 
 
 
To further confirm that glucose starvation induces ER stress in these two cell lines, I 
investigated the mRNA levels of some of the known UPR-induced genes after 24 h 
incubation with glucose free medium. A general increase in mRNA levels of all investigated 
markers was observed with: 5 ± 1 fold increase in CHOP, 16 ± 4 fold increase in BiP, 7 ± 1 
fold increase in ERDJ4 and 2 ± 0.5 fold increase in EDEM1 mRNA compared to adipocytes 
maintained for 24 h in medium supplemented with 4.5 g/l D-glucose (Figure 7.3) 
A 
C 
B 
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Figure 7.3. Glucose starvation induces an increase of mRNA levels for ER stress-related 
proteins. mRNA levels of CHOP, BiP, ERDJ4 and EDEM1 in in vitro differentiated 3T3-F422A 
adipocytes incubated for 24 h in the presence (+) or absence  (-) of glucose. * p < 0.05, ** p < 0.01, 
were p values were obtained from two-tailed, unpaired t-tests. 
 
 
Taken together these results suggest that glucose deprivation is inducing in ER stress at both 
protein and mRNA levels in in vitro differentiated 3T3-F442A adipocytes.  
 
Recently, numerous studies have associated decreased levels or absence of glucose with 
increased vascular endothelial growth factor A (VEGFA) secretion in murine ovarian cancer 
cells [472], retinal epithelial cells [473] and human hepatoma cells [474, 475]. Ghosh et al 
[476] showed that ER stress activation plays an important role in VEGFA transcription and 
it is intimately correlated with induction of angiogenesis in response to nutrient deprivation. 
Similar evidence was described by Marjon et al [477] in human breast adenocarcinoma cell 
line (TSE) who showed that both low glucose and chemical (tunicamycin and brefeldin A) 
induction of ER stress markedly increased expression of VEGFA mRNA. 
Angiogenic signalling was shown to be induced in the obese adipose tissue [478]. As I have 
previously shown that glucose starvation is inducing ER stress in in vitro differentiated 
adipocytes I decided to investigate also if glucose starvation is inducing VEGFA expression 
in adipocytes. Incubation of 3T3-F442A adipocytes for 24 h in the absence of glucose 
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revealed a 2 ± 0.5 fold induction of VEGFA mRNA (Figure 7.4) suggesting that adipocytes 
may play an important role in the continuously signalling for development of the vascular 
support in order to minimise the effects of the high nutrient intake in the rapidly expanding 
tissue in. 
 
 
Figure 7.4. Glucose starvation induces VEGFA mRNA in adipocytes. RT-qPCR analysis of 
VEGFA mRNA levels in 3T3-F442A adipocytes incubated for 24 h in the presence or absence of 
glucose. Results are representative for three biological repeats of the experiment. 
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Discussion 
 
An increasing number of studies suggest that in obesity, the adipose tissue remodelling may 
be imbalanced, with the adipocytes rapid expansion surpassing the angiogenesis rate [154, 
176]. This imbalance was observed as reduced blood flow in the obese tissue [479] resulting 
in possible local deprivation of nutrients and ER stress induction in adipocytes.  
ER stress has been shown to be closely linked to the nutrient status in various cell lines 
[480]13,14], with glucose as the main regulator of glucose-regulated ER chaperones 
(GRP78/BiP, GRP 94, GRP 170) gene expression [481] and PERK-mediated signalling 
being involved in maintenance of glucose homeostasis [482]. Low levels of glucose have 
been shown to induce UPR via multiple mechanisms including  defects in N-glycosylation 
that could lead to protein misfolding [481] and decrease in ATP cellular levels and inhibition 
of SERCA pump activity in the ER membrane resulting in decreased Ca2+ levels in the ER 
lumen and PERK activation [276].These mechanisms have been described by Xi et al [483] 
and Palorini et al [275] in cancer cells and Moore et al [276]  in pancreatic β-cells and 
showed that the ER stress induction in response to glucose deprivation is not a cell type-
specific response. In order to investigate if glucose starvation can induce UPR in adipocytes, 
in vitro differentiated 3T3-F442A and 3T3-L1 adipocytes were subjected to glucose 
starvation for various periods of time (12 to 48 h) and the expression of ER stress markers 
was assessed at both the protein and mRNA levels. Western blot experiments for CHOP 
protein expression revealed protein induction after 24 h incubation of adipocytes with 
medium without glucose (Figure 7.1), suggesting activation of ER stress PERK. Induction 
of XBP1 mRNA splicing was observed starting 12 h and was maintained up to 48 h 
incubation (Figure 7.2) showing activation of the second UPR branch, IRE1α. 
Transcriptional data investigating the mRNA levels of the UPR downstream CHOP, BiP, 
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ERDJ4 and EDEM1 proteins consolidated the previous results and validated the conclusion 
that glucose starvation is inducing ER stress in adipocytes. 
 My results are in agreement with data previously reported by Wasef et al [267] who showed 
CHOP mRNA induction in 3T3-L1 cells after 4 h exposure to medium without glucose and 
increase in CHOP protein expression after overnight glucose starvation. As this is the only 
study I am aware of that is looking at glucose starvation-induced ER stress in adipocytes, 
my results provide further evidence that UPR is indeed induced by glucose deprivation in 
adipocytes and this could contribute to the cellular dysfunction of the adipocyte in the obese 
adipose tissue. 
In the last part of this chapter I have continued my investigation by addressing a question 
related to the potential physiological implications of glucose starvation- induced ER stress 
in adipocytes. As adipocytes are known to secrete vasoactive factors as VEGFA in response 
to glucose starvation [484], and I showed that glucose starvation is inducing ER stress in in 
vitro differentiated adipocytes, I have hypothesised that the UPR may represent a mechanism 
of the stressed cells to try to alleviate the low glucose stress by inducing angiogenic 
signalling and formation of blood vessels in the affected tissue areas. In support of this 
hypothesis are the observations made by Ghosh et al [476] that showed that chemically-
induced ER stress increase VEGFA mRNA levels in PC3, HepG2 and Ins1 832/13 cells. 
Using deficient mouse embryonic fibroblasts (MEFs) for PERK (perk-/- ) and IRE1α (ire1α 
-/-) they showed that the VEGFA mRNA expression in response to chemical ER stress 
induction is reduced in these cells compared to the wild-type and that the phenotype can be 
restored by lentiviral transduction with the human IRE1α or PERK protein. Via Ire1α and 
XBP1 siRNA experiments they also provided evidence of IRE1α and downstream effector 
XBP1 involvement in VEGFA induction in HepG2 cells. As I could see induction of both 
PERK and IRE1α pathways in response to glucose starvation, I decided to investigate if 
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VEGFA is induced in adipocytes at the same time point as the ER stress pathways. 
Incubation of 3T3-F442A adipocytes in the absence of glucose for 24 h, the time point when 
all UPR markers were observed to be induced, revealed a 2 ± 0.5 fold increase in VEGFA 
mRNA. Though I could see induction of VEGFA at the same time point and in the same 
conditions with ER stress induction, a direct connection between the two could not be 
established with the present evidence. Direct investigation of ER stress pathways in VEGFA 
induction in adipocytes using chemically designed inhibitors or genetically modified cell 
lines is required in order to establish causality between glucose starvation induction of UPR 
and angiogenic signalling. This causality could not be addressed in this study due to time 
limitations but will hopefully be addressed in detail in future projects. 
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CHAPTER 8 
 
HYPOXIA INDUCES ER STRESS IN IN VITRO DIFFERENTIATED 
ADIPOCYTES 
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As discussed in the previous chapter, the adipose tissue remodeling process in obesity can 
play an important role in the pathological progress of the disease via formation of poor 
vascularised areas where the adipocytes are subjected to low blood supply. Along with the 
lack of nutrient supply, the cells could also to be subjected to low oxygen conditions that 
could further affect the homeostasis and induce dysfunction. In the last decade, increasing 
numbers of studies have brought evidence of hypoxic conditions in obese adipose tissue. 
The unchanged cardiac output [180] and postprandial blood flow [485] in the adipose tissue 
of obese vs lean subjects or the decreased oxygen partial pressure in adipose tissue of ob/ob 
or dietary obese mice compared to the lean control [278, 486] are some of the evidence 
presented. The increased size of the obese adipocytes is also supporting  the existence of 
hypoxia in obese adipose tissue, as the hypertrophic cells can reach 150-200 nm diameter 
[181], exceeding the normal O2 diffusion rate of 100-200 nm [487]  
Investigation of hypoxia effects in adipocytes have shown a positive correlation between the 
low oxygen conditions and increased secretion of proinflammatory adipokines both in in 
vitro [277, 278] and in vivo [278, 488]. Insulin signaling was also shown to be disrupted by 
hypoxia  via attenuation of glucose transport [279, 280] and inhibition of IR and IRS-1 
phosphorylation [280]. As ER stress in adipocyte has been strongly associated with both 
induction of proinflammatory cytokine and insulin resistance in obesity, in this chapter I 
have investigated if hypoxia could trigger ER stress in adipocytes.  
To fulfill this objective, in vitro differentiated 3T3-F442A and 3T3-L1adipocytes were 
cultured in 0.5 % O2 for up to 8 h and markers of ER stress induction were analyzed at the 
protein and mRNA level. Induction of hypoxia was evaluated by investigation of protein 
level of hypoxia inducible factor 1 α (HIF-1α), a key regulator of cell response in O2 
restriction [489, 490]. In normal O2 conditions HIF-1α protein is constantly synthesized in 
the cell but rapidly degraded as a result of post-translational modifications made by prolyl 
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hydroxylase enzymes (PHDs) [491]. The PHDs use oxygen to hydroxylate proline residues 
in the oxygen-dependent degradation domain of HIF-1α and make the protein accessible to 
the von Hippel-Lindau tumor suppressor protein which initiates ubiquitination and 
degradation via the 26S proteasome complex [492, 493]. In low oxygen conditions, the 
prolyl hydroxylases are inactive and HIF-1α is stabilised as the degradation complex cannot 
bind to it [491]. The strict regulation of the protein in response to oxygen levels, makes HIF-
1α protein levels a good indicator of oxygen conditions that can be used to identify hypoxic 
conditions [494, 495].  
Investigation of HIF-1α protein in the in vitro 3T3-F442A and 3T3-L1 differentiated 
adipocytes revealed an increase in the protein levels within 2 h of incubation in 0.5 % O2. 
The increase further was maintained for up to 8 h in both cell lines (Figure 8.1 A). As hypoxia 
was previously shown to induce HIF-1α also at transcriptional level [496, 497], mRNA 
levels of HIF-1α were investigated by RT-qPCR. The increase in mRNA levels observed 
followed a similar pattern to the one described by the protein expression (Figure 8.1 C) and 
further validated the experimental hypoxia induction.  
PERK activation in response to hypoxia was investigated as induction of eukaryotic 
translation initiation factor 2 α (eIF2α) phosphorylation and revealed increase in 
phosphorylation of the eIF2α protein corresponding with the HIF-1α protein expression 
(Figure 8.1 A, B). These results suggest that hypoxia may induce PERK activation but 
further investigations are needed to ensure that PERK kinase is responsible for the eIF2α 
protein phosphorylation. This is due to the fact that eIF2α protein can also be phosphorylated 
by two other kinases: general control non-derepressible 2 (GCN2) [498] and protein kinase 
R (PKR) [499]. GCN2 is a serin/threonine protein kinase that senses amino acid deficiency 
and it is involved in regulation of amino acid metabolism [498] while PKR is induced by 
double-stranded RNA (dsRNA), cytokines and mechanical stressors and is signalling for 
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inflammation. Involvement of two kinases in hypoxia induction of eIF2α phosphorylation 
have been previously investigated but the data are contradictory and vary largely with the 
model used [500-502]. Investigation of CHOP protein expression could not be used as 
evidence of PERK induction as CHOP protein expression could not be detected in the 
Western blotting experiments (data not shown). Multiple repeats of the experiments 
suggested that the lack of protein induction was not the result of a technical error as initially 
believed from the eIF2α phosphorylation observations. The explanation could reside in the 
fact that CHOP protein may be induced by hypoxia at longer time points than the ones 
investigated in my study although the mRNA levels showed increased transcription starting 
6 h exposure to hypoxia (Figure 8.3 C). This explanation is supported also by the 
observations of Lopez-Hernandez et al [503] that show CHOP induction starting 9 h 
incubation with chemical hypoxia inducer CoCl2.  
Taken together, these data suggest that hypoxia could induce PERK activation in adipocytes 
but there is no sufficient evidence to conclude that induction of eIF2α phosphorylation is 
strictly PERK-mediated. 
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Figure 8.1.  Hypoxia induces increased phosphorylation of eIF2α in adipocytes (A,B) Induction 
of HIF 1α protein and eIF2 α phosphorylation at serine 51 in in vitro differentiated (A) 3T3-F442A 
and (B) 3T3-L1 adipocytes, and (C) HIF-1α mRNA expression in 3T3-L1 adipocytes incubated for 
the indicated times under 0.5 % (v/v) O2. Results are representative for three biological repeats of 
the experiment. * p < 0.05 was calculated using ANOVA test comparing the 2-8 h samples to the 
control (0 h). 
 
 
Activation of the Ire1α branch of the ER stress response in response to hypoxia was 
investigated as XBP1 mRNA splicing induction and revealed significant splicing starting 
after 2 h exposure to low O2 conditions. The splicing induction was maintained up to 8 h of 
hypoxia incubation and followed a similar pattern with HIF-1α and induction of eIF2α 
phosphorylation (Figure 8.2) 
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Figure 8.2. Low oxygen conditions induce XBP 1 mRNA splicing in in vitro differentiated 
adipocytes. XBP1 mRNA splicing levels in in vitro differentiated (A) 3T3-F442A and (B) 3T3-L1 
adipocytes incubated for the indicated times under hypoxic conditions. Results are representative for 
three biological repeats of the experiment. 
 
 
In order to further investigate ER stress induction in response to low oxygen conditions, I 
have also assessed the mRNA levels of the UPR downstream genes BiP, CHOP and ERDJ4 
in adipocytes incubated under hypoxic conditions. Elevated mRNA levels for BiP, CHOP 
and ERDJ4 mRNA were observed in adipocytes incubated in hypoxic conditions compared 
to normal O2 ones (Figure 8.3). The increase in mRNA levels followed a similar pattern with 
the one observed in HIF-1α mRNA, XBP1 mRNA splicing and eIF2α phosphorylation.  
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Figure 8.3. Hypoxia induces ER-stress related genes in in vitro differentiated adipocytes. mRNA 
levels of BiP in (A) 3T3-F442A, (B) 3T3-L1 and of (C) CHOP and (D) ERDJ4 in in vitro 
differentiated 3T3-L1 adipocytes incubated for up to 8 h in 0.5% (v/v) O2. * p< 0.5, ** p< 0.05. p 
values were calculated using ANOVA test. 
 
 
 
Taken together, these results suggest that hypoxic conditions validated by HIF-1α 
expression, induce ER stress in in vitro differentiated adipocytes although further 
experiments are needed to conclude that PERK induction is the only kinase responsible for 
the eIF2α phosphorylation observed. 
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Discussion 
Adipose tissue remodelling in obesity has been associated with formation of poor 
vascularised areas where adipocytes are subjected to nutrient and oxygen starvation. These 
cells have been previously shown to exhibit markers of cellular stress and alterations in 
proinflammatory adipokines secretion and insulin signalling. In Chapter 7 I have provided 
evidence that glucose starvation induces ER stress in in vitro differentiated adipocytes. The 
present chapter continues the investigation of the factors associated with adipose tissue 
remodelling, by addressing the question if hypoxia can also induce ER stress in adipocytes. 
Incubation of 3T3-F442A and 3T3-L1 adipocytes in hypoxic conditions (0.5 % O2) revealed 
induction of eIF2α phosphorylation (Figure 8.1 A, B) and IRE1α- induced XBP1 mRNA 
splicing (Figure 8.2) starting 2 h incubation. The induction was correlated with increase in 
O2 sensing HIF-1α protein and mRNA expression indicating hypoxia (Figure 8.1 A-C). 
Quantitation of mRNA levels for ER stress-related genes BiP, CHOP and ERDJ4 showed 
up-regulation of the gene expression in response to low O2 conditions (Figure 8.3). The 
induction was observed at similar time points as the induction of HIF-1α expression (and 
Figure 8.1) supporting the previous results suggesting that hypoxia is inducing ER stress in 
the in vitro differentiated model of adipocytes. Although my experiments could not conclude 
that phosphorylation of eIF2α is induced by PERK only, the cumulating results from the 
IRE1α branch of UPR and the mRNA induction of ER-downstream indicate without doubt 
that hypoxia is inducing ER stress in the differentiated adipocytes. 
My observations are similar to the ones described by Hosogai et al [277] that showed 
induction of eIF2α phosphorylation after 2 h incubation of 3T3-L1 adipocytes in 1 % O2 
conditions. Induction of XBP1 mRNA splicing was also observed in Hosogai’s study but at 
a later time point (6 h) probably due to the sensitivity of the method used for evaluation (PstI 
digestion of PCR products) and maybe the stringency of the hypoxic conditions. 
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Similar to my data regarding eIF2α phosphorylation in response to hypoxic conditions, 
Koumenis et al [500] described induction of eIF2α phosphorylation in lung carcinoma A549 
cells, human fibroblasts AG1522 and HeLa cervical carcinoma cells after 2 h exposure to 
0.02 % O2 chemically-induced hypoxia. Using cells expressing a dominant-negative PERK 
allele or PERK-/- mouse embryo fibroblasts (MEFs), they have also shown that PERK is the 
only kinase responsible for phosphorylation of eIF2α in response to hypoxia. Interestingly, 
using PERK -/- cells maintained for 24 h in stringent hypoxic conditions (0.05 % O2), they 
have also showed that PERK activation is very important in survival of the cells in hypoxic 
conditions, a decreased viability of PERK the deficient cells being observed compared to the 
control. In agreement with their results and previously described effects of PERK induction, 
the authors formulated the hypothesis that PERK protection in hypoxia is based on the 
transcriptional arrest induced by eIF2α phosphorylation, helping the cell to minimize the 
energetic needs and use the resources left for the basic functions that can ensure survival. 
They also suggest that extended hypoxia becomes negative towards the cell homeostasis 
either directly via induction of HIF-1α and expression of proinflammatory genes [490, 495, 
504] or indirectly via prolonged translational arrest. The indirect effects include induction 
of NFκB due to degradation of IκB inhibitor as a results of the short half-life of the protein 
[27] and alteration of adipokines expression[277]. Although the proposed mechanism could 
explain some of the protective effects of PERK induction, it does not seem to correlate with 
induction time frame of eIF2α phosphorylation and HIF-1α observed in my experiments. 
Though eIF2α phosphorylation was detected within 2 h of hypoxia, absence of CHOP 
induction after 8 h of hypoxia in my experiments or the late induction of CHOP protein 
observed by [503] suggest that the PERK-mediated signaling is not rapid. Also, if HIF-1α 
accumulation is detrimental to the cell then the observed increase in HIF-1α protein and 
mRNA levels starting 2 h exposure to hypoxia would induce detrimental effects before 
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PERK induction can exert the protective effects. This suggests that although both studies 
show PERK induction by hypoxia, the role and kinetics of PERK activation may differ due 
to cell-specific mechanisms or different type of hypoxia induction used. Future experiments 
using longer exposure of adipocytes to hypoxic conditions and different type of hypoxia 
(chemically induced or low O2 conditions) may provide a better insight in the kinetics of ER 
induction in adipocytes and the role of different UPR components in the cellular response to 
hypoxia. Another important aspect that could be investigated in future experiments is the 
role of hypoxia-induced ER stress in angiogenesis induction. Previous observations have 
shown that ER stress induces expression of pro-angiogenic VEGFA factor via PERK-ATF4 
and IRE1α-XBP1 induction in cancer cells exposed to low O2 conditions [31,32]. HIF-1α 
has been also shown to induce VEGFA expression in adipocytes [505] and cancer cells [506]. 
Taken together, these observations could suggest that the ER stress induced by hypoxia may 
play an important role in stimulation of angiogenesis together with HIF-1α independent 
effects. 
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CHAPTER 9 
 
DISCUSSION 
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The data presented in this thesis provides an insight into the role of several obesity-related 
factors in ER stress induction in murine adipocytes. Although some of the investigated 
factors have been previously shown to be correlated with insulin resistance, inflammation 
and lipotoxicity, few data are available about the role that they play in ER stress induction.  
My work provides some evidence that glucose starvation and hypoxia resulted from the 
adipose tissue remodelling in obesity, but not palmitate, cholesterol or several 
proinflammatory cytokines (TNFα, IL-6 and IL-1β) induce ER stress in two in vitro 
adipocyte models, 3T3-F442A and 3T3-L1.  
Two murine 3T3 preadipocyte cell lines, 3T3-F442A and 3T3-L1 were chosen as model for 
in vitro differentiation of adipocytes. The choice of the cell lines was made according to the 
few advantages provided: (1) the cells are known to be committed to the adipogenic lineage 
and undergo differentiation into adipocytes under established adipogenic stimulation [283, 
287], (2) the cell cultures presents continuous replication capacity compared to the primary 
cells [282] and (3) the cell lines are well characterised and present less heterogeneity than 
the primary cultures providing a more accurate observation of the cellular responses [287]. 
Evidence for the in vitro differentiation of the two cell lines were presented in Chapter 3 
showing a 70-80 % differentiation of the cultures 12 d after the adipogenic induction. 
In chapter 4, I have shown that palmitate does not induce ER stress or impair insulin 
signalling in adipocytes. Although the effects of palmitate on insulin signalling have been 
previously investigated [334], this is the first study to show that the saturated fatty acid 
palmitic acid does not induce ER stress in in vitro differentiated adipocytes. Considering that 
palmitate induces UPR in preadipocytes as I have also shown, my results suggest the 
existence of an adipocyte-specific mechanism(s) that protects the cell against fatty acid 
induced-ER stress. Therefore, I have hypothesised and investigated two possible 
mechanisms: (1) alteration of mRNA basal levels of ER stress components PERK and IRE1α 
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in adipocytes vs preadipocytes and (2) up-regulation of gene expression for enzymes 
involved in FA and TAG metabolism during the differentiation process due adipocyte 
specialisation in lipid storage. The mRNA expression for the two ER stress sensor proteins 
IRE α and PERK was found to be similar in preadipocytes and adipocytes for the 3T3-L1 
cell line suggesting that increased basal activity of ER stress signalling pathways is not the 
mechanism protecting the cells against palmitate-induced ER stress. In 3T3-F442A, due to 
possible technical errors, PERK basal levels are up-regulated in adipocytes vs preadipocytes 
whereas IRE1α levels were decreased after differentiation.  
The observed up-regulation of genes encoding for enzymes involved in FA metabolism and 
TAG synthesis was in accordance with literature data showing induction of lipid metabolism 
enzymes during adipocytes differentiation [297, 507] and supported the  protection 
mechanism hypothesised. Increased levels of stearoyl-CoA desaturase observed could also 
explain, in accordance with the proposed mechanism, the ability of the cell to avoid saturated 
fatty acid lipotoxicity and dispose the excess palmitate in the triacylglycerol pools. Data 
provided in Chapter 5 shows that cholesterol does not induce ER stress in the two in vitro 
differentiated adipocyte cell lines. The results obtained could be linked to the protection 
mechanism formulated in the previous chapter as the expansion of the triacylglycerol pool 
would also affect the storage capacity for cholesterol, more than a third of the total 
cholesterol in the adipocyte cell being stored in the lipid droplets [411] Therefore, 
cholesterol storage and utilisation in lipid droplet formation may explain why high 
concentrations of cholesterol do not induce ER stress in adipocytes.  
Proinflammatory cytokines TNFα, IL-6 and IL-1β were also shown to be unable to induce 
ER stress in my model of adipocytes (Chapter 6). Though few other studies proposed 
possible mechanisms for TNFα induction of ER stress, my data did not found any evidence 
to support proposed the role of TNFα in UPR induction. The role of IL-6 and IL-1β in ER 
School of Biological and Biomedical Sciences Chapter 9 
 
199 
 
stress induction in adipocytes was not studied before, my data showing for the first time that 
the two proinflammatory cytokines do not induce UPR in in vitro differentiated adipocytes, 
Chapter 7 and 8 have addressed the obese adipose tissue remodelling process-induces 
factors: the low nutrient and oxygen supply. My results showed that both glucose starvation 
and hypoxia are inducing ER stress activation in in vitro differentiated adipocytes and could 
contribute to cellular dysfunction and inflammation. Also, due to large overlap of the known 
effects of hypoxia and ER stress on the adipose tissue, including inflammation [251, 278, 
509], insulin resistance [207, 510], my results suggest that ER stress may contribute to or 
mediate the effects of hypoxia on adipocytes.  
My conclusions differ from the ones drawn in other studies, which suggest that free fatty 
acids [266, 340, 511], cholesterol [391] and TNF α [352] induce ER stress in in vitro 
differentiated adipocytes. Kawasaki et al. [266] reported induction of XBP1 mRNA splicing, 
ATF4, BiP, CHOP, EDEM, ERDJ4, and PDI mRNA in 3T3-L1 adipocytes in response to 
50 μg/ml of a free fatty acid mixture derived from human serum. Although the composition 
of the fatty acid mixture used in the study is unknown, palmitic acid should be one the 
components as it was previously shown to be the most abundant SFA in human serum 
composition. Also, palmitic acid is considered to be the SFA with the highest potential for 
cell injury as palmitate-CoA represent a poor substrate for DGAT enzyme [512] contributing 
to accumulation of potential toxic ceramide. High concentrations of palmitate were shown 
to also induce synthesis of 1,2-dipalmitate-phosphatidilglycerol, a cardiolipin precursor that 
inhibits the cardiolipin synthase activity and can induce apoptosis [513]. But, if their mixture 
contains palmitic acid, the FA was shown to only elicit ER stress, insulin resistance or cell 
injury at much higher concentrations in different cell lines [268, 316, 514], and my results 
did not show any induction of ER stress markers in 3T3-F442A or 3T3-L1 adipocytes in 
response to concentrations up to 20 times higher than the ones used in their study. Therefore, 
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I consider that compounds other than the saturated fatty acids present in the fatty acid 
mixture used by Kawasaki et al [266] may cause the ER stress in adipocytes described by 
the group. Jiao et al [342] reported that a mixture of lauric, myristic, oleic, linoleic and 
arachidonic acids induces ER stress and potently inhibits insulin-stimulated AKT serine 473 
and threonine 308 phosphorylation in in vitro differentiated 3T3-L1 adipocytes. These 
results contradict not only my observations but also several other papers which have reported 
that the unsaturated fatty acids oleic and linoleic acid protect cells from the negative effects 
of saturated fatty acids [345, 346, 348] and that the medium-chain fatty acids lauric and 
myristic acid do not induce insulin resistance [334]. The explanation could reside in the 
concentration of the arachidonic acid present in the used mixture, as the polyunsaturated FA 
was shown to be able to induce Ca2+ release from the ER and induce ER stress [350, 351].  
Chen et al [391] reported that oxLDL induces BiP and CHOP in 3T3-L1 adipocytes and 
suggested that intracellular cholesterol overload may be partially responsible for this ER 
stress response. Though both AcLDL and oxLDL are taken up by adipocytes via the 
scavenger receptor A [399], the oxidised components of oxLDL have been previously shown 
to induce enhanced degradation [393] and inflammation [397]. As I have not observed 
induction of XBP1 splicing in 3T3-F442A or 3T3-L1 adipocytes exposed to AcLDL I 
concluded that an oxidized lipid or protein component of oxLDL [515], but not cholesterol 
was responsible for the ER stress induction described by the group.  
Koh et al.[352] and Jeon et al.[340] have reported that TNF-α and palmitate elevate 
phosphorylation of eIF2α, induce ATF3 mRNA and activate JNK in 3T3-L1 adipocytes and, 
on the basis of these changes, concluded that TNF-α and palmitate cause ER stress in 
adipocytes. eIF2α phosphorylation and the increase in ATF3 mRNA downstream of eIF2α 
phosphorylation are controlled by four protein kinases [353] of which only PERK directly 
responds to ER stress [516]. JNK is activated by many stresses [192]. As my data show 
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absence of XBP1 splicing that is a more specific marker for ER stress, I concluded that other 
stresses are responsible for the increase in the stress markers monitored by the two studies. 
 
In conclusion, some of my work shows that glucose and oxygen deprivation rather than 
elevated saturated fatty acids, cholesterol or proinflammatory cytokines (TNFα, IL-6 and IL-
1β) levels cause ER stress in adipocytes in vitro,  suggesting that the adipose tissue 
remodelling in obesity may play a more central role in adipocyte dysfunction then initially 
believed. My observations open new perspectives in understanding the factors inducing 
adipocyte dysfunction in obesity and their role and succession in the pathological progress 
of the disease.  If the reduced blood supply will be identified as one of the first ER stress 
inducers in the overloaded adipocytes, then increased vascularisation of the obese adipose 
tissue may alleviate the ER stress effects on adipocytes. Future experiments investigating 
hypoxia, glucose starvation and ER stress markers co-localisation (e.g. via 
immunofluorescence) in animal models of obesity could provide evidence of in vivo ER 
stress induction in response to the two proposed factors. Assessment of ER stress induction 
in obese adipose tissue exhibiting genetically or chemically induced angiogenesis could 
provide more insight in the role of imbalanced expansion of the tissue in obesity.  
My data and the hypothesis of adipocyte-specific mechanism of protection against saturated 
fatty acid and cholesterol lipotoxicity also set the premises for future studies that could 
provide more evidence to support the hypotheses proposed. Genetic approaches using 
knockdown or over-expression of the genes for enzymes involved in the FA metabolism 
could be used to indicate the role of these enzymes in the adipocyte protection against FA-
injury. Experiments using fluorescent conjugated palmitate or fluorescent fatty acids analogs 
(e.g. BODIPY-conjugated palmitate, BODIPY fatty acid analogs) [517, 518] could allow 
intracellular tracing of the fatty acid and establish if the excess FA is indeed metabolised and 
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stored in the triacylglycerol pool as hypothesised. Similar methodology using fluorescent or 
radiolabeled cholesterol [519] could be used to investigate the intracellular trafficking and 
localisation of up-taken excess cholesterol in adipocytes. Genetic approaches using ACAT1 
shRNA could also elucidate the role of the enzyme in the cholesterol loading-induced 
lipotoxicity.  
All these approaches will provide a better insight into the mechanisms that underlie the ER 
stress induction in adipocytes and the role that the UPR activation plays in cellular 
dysfunction in obesity. Identifying the obesity-related factors that induce ER stress and 
promote the pathological progress of the disease could provide new prevention strategies 
and help to formulate more targeted therapeutic approaches of the disease. 
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